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 ABSTRACT 
 
Tissue Engineering Approaches for Studying the Effect of Biochemical and 
Physiological Stimuli on Cell Behavior. (August 2012) 
Andrea Carolina Jimenez Vergara, B.S., Universidad Industrial de Santander 
Chair of Advisory Committee: Dr. Mariah Hahn 
 
Tissue engineering (TE) approaches have emerged as an alternative to traditional 
tissue and organ replacements. The aim of this work was to contribute to the 
understanding of the effects of cell-material and endothelial cell (EC) paracrine signaling 
on cell responses using poly(ethylene glycol) diacrylate (PEGDA) hydrogels as a 
material platform. Three TE applications were explored. First, the effect of 
glycosaminoglycan (GAG) identity was evaluated for vocal fold restoration. Second, the 
influence of GAG identity was explored and a novel approach for stable 
endothelialization was developed for vascular graft applications. Finally, EC paracrine 
signaling in the presence of cyclic stretch, and hydrophobicity and inorganic content 
were studied for osteogenic applications. 
In terms of vocal fold restoration, it was found that vocal fold fibroblast (VFF) 
phenotype and extracellular matrix (ECM) production were impacted by GAG identity. 
VFF phenotype was preserved in long-term cultured hydrogels containing high 
molecular weight hyaluronan (HAHMW). Furthermore, collagen I deposition, fibronectin 
production and smooth muscle α-actin (SM-α-actin) expression in PEG–HA, PEG– 
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chondroitin sulfate C and PEG– heparan sulfate (HS) gels suggest that CSC and HS may 
be undesirable for vocal fold implants.  
Regarding vascular graft applications, the impact of GAG identity on smooth 
muscle cell (SMC) foam cell formation was explored. Results support the increasing 
body of literature that suggests a critical role for dermatan sulfate (DS)-bearing 
proteoglycans in early atherosclerosis. In addition, an approach for fabricating bi-layered 
tissue engineering vascular grafts (TEVGs) with stable endothelialization was validated 
using PEGDA as an intercellular ‘‘cementing’’ agent between adjacent endothelial cells 
(ECs). 
Finally, mesenchymal stem cell (MSC) differentiation toward osteogenic like 
cells was evaluated. ECM and cell phenotypic data showed that elevated scaffold 
inorganic content and hydrophobicity were indeed correlated with increased osteogenic 
differentiation. Moreover, the present results suggest that EC paracrine signaling 
enhances MSC osteogenesis in the presence of cyclic stretch. 
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CHAPTER I 
INTRODUCTION AND 
LITERATURE REVIEW 
 
 
1.1. Problem Statement 
 
Annually tissue damage or loss and organ failure related diseases affect millions of 
people around the world. These health problems are commonly treated by tissue and 
organ transplantation from a donor. However, these treatments have limitations such as 
availability and immune response. Based on the high demand for suitable tissue and 
organ donors, research efforts have focused on alternative treatments that promote fast 
body healing or devices that mimic tissue function. 
Tissue engineering approaches have emerged as an alternative to traditional 
tissue and organ replacements. The use of engineered materials capable of closely 
mimicking the cell microenvironment opens a vast number of possibilities to address the 
need for tissue replacement.  
 
 
 
 
 
_____ 
This dissertation follows the style of Acta Biomaterialia. 
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Ideal tissue engineering scaffolds should fulfill three major challenges: first, fill 
the defect caused by tissue damage; second, stimulate new tissue growth, and finally, 
have the ability to be resorbed over time and be replaced by newly formed tissue [1]. In 
order to develop a graft with such characteristics it is fundamental to understand the 
effect of scaffold properties and physiological stimuli on cell behavior. 
This work focuses on the understanding of cell material interactions with the 
systematic and controlled design of material properties and the controlled introduction of 
endothelial cell (EC) paracrine signaling and their effect on cell response for 3D tissue 
engineering applications: vocal fold restoration, small diameter vascular graft, and bone 
regeneration. Cell responses were analyzed at the biochemical, histological and 
microstructural levels. The specific aims and rationale for this work were: 
 Verify the ability of vocal fold fibroblasts (VFFs) to respond consistently to 
biochemical stimuli despite the abnormal cell shapes imposed by poly (ethylene 
glycol) diacrylate (PEGDA) hydrogels. Rationale: PEGDA hydrogels have been 
examined as VFF regeneration scaffolds due to their injectability and tunable 
viscoelastic properties [2-6]. However, a limitation of PEGDA scaffolds is that they 
force cells to take on round morphology, whereas VFFs are natively elongated. Thus, 
to further evaluate the potential utility of PEGDA hydrogels as vocal fold 
regeneration scaffolds, the ability of VFFs encapsulated in PEGDA hydrogels to 
respond appropriately (i.e. as if elongated) to scaffold biochemical stimuli was 
examined. Since hyaluronan (HA) based hydrogels have been extensively studied as 
VF regeneration scaffolds [4, 7, 8], PEGDA-HA hybrid hydrogels were examined so 
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as to permit direct comparison with previous studies involving scaffolds permissive 
of cell elongation. Alterations in VFF phenotype were examined by evaluating the 
relative expression of collagen III versus collagen I (with a higher collagen 
III:collagen I ratio being desirable), elastin expression (with lower levels of elastin 
being desirable), and SM-α-actin expression (with lower levels of this myofibroblast 
marker being desirable). 
 Evaluate the effects of chondroitin sulfate C (CSC) and heparin sulfate (HS) 
incorporation on the mechanical response of PEG gels and VFF behavior relative to 
HA. Rationale: PEG-based hydrogels have recently begun to be examined as vocal 
fold augmentation substances [9-14], due to their tailorable mechanical properties 
and resistance to fibroblast-mediated contraction. However, pure PEG hydrogels lack 
intrinsic biochemical signals to guide cell behavior and generally fail to mimic the 
frequency- dependent viscoelastic response critical to normal superficial lamina 
propia (SLP) function [10-12, 14, 15]. Recent results suggest that conjugating 
viscoelastic bioactive substances, such as GAGs, into PEG networks may allow these 
hydrogels to more closely approach the mechanical responses of normal SLP while 
stimulating desired VFF behaviors [10, 16]. GAGs are a family of charged 
polysaccharides which play key roles in inflammation, cell migration, and cell 
phenotype modulation [19] and which include unsulfated forms (e.g. HA) as well as 
sulfated forms (e.g. HS, CSC). While a number of vocal fold studies have examined 
the impact of HA on implant mechanics and/or fibroblast behavior [10, 11, 13, 16-
19], the influence of sulfated GAGs has been relatively unexplored. CSC and HS 
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were selected for investigation over other sulfated GAGs for several reasons 
including recent quantitative measures which suggest that expression of CSC, rather 
than dermatan sulfate (DS), is substantially decreased in scarred lamina propria [20]. 
In addition, a separate study has shown that levels of specific HS proteoglycans are 
altered in scarred lamina propria [21]. 
 Investigate the regulation of smooth muscle cell (SMC) foam cell formation by 
glycosaminoglycan identity within a hydrogel environment mimetic of early 
atherosclerosis. Rationale: Recently, it has been recognized that the early 
accumulation of lipids associated with atherosclerosis arises primarily from 
enhanced lipoprotein retention by the ECM of the arterial intima [22-24]. In 
particular, studies suggest that proteoglycans (PGs) play a key role in the enhanced 
retention of low density lipoproteins (LDL) [25, 26]. For example, versican has been 
shown to have high affinity for apolipoprotein B (apoB) and decorin has been related 
to LDL binding [27].  Recent studies indicate that the ionic interactions between the 
negatively charged GAG side-chains of these PGs and the positively charged 
apolipoprotein residues of LDL are critical to early atherosclerotic lipid retention 
[25-27]. Although it is recognized that GAG retention of lipoproteins is a key event 
in SMC foam cell formation [22], the extent to which specific GAG types contribute 
to this process is relatively poorly understood.  This study has been designed to 
compare the effects of CSC, DS, and HS side chains on SMC foam cell formation. 
 Validate an approach for generating a thin, mechanically stable EC layer in the 
lumen of PEG hydrogel-based tissue engineered vascular grafts (TEVGs). Rationale: 
5 
 
Achieving endothelialization of PEG-based hydrogels that is stable under 
physiological loading conditions is challenging, and engineered EC layers frequently 
delaminate upon exposure to high shear pulsatile flow [28, 29]. A range of methods 
have been employed to enhance stable vascular graft endothelialization, including 
specialized EC seeding methods [29] and luminal coatings [30]. However, only 
moderate long-term success has been attained with these approaches. In the present 
study, an approach which utilizes PEGDA as an intercellular “cementing” agent 
rather than as an encapsulating agent is developed. 
 Examine the effects of simultaneous increases in scaffold hydrophobicity and 
inorganic content on mesenchymal stem cell (MSC) osteogenic fate decisions in a 
3D culture environment. Rationale: A number of studies have shown that the 
addition of inorganic components to organic scaffolds can enhance both their 
osteoconductivity and osteoinductivity [31-33]. These inorganic additives have 
included not only hydroxyapatite, but also a range of silicon-containing compounds, 
such as silica, silane, and siloxane [33-36]. In addition, scaffold hydrophobicity has 
been demonstrated to influence osteogenic differentiation [37-39]. However, the 
combined effects of scaffold inorganic content and hydrophobicity have not been 
systematically explored. Furthermore, most of the aforementioned studies were 
performed in two-dimensional (2D) culture, and, thus, may not be indicative of the 
effects of the same scaffold variables in more biomimetic, three-dimensional (3D) 
culture systems. The aim of the present study was therefore to examine the impact of 
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simultaneous increases in scaffold hydrophobicity and inorganic content on MSC 
osteogenic lineage progression in a 3D culture environment. 
 Examine the effect of EC paracrine signaling on osteogenesis in the context of 
scaffolds with “osteogenic” moduli and in the presence of mechanical stimulation. 
Rationale: Neovascularization and mechanical stress play critical roles in 
endochondral ossification, a key bone formation mechanism during bone growth and 
fracture healing [40]. Indeed, in endochondral ossification, blood vessels invade 
hyaline cartilage, and MSCs associated with invading vessels differentiate into 
osteoblasts which begin depositing bone matrix [40]. In addition, physiological 
loading during endochondral ossification enhances the rate and quality of bone 
matrix deposition [41, 42]. Consistent with the endochondral ossification process, 
studies have shown MSC osteogenic differentiation to be separately influenced by 
cyclic loading [43, 44] and EC presence [45-47]. However, potential synergistic 
interactions between mechanical stimulation and EC presence on MSC osteogenesis 
remain to be elucidated. The goal of the present study is to examine the effects of EC 
paracrine signaling on MSC osteogenesis in the presence of physiological loading. 
These goals are designed to elucidate the relevance of scaffold properties and EC 
paracrine signaling on cell behavior and tissue regeneration. This work represents a 
novel strategy for the tuning and optimization of scaffold properties and physiological 
stimuli for tissue engineering applications in 3D contexts, which was accomplished by 
the use of PEG hybrid hydrogels as a material platform. Understanding the relative 
impact of each individual stimulus on cell response allows the design of more efficient 
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scaffolds by narrowing down the number of variables and range of stimuli needed for a 
specific application.  In addition, it is important understand not only the effect of each 
individual factor, but also the combined effect of these factors on cell behavior 
particularly on MSC differentiation. 
 
1.2. Background  
 
Tissue regeneration is a complex process that is regulated by local 
microenvironment. This specific microenvironment involves different factors such as 
ECM and EC paracrine signaling that guide cell fate. 
ECM is the material that surrounds the cells which is responsible for tissue 
mechanical support, organization and cell behavior [48]. ECM is mostly composed of 
proteins such as collagen and elastin and polysaccharides such as hyaluronic acid and 
glycosaminoglycans. ECM plays a role in regulating water content, selecting and 
retaining different growth factors as well as interacting with the cells through cell 
receptors. 
Research efforts have focused on engineering scaffolds that mimic the ECM 
microenvironment using biomaterials. Scaffold properties such as chemical composition, 
surface chemistry and mechanical properties can be used to control cell adhesion, 
migration, differentiation, diffusion of nutrients and waste, and matrix composition. A 
variety of materials have been developed for controlling cell behavior such as natural 
and synthetic polymers, metals and ceramics materials. These materials have been used 
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to induce stem cell (SC) differentiation toward specific cell linage [49]. Several studies 
of natural and synthetic polymers in SC differentiation have also been reported. Natural 
materials are biocompatible and biodegradable, and provide biochemical and biophysical 
cues that influence cell behavior. Natural materials such as agarose, alginate, hyaluronic 
acid, fibrin, collagen and matrigel have been used to support SC differentiation [50]. On 
the other hand, despite the fact that synthetic materials lack the biochemical cues present 
in natural materials, they offer a great deal of controllability and potential for the 
understanding of SC behavior. Synthetic materials are easy to control, consistent across 
batches, have good mechanical properties, and the desired biochemical stimuli can be 
incorporated as a design parameter. One of the most widely used synthetic biomaterials 
for the study of cell behavior are polymers. Mechanical properties, chemical 
composition and specific degradation rate of these biomaterials can be controlled [51]. In 
addition, they have high purity and reproducibility Poly(ethylene glycol) (PEG), 
poly(vinyl alcohol) (PVA), poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) 
(PLGA), poly(hydroxyl ethyl methacrylate) (PHEMA), and poly(anhydride) are the most 
common synthetic polymers used in tissue engineering applications [50]. 
PEG is a synthetic polymer with high hydrophilicity, biocompatibility, and 
resistance to protein absorption, and it is considered to behave as a biological blank 
slate. A commonly used form of PEG hydrogels involves vinyl chemistry in order to 
create a 3D environment by crosslinking under UV exposure. A brief description of PEG 
modification end vinyl groups as well as an idealized PEG network is presented in Fig. 
1. PEG based hydrogel platforms can be used to understand the isolated effect of 
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material properties such as mesh size, mechanical properties, biochemical and EC 
paracrine signaling interactions on cell behavior. 
 
 
  
 
 
 
 
 
 
 
Fig.  1. (A) Schematic representation of PEGDA synthesis and (B) idealized 3D network [52]. 
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An additional advantage of PEG-based hydrogels is that the “blank state” feature 
of PEGDA can be modified with the addition of biomolecules, peptides, small functional 
groups and other polymers. These modifications could change hydrogel chemical 
functionality and hydrophobicity/hydrophilicity which have shown to play a role in cell 
adhesion, function and differentiation [53]. 
Additional studies have focused on EC paracrine signaling which seem to play an 
important role in organ formation, especially on MSC differentiation. Several research 
works have been directed to evaluate the role of these interactions on MSCs fate 
commitment [54]. For instant, MSCs direct contact with other cell types has 
demonstrated to have an influence in MSC behavior [55]. Furthermore, it has been 
shown that EC express several factors such as BMP-2 [45] and VEGF [56] in contact 
with MSCs, which could induce osteogenic differentiation [57].   
 
 
 
 
 
 
 
 
 
 
 
 
 
11 
 
CHAPTER II 
PROBING VOCAL FOLD FIBROBLAST RESPONSE TO 
HYALURONAN IN 3D CONTEXTS* 
 
 
2.1. Overview 
 
A number of treatments are being investigated for VF scar, including designer 
implants. The aim of the present study was to validate a 3D model system for probing 
the effects of various bioactive moieties on VFF behavior toward rational implant 
design. We selected PEGDA hydrogels as our base-scaffold due to their broadly tunable 
material properties. However, since cells encapsulated in PEGDA hydrogels are 
generally forced to take on rounded/ stellate morphologies, validation of PEGDA gels as 
a 3D VFF model system required that the present work directly parallel previous studies 
involving more permissive scaffolds. We therefore chose to focus on HA, a 
polysaccharide that has been a particular focus of the VF community.  
 
 
 
 
 
 
_____ 
*Reprinted with permission from “Probing vocal fold fibroblast response to hyaluronan using PEG-based 
hydrogels” by Dany J. Munoz-Pinto, Andrea Carolina Jimenez-Vergara, L. Marcela Gelves, Rebecca E. 
McMahon, Viviana Guiza-Arguello, Mariah S. Hahn, 2008, Biotechnology and bioengineering (2009) 
821-31, Copyright 2009, Wiley Periodicals, Inc. 
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Toward this end, porcine VFFs were encapsulated in PEGDA hydrogels 
containing consistent levels of high Mw HA (HAHMW), intermediate Mw HA (HAIMW), or 
the control polysaccharide, alginate, and cultured for 7 and 21 days.  
HAHMW promoted sustained increases in active ERK1/2 relative to HAIMW. 
Furthermore, VFFs in HAIMW gels displayed a more myofibroblast-like phenotype, 
higher elastin production, and greater protein kinase C (PkC) levels at day 21 than VFFs 
in HAHMW and alginate gels.  
The present results are in agreement with a previous 3D study of VFF responses 
to HAIMW relative to alginate in collagen-based scaffolds permissive of cell elongation, 
indicating that PEGDA hydrogels may serve as an effective 3D model system for 
probing at least certain aspects of VFF behavior. 
 
2.2. Introduction  
 
Voice disorders resulting from scarring of the VF lamina propria (LP) affect 
millions in the US alone and can significantly impact quality of life [58]. VF scar has 
proven difficult to treat with current surgical techniques and standard augmentation 
substances, such as collagen and fat [59-61]. Researchers are actively exploring 
alternative treatment routes, including the development of designer implants for 
functional LP regeneration [2, 4, 6, 62].  
HA has been a particular focus as a component of these designer implants due to 
its role in wound healing and in VF mechanical properties [3, 4, 6]. Although several in 
13 
 
vivo studies suggest HA to be a promising material for VF regeneration [4, 7, 8], to 
rationally improve the design and formulation of these HA-based implants requires a 
deeper understanding of the impact of HA on VFF ECM production and phenotype. 
A number of studies have examined cellular response to HA in 2D scenarios [63-
66]. However, evaluating the specific influence of HA in more physiolo-gically relevant 
3D contexts has proven challenging due to the additional, often interdependent, matrix 
variables introduced in 3D. To understand this, examine a recent study in which 
mesenchymal stem cells encapsulated within collagen beads displayed an increased 
tendency to differentiate into chondrocytes as collagen density increased [67]. Whether 
this increased chondrocytic potential was due primarily to the increased spatial density 
of bioactivity (collagen) or to the increased matrix stiffness associated with heightened 
collagen concentration is unclear. Being able to make such distinctions is important 
since both scaffold modulus [68] and bioactivity [69] have been shown to exert profound 
effects on cell behavior in 2D.  
To begin to uncouple the effects of various stimuli on VFF behavior in 3D 
requires a scaffold whose material properties can be more tightly controlled. Hydrogels 
prepared from PEGDA are intrinsically resistant to cell attachment and spreading [70]. 
This biological ‘‘blank slate’’ character of PEGDA hydrogels permits the controlled 
introduction of desired bioactivity and examination of its effects on cell behavior [71]. 
Furthermore, the initial bulk average mesh size and modulus of  PEGDA hydrogels can 
be tuned in an uncoupled manner by simultaneously varying both the molecular weight 
(Mw) and/or concentration of  PEGDA [72].  PEGDA gels have been widely employed 
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in cartilage tissue engineering due to their tailorable material properties [73-75]. 
However, they are rarely used for encapsulation of natively elongated cells, such as 
fibroblasts, due to the fact that encapsulated cells are generally forced to take on 
rounded/stellate morphologies. Thus, validation of PEGDA gels as a 3D VFF model 
system requires that the present study be performed so as to permit direct comparison 
with previous studies involving scaffolds permissive of cell elongation.  
We therefore designed the current work to be a direct analog of a previous 3D 
study of the influence of HA on VFF behavior by Hahn et al.[76]. In that work, porcine 
VFF responses to intermediate Mw HA (HAIMW, ~490 kDa) relative to the control 
polysaccharide alginate (~300– 350 kDa, 65–75% guluronate) were investigated in 
basehydrogels of collagen type I. In the present work, porcine VFFs from the same 
explant population employed in Hahn et al.[76] were encapsulated in PEGDA hydrogels 
containing high Mw HA (HAHMW, ~1.65x10
3 kDa), HAIMW (~600 kDa), or alginate 
(~300–350 kDa, 65–75% guluronate). The promiscuous integrin adhesion peptide RGDS 
[77] was used in place of collagen type I. Following 7 and 21 days of culture, VFF ECM 
production and phenotype in each formulation was assessed biochemically and 
histologically. Furthermore, the modulation of two primary signaling pathways (protein 
kinase C (PkC) and ERK) triggered by HA interactions with cell receptors, CD44 and 
RHAMM [78-80], was semi-quantitatively evaluated. 
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2.3. Material and Methods  
 
2.3.1. Polymer Synthesis and Characterization 
 
2.3.1.1. PEG-Diacrylate Synthesis  
  PEGDA was prepared as previously described [71] by combining 0.1mmol ml-1 
dry PEG (10 kDa, Sigma, St. Louis, MO), 0.4 mmol ml-1 acryloyl chloride, and 0.2 
mmol ml-1 triethylamine in anhydrous dichloromethane (DCM) and stirring under argon 
overnight. The resulting solution was washed with 2M K2CO3 and separated into 
aqueous and DCM phases to remove HCl. The DCM phase was subsequently dried with 
anhydrous MgSO4, and PEGDA was precipitated in diethyl ether, filtered, and dried 
under vacuum. The degree of acrylate functionalization was determined by 1H-NMR to 
be 70%.  
 
2.3.1.2.  Synthesis of Acrylate-Derivatized  
Cell Adhesion Peptide Cell adhesion peptide RGDS (American Peptide, 
Sunnyvale, CA) was reacted with acryloyl-PEG-N-hydroxysuccinimide (ACRL-PEG-
NHS, 3.4 kDa, Nektar, San Carlos, CA) at a 1:1 molar ratio for 2 h in 50mM sodium 
bicarbonate buffer, pH 8.5 [71]. The product (ACRLPEG- RGDS) was purified by 
dialysis, lyophilized, and stored at -20°C until use. 
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2.3.1.3. Synthesis of Methacrylate-Derivatized High Molecular Weight HA and 
Alginate 
 Methacrylate-derivatized high Mw HA (HAHMW-MA) and methacrylate-
derivatized alginate (alginate-MA) were prepared according to standard methodologies 
[81]. HA (Streptococcus equi, Mw 1.65 x 10
3 kDa, Fluka) or alginate (Laminaria 
hyperborea, 300–350 kDa, 65–75% guluronate, FMC BioPolymer Philadelphia, PA) was 
dissolved at 1-wt% in dIH2O and the pH of the resulting solution was adjusted to 8.0 
using NaOH. A 10-fold molar excess of methacrylic anhydride (Polysciences, 
Warrington, PA) was added per disaccharide unit. Each reaction was allowed to proceed 
under constant stirring at 4°C, with the solution pH being maintained at 8.0 by periodic 
addition of 5M NaOH. The product of each reaction was precipitated twice into chilled 
ethanol 95%, dialyzed against dIH2O for 48 h, and lyophilized. The extent of 
methacrylatederivatization of both HA and alginate was characterized by 1H-NMR to be 
3.2%. 
 
2.3.1.4. Synthesis of Methacrylate-Derivatized  
Intermediate Molecular Weight HA HAHMW-MA was dissolved at 1 mg ml
-1 in 
PBS containing 0.05% sodium azide and 5 U ml-1 hyaluronidase IV-S (H3884, Sigma). 
Following incubation at 37°C for 12 h, the enzyme was heat-inactivated. The digestion 
time and conditions were selected to yield a mean HA product size consistent with the 
HA Mw used in Hahn et al.[76]. The resulting digestion product (HAIMW-MA) was 
dialyzed against dIH2O for 48 h and lyophilized. The Mw of the isolated HAIMW-MA was 
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determined to be ~600 kDa using gel permeation chromatography (Viscotek, Houston, 
TX).  
 
2.3.1.5. Assessment of Alginate as a Control and of HA-MA Activity  
The ability of alginate and HAHMW-MA to interact with HA link protein (HABP) 
was evaluated relative to HAHMW using an HA competitive ELISA assay (Echelon 
Biosciences, Salt Lake City, UT).  
 
2.3.2. Cell Culture  
 
Cryopreserved porcine VFFs at passage 3 from the same VFF explant culture 
employed in Hahn et al. [76] were obtained from Robert Langer, ScD (Massachusetts 
Institute of Technology (MIT), Cambridge, MA). These cells had been isolated from the 
mid-membranous LP of 6- to 12-month-old pigs, a common animal model for the human 
VF LP [82]. The discarded animal tissue was obtained via the MIT Division of 
Comparative Medicine and with the approval and according to the guidelines of the MIT 
animal care committee. The cryopreserved VFFs were thawed and expanded at 37°C/5% 
CO2 in Dulbecco’s Modified Eagle’s Media (DMEM, Hyclone, Logan, UT) 
supplemented with 10% fetal bovine serum (FBS), 2 ng ml-1  bFGF, 100 mU ml-1  
penicillin, and 100 mg l-1  streptomycin (Hyclone).  
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2.3.3. Cell Encapsulation and Hydrogel  
 
Maintenance Hydrogels were fabricated by preparing precursor solutions 
containing 100 mg -1 ml (10 wt%) PEGDA, 5 mg ml-1 of methacrylate-derivatized 
polysaccharide (HAHMW-MA, HAIMW-MA, or alginate-MA), and 1 mmol ml
-1 
ACRLPEG- RGDS in HEPES buffered saline (HBS; 10mMHEPES, 150mM NaCl, pH 
7.4). The concentrations of HA and alginate were selected to be consistent with Hahn et 
al. [76]. A 10-wt% 10 kDa PEGDA hydrogel was chosen for the base-scaffold due to a 
previous study of VFF responses to PEGDA gels [12]. In addition, the 100:5 weight 
ratio of PEGDA to polysaccharide was selected so that the degradation rate, modulus, 
and initial mesh structure of each hydrogel network would be dominated by PEGDA.  
A 300 mg ml-1 solution of UV photoinitiator 2,2- dimethoxy-2-phenyl-
acetophenone in N-vinylpyrrolidone was added at 1% (v/v) to each precursor solution. 
VFFs at passages 8–9 were harvested and resuspended in the filtersterilized precursor 
solutions at ~1 x 106 cells ml-1  (the seeding density employed in Hahn et al. [76]. The 
cell suspensions were then poured into molds composed of two glass plates separated by 
1.1mm polycarbonate spacers and polymerized by 2 min exposure to longwave UV light 
(Spectroline, Westbury NY, ~6mW cm-2, 365 nm). The hydrogel slabs were transferred 
to Omnitrays (Nunc, Rochester, NY) fitted with four sterile polycarbonate bars to 
simultaneously prevent gel flotation and prevent gel contact with the tray bottom. 
Hydrogels were immersed in DMEM supplemented with 10% FBS, 100 mU ml-1 
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penicillin, and 100 mg l-1 streptomycin, and maintained at 37°C/5% CO2. Media was 
changed every 2 days.  
 
2.3.4. Hydrogel Characterization  
 
2.3.4.1.  Initial Water Uptake  
To compare the extent of initial water uptake by the various hydrogel 
formulations following polymerization, the initial weight (Wi) of each hydrogel was 
determined immediately following polymerization, after which the gels were submerged 
in media. Following 3 days of culture, the swollen weight (Ws) of each gel was 
determined. The equilibrium water uptake (S) was calculated as: S 
 s
 i
. 
 
2.3.4.2. Hydrogel Mechanical Properties and Contraction  
After 72 h swelling, three 8mmdiameter samples were cored from each hydrogel. 
The thickness of each disc was measured using a digital caliper. These thickness 
measures served both as gauge lengths for mechanical testing and as indicators of 
hydrogel degradation and/or VFF-mediated gel compaction. Following application of a 
0.01N preload, each hydrogel was subjected to cyclic unconstrained compression (~1% 
cyclic strain) at 2.5 Hz using an Instron 3342 (Instron, Norwood, MA). During 
mechanical testing, samples were immersed in silicone oil to prevent hydrogel 
dehydration. The dynamic compressive modulus of each hydrogel formulation was 
extracted from the resulting stress–strain data.  
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2.3.5. Biochemical Analyses 
 
At days 7 and 21 of culture, a series of 8mm diameter samples were collected 
from each hydrogel formulation for mechanical, biochemical, and histological analyses. 
Mechanical samples were tested as described above. Samples harvested for biochemical 
analyses were transferred to screw-cap vials, weighed, flash-frozen in liquid nitrogen, 
and stored at -80°C until time of analysis. The weight of each 8mm disc was used as a 
second indicator of gel degradation and/or compaction, since associated reductions in gel 
volume would be reflected in a mass loss. Hydrogel samples were digested for 72 h at 
37°C in 1 ml of 0.12M NaOH per 0.2 g hydrogel wet weight [83, 84]. Digest aliquots 
were then analyzed for DNA, total collagen, elastin, and sulfated GAGs content per 
established protocols.  
 
2.3.5.1. DNA Analysis  
Aliquots of the hydrolyzed samples (n = 3–6 per formulation) were neutralized 
and their DNA content determined using the Invitrogen (Carlsbad, CA) PicoGreen assay 
[84]. DNA measures were translated to cell number using a conversion factor of 6.6 pg 
DNA per cell [85]. Calf thymus DNA (Sigma) served as a standard.  
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2.3.5.2. Sulfated GAG  
Analysis GAGs production was measured using a modification of the Biocolor 
Blyscan assay (Accurate Chemical and Scientific Corp., Westbury, NY) [72]. In brief, 
40 ml of each sample digest (n = 3–4 per formulation) was neutralized, mixed with 60 
ml Blyscan dye reagent, and the absorbance at 525nm immediately measured relative to 
chondroitin sulfate B (Sigma).  
 
2.3.5.3. Collagen Analysis  
The amino acid hydroxyproline was quantified as an indirect measure of total 
collagen. In brief, aliquots (n = 3–7 per formulation) collected for collagen quantitation 
were hydrolyzed for 18 h at 110°C in 6 M HCl. Each sample was then dried on a 
Labconco Centrivap to remove HCl, resuspended in deionized water, and passed through 
a charcoal-packed centrifugal microcolumn (Nunc). The resultant samples were reacted 
with chloramine T and p-dimethylbenzaldehyde reagents [83, 84]. Sample absorbance 
was read at 550 nm relative to that of L-4-hydroxyproline (Sigma). Total collagen 
content was estimated from measured grams of hydroxyproline by dividing by 0.13.  
 
2.3.5.4. Elastin Analysis  
Elastin production was measured using direct ELISA [86]. NaOH digested 
samples (n = 4–11 per formulation) were neutralized and further digested with 0.25 M 
oxalic acid at 100 °C overnight. Oxalic acid was removed from the samples and 
exchanged for PBS using Microcon YM-3 centrifugal filters (Millipore, Billerica, MA). 
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One hundred microliters of the resulting samples were applied to a high binding 
multiwell plate for 3 h at room temperature. After blocking the plate with bovine serum 
albumin, adsorbed elastin fragments were detected by applying elastin antibody (BA-4, 
Santa Cruz Biotechnology, [SCBT], Santa Cruz, CA) followed by donkey anti-mouse 
HRP secondary antibody (SCBT) and 2,20-azino-bis(3- ethylbenzthiazoline-6-sulphonic 
acid). Absorbance was read at 410 nm, with bovine aortic elastin (Sigma) serving as a 
standard.  
 
For each assay, the standards used were subjected to the same association with 
PEGDA and polysaccharide and to the same digestion conditions as the samples. 
Resulting collagen, elastin, and GAGs levels were normalized to cell number.  
 
 
2.3.6. Histological  
 
Analyses Days 7 and 21 samples harvested for histological analyses were fixed 
in 10% formalin for 30 min, embedded in Tissue- Tek freezing media, and frozen at -
80°C. Thirty-five micrometer-thick sections were cut using a cryomicrotome. All 
immunostaining steps took place at room temperature unless otherwise noted.  
 
2.3.6.1. ECM and Cell Phenotype  
Analyses ECM deposition was analyzed in duplicate sections for each 
formulation using standard immunohistochemical technique. Rehydrated sections were 
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blocked with peroxidase for 10 min followed by 10 min exposure to Terminator (Biocare 
Medical, Concord, CA). Primary antibodies for elastin (BA-4, SCBT), collagen type I 
(Rockland Immunochemicals, Gilbertsville, PA), or collagen type III (Rockland 
Immunochemicals) diluted in HBS were then applied for 1 h. To identify VFFs 
displaying a myofibroblast-like phenotype, primary antibody for SM-α-actin (1A4, 
LabVision, Fremont, CA) was applied. HA cell surface receptors were also examined 
using antibodies to RHAMM (H-90, SCBT) and CD44 (F-4 SCBT). Bound primary 
antibody was detected by using AP-conjugated secondary antibody followed by 
application of the chromogen Ferangi Blue (Biocare Medical) or by using HRP-
conjugated secondary antibody followed by application of the chromogen AEC 
(LabVision).  
 
2.3.6.2. Cell Proliferation and Apoptosis and Signaling  
To identify VFFs undergoing proliferation, sections were stained for 
Proliferating Cell Nuclear Antigen (PCNA; PC10, Invitrogen) per the above staining 
procedure, except that rehydrated sections were permeabilized (10 mM HEPES, pH 6.8, 
100 mM NaCl, 3mM MgCl2, 300 mM sucrose, 0.5% Triton X-100) for 30 min prior to 
Terminator application. Apoptotic cells were identified using a Terminal 
deoxynucleotidyl transferase dUTP nick end-labeling (TUNEL) assay (Roche, 
Indianapolis, IN) per manufacturer’s protocol. Cell signaling was evaluated by staining 
permeabilized sections for PkC (C-15, SCBT) and active ERK1/2 (pERK1/2(Thr 
202/Tyr 204), SCBT).  
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2.3.6.3. Semi-Quantitative Assessments  
For intracellular markers of cell behavior (SM-α-actin, pERK1/2, PkC, PCNA, 
TUNEL), cell counts were carried out to semi-quantitatively evaluate immunostaining 
results. These assessments were conducted per established protocols [53, 87-89]. For 
each cell, i, in a given section, a staining intensity, di, was recorded on a scale of 0–3, 0 
  ‘‘no staining’’ and 3   ‘‘highest intensity among all treatment groups for that 
antibody.’’ The cumulative staining intensity, d, for a given antibody in a particular 
section was calculated using the following equation: d  
∑ di
total cell number
. 
Since deposited ECM remained localized around the parent cells in each 
hydrogel formulation, as is characteristic for PEGDA gels [73, 90, 91], the relative levels 
of collagen and elastin among hydrogel formulations were also evaluated by cell counts 
per the above procedure. Each HAHMW and HAIMW cumulative staining intensity 
assessment was normalized to the corresponding intensity assessment for alginate 
hydrogels.  
 
2.3.7. Statistical Analyses  
 
Data are reported as mean ± standard error of the mean. Comparison of sample 
means was performed by one-way ANOVA and Tukey’s post hoc test (SPSS software, 
Chicago, IL),    P < 0.05.  
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2.4. Results 
 
The present study was designed to examine the impact of HAHMW and HAIMW 
relative to alginate on VFF ECM production and phenotype. Following 7 and 21 days of 
total culture, constructs were harvested and subjected to mechanical, histological, and 
biochemical analyses. 
 
2.4.1. Alginate as a Control and HA-MA Activity  
 
We first verified that alginate was an effective control for HA and that HA-MA 
retained similar biological function as pure HA. Alginate was intended to serve as a 
‘‘scrambled’’ polysaccharide sequence which would impart similar viscoelasticity to the 
hydrogel network as HA but which would not have the associated cell-interactions. This 
is similar in concept to the use of the ‘‘scrambled’’ peptide sequence RGES as a control 
for the cell adhesion peptide RGDS [69]. Competitive ELISA results indicated that 
alginate was unable to effectively interact with HABP (Fig. 2B), despite the 
physiochemical similarities between alginate and HA (Fig. 2A). In contrast, HA-MA 
appeared to retain a similar level of affinity for HABP as unmodified HA (Fig. 2B). This 
was consistent with the work of Masters et al., which demonstrated that HA-MA and 
unmodified HA each resulted in similar valvular interstitial cell (VIC) ECM production 
at the HA methacrylation level used herein. 
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Fig. 2. (A) Structure of hyaluronan (HA) versus alginate disaccharide units. (B) Competitive ELISA 
results in which an increased absorbance signal corresponds to a decreased concentration of the test 
molecule and/or lower affinity of the test molecule for HA link protein (HABP). The ELISA results 
demonstrate that alginate does not effectively interact with HABP but that methacrylate-derivatized HA 
(HA-MA) has a similar affinity for HABP as unmodified HA. 
 
 
2.4.2. Hydrogel Material Properties  
 
The dense covalent crosslinking and chemical composition of pure PEGDA 
hydrogels result in gels that are essentially non-degradable and which permit limited 
cell-mediated remodeling [84, 90-92]. These features, although non-physiological, are 
desirable for studies focused on controlled evaluation of the impact of specific material 
properties (in the present work, bioactivity) on cell responses. To assess the degree to 
which the selected polysaccharide hydrogels retained the character of pure PEGDA 
hydrogels, the ‘‘bulk’’ material properties of each gel formulation were characterized.  
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Table 1. Hydrogel Modulus, Thickness, and Mass Assessments. 
 Modulus (kPa) Thickness (mm) Mass of 8 mm Discs (mg) 
 Day 3 Day 21 Day 3 Day 21 Day 3 Day 7 Day 21 
HAHWM 58.1 ± 0.9 54.2 ± 6.5 1.12 ± 0.03 1.08 ± 0.03 58.3 ± 1.1 59.9 ± 1.2 57.7 ± 1.1 
HAIMW 55.0 ± 5.3 49.1 ± 2.7 1.12 ± 0.03 1.13 ± 0.03 59.7 ± 1.0 60.6 ± 0.9 59.7 ± 0.9 
Alginate 60.5 ± 7.6 57.0 ± 6.1 1.12 ± 0.02 1.11 ± 0.02 58.1 ± 1.2 59.6 ± 0.8 59.1 ± 0.6 
PEGDA 51.9 ± 2.6 46.1 ± 3.3 1.12 ± 0.03 1.13 ± 0.02 58.7 ± 1.0 61.6  ±0.5 59.5 ± 0.9 
 
 
The initial water uptake, S, of each gel following polymerization was similar to 
that of a pure PEGDA gel (HAHMW: 1.37 ± 0.06, HAIMW: 1.43 ± 0.04, alginate: 1.43 ± 
0.04, pure PEGDA: 1.40 ± 0.05). Furthermore, the initial (day 3) moduli of the HAHMW, 
HAIMW, and alginate cells were statistically indistinguishable, as were the day 21 moduli 
(Table 1). Comparison of the day 7 and day 21 moduli indicated that the reduction in 
modulus for each gel with time in culture was similar to that of pure PEGDA hydrogels 
(also containing encapsulated VFFs). To evaluate the potential contribution of gel 
degradation and VFF mediated compaction on the observed temporal changes in gel 
modulus, the thickness and mass of harvested gel discs were measured with time in 
culture (Table 1). These data correspond to a negligible reduction in gel volume with 
time. Collectively, the bulk modulus, thickness, water uptake, and gel mass assessments 
indicate that the material properties of the polysaccharide-containing gels were 
dominated by the presence of PEGDA rather than by the associated polysaccharides.  
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Fig. 3. Cell density, proliferation, and apoptosis. (A) The cell density within each hydrogel at days 7 and 
21. (B) Relative levels of proliferation at days 7 and 21 based on PCNA immunostaining. (C) Relative 
levels of apoptotic cells at days 7 and 21 based on TUNEL assay results. *Significantly different from 
HAHMW hydrogels, P<0.05. 
ϛSignificantly different from HAIMW hydrogels, P < 0.05. 
 
 
2.4.3. Cell Density, Proliferation, and Apoptosis  
 
The influence of scaffold composition on VFF proliferation and apoptosis was 
assessed via PCNA and TUNEL-based immunostaining, respectively. At day 7, no 
differences in cell proliferation or apoptosis across hydrogel formulations were noted 
(Fig. 3B and C). These day 7 PCNA and TUNEL results are reflected in the day 21 DNA 
measures, which indicate that net VFF proliferation and loss was similar across hydrogel 
formulations from day 7 to day 21 (Fig. 3A). Similar levels of cell apoptosis across 
hydrogel formulations continued to be observed through day 21 (Fig. 3C). However, 
PCNA expression was significantly elevated in HAIMW hydrogels relative to HAHMW (P 
= 0.013) and alginate gels (P = 0.016, Fig. 3B). These day-21 proliferation and apoptosis 
results suggest that, if cell densities had continued to be monitored past 21 days of 
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culture, differences in cell densities across formulations would have begun to be 
detected. 
 
2.4.4. VFF ECM Deposition and Phenotype  
 
VFF ECM production showed marked variations with hydrogel bioactivity (Fig. 
4). The trends in elastin production at both days 7 and 21 indicated that elastin synthesis 
was greater in HAIMW gels than in HAHMW and alginate gels, with the differences at day 
21 being statistically significant (HAHMW, P = 0.050; alginate, P < 0.001). Although both 
days 7 and 21 data suggested an increasing trend for GAGs levels in alginate gels 
relative to both HAIMW and HAHMW hydrogels, these differences fell below statistical 
significance (Fig. 4B). Total collagen levels were significantly higher at day 7 in HAHMW 
hydrogels than in HAIMW (P < 0.001) and alginate (P = 0.03) gels. By day 21, this trend 
had shifted, with collagen levels in the alginate controls exceeding those in the HAHMW 
hydrogels (P = 0.025, Fig. 4C). In contrast, the trend of lower total collagen production 
in HAIMW hydrogels relative to alginate controls was stable from day 7 (P = 0.015) to 
day 21.  
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Fig. 4. Evaluation of VFF ECM deposition. (A) Elastin, (B) sGAG, and (C) total collagen production on 
a per cell basis at days 7 and 21. *Significantly different from HAHMW hydrogels, P<0.05. 
ϛSignificantly 
different from HAIMW hydrogels, P < 0.05. 
 
 
To gain further insight into effects of HAHMW and HAIMW on VFF ECM 
deposition, immunostaining for the two primary VF LP collagen types (collagen types I 
and III) [93] was conducted (Fig. 5A and B). Expression of both collagen type I and 
collagen type III displayed similar trends with hydrogel formulation at day 7, with 
collagen type I deposition being significantly higher in the HAHMW gel relative to HAIMW 
(P < 0.001) and alginate (P = 0.001) gels. By day 21, differences in collagen type I 
expression across hydrogels had flattened. However, collagen type III production was 
significantly higher in HAHMW hydrogels relative to alginate controls (P = 0.003). As 
expected for PEGDA gels [73], staining for collagen types I and III (Fig. 6) and elastin 
(data not shown) was confined to the immediate pericellular space in each formulation. 
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To identify VFFs displaying a myofibroblast-like phenotype, expression of SM-
α-actin was evaluated. The results for SM-α-actin were analogous to those for PCNA in 
that SM-α-actin levels were statistically indistinguishable across hydrogel formulations 
at day 7 (Fig. 5C). However, by day 21, VFFs in HAIMW gels expressed higher levels of 
SM-α-actin relative to HAHMW (P = 0.004) and alginate (P < 0.001) gels (Fig. 5D).  
 
 
 
 
Fig. 5. Assessment of VFF collagen type production, phenotype, and signaling. Relative collagen type I 
and collagen type III expression across hydrogels at (A) day 7 and (B) day 21. Relative expression of 
PKC, pERK1/2, and SM-α-actin at (C) day 7 and (D) day 21. *Significantly different from HAHMW 
hydrogels, P < 0.05. ϛSignificantly different from HAIMW hydrogels, P < 0.05. 
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2.4.5. Cellular Signaling  
 
HA interactions with cell receptors, RHAMM and CD44, [78-80] trigger two 
primary signaling pathways, PkC and ERK, which then modulate cell gene expression. 
Therefore, the relative levels of RHAMM, CD44, PkC, and active ERK1/2 (pERK1/2) 
were semi-quantitatively assessed across hydrogel formulations. CD44 staining at both 
day 7 and day 21 was weak (<4 % of cells positively stained despite several antibody 
dilutions being assayed). In contrast, RHAMM staining was prominent at both time 
points and was significantly greater in HAHMW and HAIMW gels than in alginate gels (P < 
0.03). Specifically, VFF expression of RHAMM at day 7 in HAHMW and HAIMW gels 
was 1.94 ± 0.05 and 2.89 ± 0.32 times greater, respectively, than in alginate gels. 
Relative RHAMM levels at day 21 followed a similar trend (data not shown). PkC 
expression was consistently higher in HAHMW than in alginate gels (P < 0.006) at both 
days 7 and 21 (Fig. 4C and D). In addition, day 21 PkC levels were greater in HAIMW 
hydrogels than in HAHMW gels (P = 0.038) and alginate gels (P < 0.001). Relative 
pERK1/2 levels maintained a similar trend across formulations from day 7 to day 21, 
with day 21 pERK1/2 content being significantly higher in HAHMW hydrogels relative to 
HAIMW (P = 0.029) and alginate (P = 0.013) gels.  
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Fig. 6. Representative images of day 21 HAHMW, HAIMW, and alginate hydrogel sections immunostained 
for collagen type I, collagen type III, PKC, pERK1/2, or SM-α-actin. The scale bar in the upper-left image 
equals 40 mm and applies to all images. 
 
 
2.5. Discussion 
 
The aim of the present study was to validate PEGDA hydrogels as a model 
system to probe the effects of various bioactive moieties on VFF responses in 3D toward 
rational VF LP implant design. To accomplish this objective required that the current 
study be conducted so as to permit direct comparison with previous studies involving 
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more permissive scaffolds. Therefore, we chose to focus on HA, a polysaccharide that 
has been a particular focus in VF regeneration community. In the current work, porcine 
VFFs were encapsulated in PEGDA hydrogels containing consistent levels of HAHMW 
(~1.65 x 103 kDa), HAIMW (~600 kDa), or the control polysaccharide alginate. Modulus, 
water uptake, and gel mass assessments indicate that the bulk average microstructure, 
modulus, and degradation rate of the polysaccharide- containing gels were dominated by 
PEGDA. This enabled focus on the identity of the polysaccharide as the main source of 
variation in net cell responses. Although there were certainly local differences in gel 
properties at the microscale, our ECM and cell phenotypic measures represent averages 
over the bulk, as do our material property measures. Thus, since both the material 
property and cell response measures were made at the same length scales, the data 
represent an internally consistent set from which meaningful deductions can be made.  
Regarding ECM production, VFF elastin deposition demonstrated an increasing 
trend with decreasing HA Mw by day 21 of culture. In comparing these results to 
literature, we are limited by the fact that most HA studies which permit the impact of 
HA Mw to be isolated from other experimental variables have been conducted in 2D with 
soluble, rather than matrix-bound, HA. Thus, the comparisons to follow must be 
interpreted with caution. That being said, the present results are in agreement with a 
recent 2D study of VICs by Masters et al.In that study, elastin synthesis at 20 days of 
culture was significantly higher in VICs exposed to ~400 kDa HA relative to ~800 kDa 
HA. However, a separate 2D study by Joddar and Ramamurthi [65], showed a decrease 
in vascular smooth muscle cell (SMC) elastin deposition at 21 days of culture with a 
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decrease in HA Mw from 2 x 10
3 kDa to ~200 kDa. Combined, these studies suggest that 
the influence of HA Mw on elastin synthesis may be cell-type dependent.  
Examination of VFF GAGs deposition indicated no significant alteration in 
GAGs synthesis with increasing HA Mw, consistent with the results of Masters et al. 
Although, VFF total collagen production in HAIMW hydrogels was significantly lower 
than that in HAHMW gels at day 7, their day 21 total collagen content could not be 
statistically distinguished. As with elastin, literature shows conflicting results for the 
dependence of collagen deposition on HA Mw. Masters et al. found no significant 
difference in VIC total collagen production with increasing HA Mw at 20 days of culture. 
Joddar and Ramamurthi [65], however, observed an increase in vascular SMC collagen 
synthesis with decreasing HA Mw as HA dosages approached those used herein.  
Regarding the synthesis of individual collagen types, VFF collagen type III 
deposition displayed an increasing trend with increasing HA Mw at both days 7 and 21. 
In contrast, although collagen type I expression at day 7 decreased with decreasing HA 
Mw, day 21 collagen type I levels did not vary significantly across formulations. This 
temporal alteration in collagen type I production may be linked to the corresponding 
shifts in PKC signaling with time in culture. The present collagen type III results agree 
with the effects of HA Mw on human dermal fibroblast collagen type III synthesis 
observed by David-Raoudi et al. Further comparison of the trends in collagen types I and 
III across hydrogels with that of total collagen suggests that collagen type I was the 
dominant collagen produced by the encapsulated VFFs, in each hydrogel formulation, at 
least by day 21. The ratios of the various collagen types secreted by VFFs are significant 
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because collagen type III tends to more abundant in highly elastic tissues, such as the VF 
LP [94]. Furthermore, the ratios of the various collagen types are frequently altered in 
aging and disease [94, 95].  
Cell phenotype also appeared to be modulated by HA Mw. VFFs in HAIMW 
hydrogels displayed a more proliferative phenotype at day 21 than cells in alginate or 
HAHMW gel, as indicated by PCNA staining. A similar dependence of cell proliferation 
on HA Mw has been previously observed for VICs [81] and for vascular SMCs [65]. In 
addition, VFFs in HAIMW hydrogels demonstrated increased SM-α-actin expression by 
day 21 relative to HAHMW and alginate hydrogels. The increased levels of SM-α-actin 
and PCNA at day 21 in HAIMW gels may be associated with the increased levels of PkC 
in the HAIMW gels relative to alginate gels. Indeed, PkC signaling has previously been 
shown to increase the expression of SM-α-actin in lung fibroblasts [96]. Furthermore, 
the increased myofibroblastic phenotype of cells in the HAIMW hydrogels at day 21 was 
associated with increased elastin deposition, consistent with the literature [97-101].  
Cumulatively, the present results suggest that HA Mw must be carefully selected 
to achieve desired VFF responses. However, based on the current data, the HAHMW gels 
would be the most appropriate for VF regeneration of the formulations examined. 
Specifically, the HAHMW gel resulted in an elastin and collagen type composition most 
mimetic of normal superficial LP, which contains ~40% collagen type III [93] and a 
relatively low elastin to collagen ratio[102]. Furthermore, the lower induction of a 
myofibroblastic phenotype observed in the HAHMW gels relative to HAIMW gels with 
prolonged culture is desirable for inhibition of LP scar formation [103].  
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As previously mentioned, the effects of HAIMW on VFF behavior relative to the 
control alginate have been examined in 3D using base-hydrogels of collagen type I [76]. 
However, it is difficult to extend upon that study to probe a broader HA concentration or 
Mw range due the interdependences among collagen gel bioactivity, modulus, and 
microstructure. In addition, collagen gels are prone to fibroblast-mediated contraction, 
making gel material properties difficult to control over time [76]. Although the material 
properties of PEGDA hydrogels are tunable and more readily controlled, cells 
encapsulated within PEGDA hydrogels take on rounded/stellate morphologies even in 
the presence of cell adhesion ligands such as RGDS (Fig. 6). This particular 
characteristic of PEGDA hydrogels, which results from their dense crosslinking and 
relatively slow degradation rates [84, 90-92] is not optimal for cells such as VFFs, which 
natively take on spindle-shaped morphologies. However, due to several of their unique 
properties, PEGDA hydrogels have been employed as a model scaffold by number of 
researchers focusing on fibroblast-like cells, in spite of this limitation [81, 84, 104-106]. 
To validate PEGDA hydrogels for the investigation of VFF responses to defined 
bioactivity in 3D, the day 21 setup for the present study was designed to be a direct 
analog of the previous collagen-based 3D study in which encapsulated VFFs were able 
to assume spindle-shaped morphologies [76].  
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Interestingly, each of the aspects of VFF behavior measured for HAIMW-collagen 
relative to alginate-collagen control gels displayed similar trends in the HAIMW-PEGDA 
gels relative to alginate-PEGDA gels (Table 2). Although elastin deposition was not 
measured in the alginate-collagen and HAIMW-collagen study, the relative trends in day 
21 total collagen synthesis, GAGs production, cell proliferation, and myofibroblastic 
phenotype between hydrogel formulations were maintained across the two studies [76]. 
This similarity in relative VFF response occurred despite the significant difference in 
cell morphologies in the PEG-based gels relative to the collagen gels. The good 
agreement between these two studies indicates that PEGDA hydrogels can serve as an 
effective model system for probing at least certain aspects of fibroblast-like cell 
responses to scaffold material properties despite the enforced non-native cell 
morphologies.  
A limitation of the present study is the relatively restricted HA concentration and 
Mw range interrogated. Future experiments will explore a broader range of initial 
concentration and Mw. Furthermore, the present 3D model system can be readily 
extended to examining the influence of other biochemical moieties on VFF cell 
responses. 
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Table 2. Comparison of HA and Alginate Impact in PEGDA- Versus Collagen-Based 
Hydrogels.  
 
, indicates indeterminate,  decrease,  increase, __ not measured. In Hahn et al. [76], the levels of 
proliferative cells were assessed via BrdU incorporation and the levels of myofibroblast-like cells were 
assessed by evaluating the degree of hydrogel compaction with time in culture. Collagen synthesis and 
sGAG production were evaluated histologically by reticular collagen stain and toluidine blue stain, 
respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PEGDA hydrogels with RGDS 
functioning as the integrin 
adhesion ligand at day 21 
Collagen hydrogels with collagen 
type I functioning as the integrin 
adhesion ligand [107] 
 
HAHMW 
relative to 
HAIMW 
HAIMW relative 
to Alginate 
HAHMW relative 
to HAIMW 
HAIMW relative to  
Alginate 
Total collagen   
__ 
 
Collagen type I: type 
IIII 
  
__ __ 
Elastin   
__ __ 
sGAG    __  
Proliferative cells   
__ 
 
Myofibroblast-like cells   __  
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CHAPTER III 
INFLUENCE OF GLYCOSAMINOGLYCAN IDENTITY ON VOCAL FOLD 
FIBROBLAST BEHAVIOR* 
 
 
3.1. Overview 
 
PEG hydrogels have recently begun to be studied for the treatment of scarred 
vocal fold lamina propria due, in part, to their tunable mechanical properties, resistance 
to fibroblastmediated contraction, and ability to be polymerized in situ. However, pure 
PEG gels lack intrinsic biochemical signals to guide cell behavior and generally fail to 
mimic the frequency-dependent viscoelastic response critical to normal superficial 
lamina propria function. Recent results suggest that incorporation of viscoelastic 
bioactive substances, such as GAGs, into PEG networks may allow these gels to more 
closely approach the mechanical responses of normal vocal fold lamina propria while 
also stimulating desired vocal fold fibroblast behaviors.  
 
 
 
 
 
 
 
_____ 
*Reprinted with permission from Influence of “glycosaminoglycan identity on vocal fold fibroblast 
behavior” by Andrea Carolina Jimenez-Vergara, Dany J. Munoz-Pinto, Silvia Becerra-Bayona, Bo Wang, 
Alexandra Iacob, Mariah S. Hahn, 2011, Acta Biomaterialia 7 (2011) 3964–3972, Copyright 2011, Acta 
Materialia Inc. Published by Elsevier Ltd. 
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Although a number of vocal fold studies have examined the influence of HA on 
implant mechanics and vocal fold fibroblast responses, the effects of other GAG types 
have been relatively unexplored. This is significant, since recent studies have suggested 
that CSC and HS are substantially altered in scarred lamina propria.  
The present study was therefore designed to evaluate the effects of CSC and HS 
incorporation on the mechanical response of PEG gels and vocal fold fibroblast behavior 
relative to HA. As with PEG–HA, the viscoelasticity of PEG–CSC and PEG–HS gels 
more closely approached that of the normal vocal fold lamina propria than pure PEG 
hydrogels. In addition, collagen I deposition and fibronectin production were 
significantly higher in CSC than in HA gels, and levels of the myofibroblast marker SM-
α-actin were greater in CSC and HS gels than in HA gels. Since collagen I, fibronectin, 
and SM-α-actin are generally elevated in scarred lamina propria these results suggest 
that CSC and HS may be undesirable for vocal fold implants relative to HA. 
Investigation of various signaling intermediates indicated that alterations in NFκB-p50, 
NFκB-p65, or pERK1/2 levels may underlie the observed differences among the PEG–
GAG gels. 
 
3.2. Introduction 
 
Voice disorders resulting from scarring of the vocal fold lamina propria can be 
debilitating in terms of quality of life. The vocal folds are paired, multi-layered 
structures, each consisting of an underlying skeletal muscle layer, followed by the 
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lamina propria and overlying epithelium. The lamina propria is generally subdivided into 
the superficial lamina propria (commonly referred to as the SLP) and the vocal ligament 
[108]. During vocal fold vibration, the SLP is believed to move freely over the elastin- 
and collagen rich vocal ligament, undergoing the high frequency and strain excursions 
required for cyclic vocal fold closure. When SLP pliability and physical volume are 
reduced by the abnormal ECM deposition and fibroblast-mediated contracture associated 
with scarring, voice changes ranging from hoarseness to complete voice loss result, 
depending on the severity of the scar [60, 109].  
Vocal fold scarring has proven difficult to treat with current surgical techniques 
and standard augmentation substances, such as collagen and fat [60, 61]. Researchers are 
therefore actively exploring alternative treatment routes, including the development of 
designer implants for functional SLP regeneration [4, 13, 14, 17, 18, 110-112]. PEG-
based hydrogels have recently begun to be examined as vocal fold augmentation 
substances [9-14], due, in part, to their tailorable mechanical properties, resistance to 
fibroblast-mediated contraction, and ability to be polymerized in situ. However, pure 
PEG hydrogels lack intrinsic biochemical signals to guide cell behavior and generally 
fail to mimic the frequency- dependent viscoelastic response critical to normal SLP 
function [10-12, 14, 15]. 
Recent results suggest that conjugating viscoelastic bioactive substances, such as 
GAGs, into PEG networks may allow these hydrogels to more closely approach the 
mechanical responses of normal SLP while stimulating desired vocal fold fibroblast 
behaviors [10, 16]. GAGs are a family of charged polysaccharides which play key roles 
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in inflammation, cell migration, and cell phenotype modulation [113] and which include 
unsulfated forms (e.g. HA) as well as sulfated forms (e.g. HS, CSC, DS, and keratan 
sulfate (KS)). While a number of vocal fold studies have examined the impact of HA on 
implant mechanics and/or fibroblast behavior [10, 11, 13, 16-19], the influence of 
sulfated GAGs has been relatively unexplored. The present study was therefore designed 
to compare the effects of CSC and HS incorporation on PEG hydrogel biomechanical 
response and on associated vocal fold fibroblast behavior relative to HA. CSC and HS 
were selected for investigation over other sulfated GAGs for several reasons. First, 
although the DS-containing proteoglycan decorin has been a focus of several vocal fold 
studies [114, 115] due in part to its known role in dermal scar formation [116], recent 
quantitative measures suggest that expression of CSC, rather than DS, is substantially 
decreased in scarred lamina propria [20]. In addition, a separate study has shown that 
levels of specific HS proteoglycans are altered in scarred lamina propria [21].  
 
3.3. Materials and Methods  
 
3.3.1. Polymer Synthesis and Characterization 
 
3.3.1.1. PEG-Diacrylate Synthesis  
PEGDA was prepared as previously described by combining 0.1 mmol ml-1 dry 
PEG (10 kDa, Fluka), 0.4 mmol ml-1 acryloyl chloride, and 0.2 mmol ml-1 triethylamine 
in anhydrous dichloromethane and stirring under argon overnight [117]. The resulting 
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solution was washed with 2 M K2CO3 and separated into aqueous and dichloromethane 
phases to remove HCl. The dichloromethane phase was subsequently dried with 
anhydrous MgSO4, and PEGDA was precipitated in diethyl ether, filtered, and dried 
under vacuum. The extent of PEG diacrylation was determined by 1H NMR to be ~85%.  
 
3.3.1.2. Synthesis of Methacrylate-Derivatized CSC and HS 
 In order to conjugate specific GAGs within the PEGDA-based hydrogel 
networks, each GAG type was methacrylate-derivatized according to standard protocols 
[81]. CSC (51 kDa, Sigma) and heparin (17 kDa, Sigma) were dissolved in deionized 
water to achieve a 1 wt.% final concentration, and the pH of each solution was adjusted 
to 8.0. A 10-fold molar excess of methacrylic anhydride (Polysciences) was added per 
disaccharide unit. Each reaction was allowed to proceed under constant stirring at 4 °C, 
with the solution pH being maintained at ~8.0 by periodic addition of 5 M NaOH. The 
reaction products (CSC-MA and HS-MA) were precipitated twice in chilled 95% 
ethanol, dialyzed against deionized water for 48 h, and lyophilized. The extent of 
methacrylate derivatization was characterized by 1H NMR to be ~1–3% (per available–
OH groups). These levels of methacrylate derivatization have previously been shown to 
negligibly alter the observed cell–GAG interactions [16, 74, 81, 118] yet are sufficient to 
avoid significant sol formation [119].  
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3.3.1.3. Synthesis of Methacrylate-Derivatized Intermediate Molecular Weight HA  
Since the average molecular weight of HA in normal human vocal fold lamina 
propria is currently unknown, an intermediate molecular weight HA (~400 kDa) was 
selected for the present study [16]. To generate HA appropriate for the study, high 
molecular weight HA (~1.65 x 103 kDa from Streptococcus equi, Fluka) was first 
methacrylate-derivatized as above. The purified product was then dissolved at 1 mg ml-1 
in phosphate-buffered saline (PBS) containing 0.05% sodium azide and 5 U ml-1 
hyaluronidase IV-S (H3884, Sigma). Following incubation at 37 °C overnight, the 
enzyme was heat-inactivated. The resulting digestion product (HA-MA) was dialyzed 
against deionized water for 48 h and lyophilized. The average molecular weight of the 
isolated HA-MA was determined to be ~400 kDa with a polydispersity of ~1.25 using 
gel permeation chromatography (Viscotek).  
 
3.3.1.4. Synthesis of Acrylate-Derivatized Cell Adhesion Peptide  
Cell adhesion peptide RGDS (American Peptide) was reacted with acryloyl-
PEG-N-hydroxysuccinimide (ACRL-PEG-NHS) (3.4 kDa, Nektar) at a 1:1 M ratio for 2 
h in 50 mM sodium bicarbonate buffer, pH 8.5 [72]. The product (ACRL-PEG-RGDS) 
was purified by dialysis, lyophilized, and stored at ~20 °C until use.  
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3.3.2. Cell Culture 
  
Cryopreserved porcine vocal fold fibroblasts at passage 3 were obtained from 
Robert Langer, ScD (Massachusetts Institute of Technology) [76]. These cells had been 
isolated by primary explant from the mid-membranous lamina propria of 6–12-month-
old pigs, an accepted animal model for the human vocal fold lamina propria [109]. The 
discarded animal tissue was obtained from the MIT Division of Comparative Medicine 
and with the approval and according to the guidelines of the MIT animal care committee. 
The purity of the explant population was verified by positive staining for vimentin and 
negative staining for epithelial and endothelial cell-specific markers. The cryopreserved 
vocal fold fibroblasts were thawed and expanded at 37 °C/5% CO2 in DMEM (Hyclone) 
supplemented with 10% FBS, 2 ng ml-1 basic fibroblast growth factor (BD Biosciences), 
100 U ml-1 penicillin and 100 mg l-1 streptomycin (Hyclone).  
 
3.3.3. Hydrogel Fabrication and Maintenance  
 
Hydrogels were fabricated by preparing precursor solutions containing 100 mg 
ml-1 10 kDa  PEGDA, 1.4 mg ml-1 methacrylate- derivatized GAG (CSC-MA, HS-MA, 
or HA-MA), and 1.4 lmol ml-1 ACRL-PEG-RGDS in HEPES-buffered saline (HBS) (10 
mM HEPES, 150 mM NaCl, pH 7.4). The concentration of GAG was chosen to be 
consistent with GAG levels within the normal vocal fold lamina propria [20, 115]. In 
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addition, PEGDA molecular weight and concentration were selected to yield hydrogels 
with average dynamic elastic moduli appropriate to vocal fold applications [12, 14].  
A 300 mg ml-1 solution of UV photoinitiator 2,2-dimethoxy-2- phenyl-
acetophenone in N-vinylpyrrolidone was added at 1 vol.% to each precursor solution. 
The resulting solutions were then poured into molds composed of two glass plates 
separated by 1.1 mm polycarbonate spacers and polymerized by 3 min exposure to long 
wavelength UV light (Spectroline, ~6mWcm-2, 365 nm). To generate cell-laden 
hydrogels, vocal fold fibroblasts at passages 5–6 were harvested and resuspended in the 
filter-sterilized precursor solutions at ~1 x 106 cells ml-1 prior to transfer to the hydrogel 
mold. Polymerized hydrogel slabs were transferred to Omnitrays (Nunc) fitted with four 
sterile polycarbonate bars to simultaneously prevent gel flotation and prevent gel contact 
with the tray bottom. Hydrogels were immersed in DMEM supplemented with 10% 
FBS, 100 U ml-1 penicillin, and 100 mg l-1 streptomycin and maintained at 37 °C/5% 
CO2. The medium was changed every 2 days.  
 
3.3.4. Initial Hydrogel Characterization 
 
3.3.4.1. Initial Water Uptake  
To compare the extent of initial water uptake by the various hydrogel 
formulations following polymerization, the initial weight (Wi) of each gel (n = 8 per 
formulation) was determined immediately following polymerization, after which the gels 
were submerged in medium. After 24 h, the swollen weight (Ws) of each gel was 
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measured. The equilibrium water uptake (S) was calculated as   
  
  
. These dates were 
used to compare the post-swelling GAG levels across gels.  
 
3.3.4.2. Average Mesh Size  
 PEGDA hydrogel mesh size cannot be readily visualized using standard 
techniques such as scanning electron microscopy. In the present study, hydrogel mesh 
size was therefore characterized via a series of dextran diffusion experiments based on 
an adaptation of the methodology of Watkins and Anseth [120]. To avoid charge–charge 
interactions between the diffusing dextrans and the GAG chains in the hydrogel 
networks, fluorescently-labeled, charge-neutral dextrans were employed.  
In brief, PEG–GAG hydrogels were prepared and allowed to swell overnight at 
37 °C in PBS containing 0.05% azide (PBS–azide). One centimeter diameter discs were 
cored from each hydrogel formulation. Fluorescently-labeled, charge-neutral dextrans 
(40 and 70 kDa, Invitrogen) were dissolved at 0.05 mg ml-1 in PBS–azide and added at 1 
ml per hydrogel disc (eight discs per formulation per dextran molecular weight). Dextran 
solutions were allowed to diffuse into the hydrogels for 24 h at 37 °C. Each gel disc was 
gently blotted and transferred to 1 ml of fresh PBS–azide. Dextran that had penetrated 
into the hydrogels was then permitted to diffuse out into the surrounding solution at 37 
°C. After 24 h, the fluorescence of the PBS–azide solution surrounding each disc was 
measured at excitation and emission wavelengths of 530 and 590 nm. Dextran standard 
curves were used to convert each fluorescence signal to a concentration. For each 
hydrogel formulation, the measured concentration readings for each dextran molecular 
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weight were divided by gel weight and then plotted versus dextran hydrodynamic radius 
[121]. The area (A) under the resulting curve served as a quantitative indicator of the 
permissivity of each hydrogel (x) over the hydrodynamic radii range assayed. For the 
purposes of comparison, the calculated area values for CSC and HS gels were 
normalized to that of the HA gels to yield a relative mesh size value:  x (
Ax
AHA
). 
 
3.3.4.3. Hydrogel Mechanical Properties  
Following initial swelling, 8 mm diameter discs (n = 7–8 per formulation) were 
cored from each cell-laden hydrogel. The thickness of each disc was measured using a 
digital caliper. These thickness measures served both as gage lengths for mechanical 
testing as well as indicators of hydrogel degradation and/or cell-mediated gel 
compaction with time. Each hydrogel disc was mounted onto the compression platens of 
a DMA 800 (TA Instruments) and surrounded at the edges by silicone oil to prevent gel 
dehydration. Following application of a 0.01 N pre-load, each hydrogel disc was 
subjected to unconstrained compression at 1% cyclic strain at room temperature over the 
frequency range 1–100 Hz (100 Hz being the system maximum). The higher frequency 
testing conditions were selected to approach the frequencies of cyclic lamina propria 
loading experienced during phonation, with the onset of adult phonation occurring at 
~150 Hz in males. Sample elastic compressive modulus (E′) and damping ratio (  
E 
E  
 , 
where E′′ is the viscous compressive modulus) were extracted from the resulting stress 
strain data.  
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The fact that PEGDA hydrogels can be considered homogeneous and isotropic 
[122, 123] was used in comparing these compressive mechanical property data to 
literature values for the vocal fold lamina propria (which are generally obtained under 
shear). Specifically, the elastic compressive modulus of homogeneous, isotropic 
materials is related to the elastic shear modulus (G′) by the relationship G  
E 
(2 2  )
, where 
  is the Poisson ratio. For polymeric hydrogels,   ≈ 0.5, and thus, G  
E 
3
 [36].  
 
3.3.5. End-Point Hydrogel Analyses  
 
After culture for 18 days, gels were harvested for mechanical, biochemical, and 
histological analyses. Mechanical samples (n = 3–5 per formulation) were tested as 
described above. 
 
3.3.5.1. Biochemical Analyses  
Samples harvested for biochemical analyses were transferred to screw cap vials, 
weighed, flash-frozen in liquid nitrogen, and stored at -80 °C until the time of analysis. 
The weight of each 8 mm disc was used as a second indicator of gel degradation and/or 
compaction, since the reduction in gel volume associated with both of these processes 
would be reflected in a mass loss, assuming lack of commensurate new matrix 
deposition [76]. Hydrogel samples were digested for 72 h at 37 °C in 1 ml of 0.12 M 
NaOH per 0.2 g hydrogel wet weight [16, 83]. DNA, total collagen, and elastin were 
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then analyzed by established protocols. For each assay, the standards used were 
subjected to the same association with PEGDA and GAG and to the same digestion 
conditions as the samples. The resulting collagen and elastin data were normalized to 
cell number, as determined from the DNA measurements.  
 
3.3.5.2. DNA Analysis  
Aliquots of the hydrolyzed samples (n = 3–6 per formulation) were neutralized 
and their DNA contents determined using the Invitrogen PicoGreen assay [84]. DNA 
measures were translated to cell numbers using a conversion factor of 6.6 pg DNA per 
cell [85]. NaOH-treated calf thymus DNA (Sigma) served as a standard.  
 
3.3.5.3. Collagen Analysis  
The amino acid hydroxyproline was quantified as an indirect measure of total 
collagen. In brief, aliquots (n = 4–6 per formulation) collected for collagen quantitation 
were hydrolyzed for 18 h at 110 °C in 6 M HCl. Each sample was then dried in a 
Labconco Centrivap to remove HCl, resuspended in deionized water, and passed through 
a centrifugal microcolumn (Nunc) packed with charcoal to remove caramelized sugars. 
The resultant samples were reacted with the reagents chloramine T and p-
dimethylbenzaldehyde [83]. Sample absorbance was read at 550 nm relative to that of L-
4-hydroxyproline (Sigma). Total collagen content was estimated from measured grams 
of hydroxyproline by dividing by 0.13 [124].  
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3.3.5.4. Elastin Analysis  
Elastin production was measured using indirect ELISA [86]. NaOH-digested 
samples (n = 3–4 per formulation) were neutralized and further digested with 0.25 M 
oxalic acid at 100 °C overnight. Oxalic acid was removed from the samples and 
exchanged for PBS using Microcon YM-3 centrifugal filters (Millipore). One hundred 
microliters of the resulting samples were applied to a high binding multiwell plate for 3 
h at room temperature. After blocking the plate with bovine serum albumin, adsorbed 
elastin fragments were detected by applying elastin antibody (BA-4, SCBT) followed by 
donkey anti-mouse HRP-conjugated secondary antibody (Jackson Immunochemicals) 
and 2,20-azino-bis(3-ethylbenzthiazoline 6-sulphonic acid). Absorbance was read at 410 
nm, with bovine aortic elastin (exposed to both NaOH and oxalic acid treatment) serving 
as a standard.  
 
3.3.6. Histological Analyses  
 
Day 18 samples harvested for histological analyses were fixed in 10% formalin 
for 30 min, embedded in Tissue-Tek freezing medium, and frozen at -80 °C. Thirty-five 
micron sections were cut using a cryomicrotome. All immunostaining steps took place at 
room temperature unless otherwise noted.  
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3.3.6.1. Immunostaining  
ECM deposition was analyzed for each formulation using standard 
immunohistochemical techniques. Rehydrated sections were blocked with peroxidase for 
10 min, followed by 30 min exposure to Terminator blocking agent (Biocare Medical). 
Primary antibodies for collagen I (Rockland Immunochemicals), collagen III (Rockland 
Immunochemicals), elastin (BA-4, Santa Cruz Biotechnology), fibrillin-1 (C-19, Santa 
Cruz Biotechnology), or fibronectin (C-20, Santa Cruz Biotechnology) diluted in HBS 
were then applied for 1 h. To identify vocal fold fibroblasts displaying a 
myofibroblastlike phenotype, a primary antibody for SM-α-actin (1A4, LabVision) was 
applied. Bound primary antibody was detected using alkaline phosphatase-conjugated 
secondary antibody (Jackson Immunochemicals) followed by application of the 
chromogen Ferangi Blue (Biocare Medical) or using HRP-conjugated secondary 
antibody (Jackson Immunochemicals) followed by application of the chromogen AEC 
(LabVision). For cell signaling studies involving antibodies for pERK1/2 (Thr 202/Tyr 
204, Santa Cruz Biotechnology), pPLC-γ1 (Tyr 1253, Santa Cruz Biotechnology), 
NFκB-p50 (C-19, Santa Cruz Biotechnology), and NFκB-p65 (C-20, Santa Cruz 
Biotechnology), rehydrated sections were permeabilized (10 mM HEPES, pH 6.8, 100 
mM NaCl, 3 mM MgCl2, 300 mM sucrose, 0.5% Triton X-100) for 30 min prior to 
Terminator application.  
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3.3.6.2. Semi-Quantitative Assessments  
For intracellular markers (SM-α-actin, pERK1/2, pPLC-γ1, NFjBp50, NFjB-
p65), cell counts were carried out to semi-quantitatively evaluate the immunostaining 
results. These counts were conducted according to established methods [53, 88, 89] on 
sections from at least three different discs (a total of ~1500 vocal fold fibroblasts) for 
each formulation. For each cell i in a given section, a staining intensity di was recorded 
on a scale of 0–3 (0 = no staining; 3 = highest intensity among all formulations for that 
antibody) by a single observer blinded to outcome. The cumulative staining intensity d 
for a given antibody in a particular section was calculated using the equation: 
d  
∑ di
total cell numbe 
 . In addition, since deposited ECM remained localized around the parent 
cells in each hydrogel formulation, as is characteristic for PEGDA gels [15], the relative 
levels of collagen I, collagen III, fibrillin-1, and fibronectin among hydrogel 
formulations were also evaluated by cell count using the above procedure.  
Counts for all stainings for which statistically significant differences were 
observed among PEG–GAG formulations were repeated by two additional observers 
blinded to both sample identity and outcome. Each of these recounting assessments 
demonstrated at least 95% correlation with the original counts. The resulting average 
cumulative staining intensities for each antibody were regarded as vectors with CSC, 
HS, and HA components: [dCSC dHS dHA]. For the purposes of comparison, these vectors 
were normalized to unit magnitude by standard methods: 
[dCSC dHS dHA]
√d
CSC
2  d
HS
2  d
HA
2
.  
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3.3.6.3. Comparison of Collagen I and Collagen III  
Although the collagen I counting assessments do not give the absolute amounts 
of collagen I in each formulation, they do bind the ratios between the collagen I levels 
among formulations. Similarly, the collagen III counting assessments bind the ratios 
between the collagen III levels among formulations. Given the predominance of collagen 
I and collagen III (>90% of total collagen) in the vocal fold lamina propria [93], 
weighting factors for the collagen I and collagen III staining intensity vectors should 
exist for which the sum of the weighted vectors approximates the total collagen vector:  
(α1 [
 Col ICSC
Col IHS
Col IHA
]  α3 [
 Col IIICSC
Col IIIHS
Col IIIHA
]  [
 total collagenCSC
total collagenHS
total collagenHA
]) (1) 
i.e. α1 and α3 which minimize the error between the left- and righthand sides of Eq. (1) 
can be determined. When the collagen I and collagen III vectors are first normalized to 
unit magnitude prior to the determination of α1 and α3, the ratio of the resultant α1 and α3 
can be interpreted as the relative contribution of the collagen I and collagen III vectors to 
the overall total collagen vector. Thus, the ratio 
(α1xCol Ix)
α3xCol IIIx
 can be interpreted as the 
relative amount of collagen I versus collagen III in formulation x. In the present study, 
α1 and α3 were determined to be 3.0 x 10
-5 and 1.5 x 10-5, respectively, using the Solver 
function of the Excel Analysis Toolbox, with the sum of the mean square error utilized 
as the error function to be minimized.  
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3.3.7. Statistical Analyses  
 
Data are reported as means ± standard deviation. Comparison of sample means 
was performed by ANOVA. When readings for various measures could be attributed to 
the same sample group (e.g. 24 h elastic compressive modulus values at each sampled 
frequency), a single two-way ANOVA was performed for sample comparison. In the 
case of immunostaining, the sections used for two different antibodies were not be 
considered as representing the same sample, even if arising from the same gel disc. 
Therefore, statistical comparisons for each antibody were performed separately using 
one-way ANOVA.  
When the P value associated with the independent variable main effect fell below 
0.05, pair-wise comparisons between specific formulations were conducted using 
Tukey’s post hoc test (two-tailed, SPSS software). The significance values associated 
with subsequent pair-wise comparisons are given in the main text.  
 
3.4. Results 
 
3.4.1. Hydrogel Material Properties  
 
In order to attribute differences in vocal fold fibroblast behavior across hydrogel 
formulations specifically to initial differences in gel GAG composition, it was important 
that the remaining hydrogel material properties could be considered consistent across 
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gels. The ‘‘bulk’’ material properties of each gel formulation were therefore 
characterized and compared. The initial water uptake S of each gel type following 
polymerization was similar (Table 3), indicating that the post-swelling concentration of 
GAG in each gel type was similar at (0.14/1.38) or ~0.1 wt.% [119]. Similarly, 
comparison of the equilibrium diffusion of charge-neutral dextrans indicated that the 
bulk average mesh size of the swollen gel networks could be considered consistent 
across formulations (Table 3). Mechanical property data for the PEG–GAG hydrogels 
over the frequency range 1–40 Hz are summarized in Fig. 7 and Table 4. Although 
mechanical measures were collected up to 100 Hz (approaching the onset of phonation at 
~150 Hz), values above 40 Hz were neglected due to data quality limitations associated 
with testing device inertia. The average elastic compressive modulus values of both pure 
PEG and the PEG–GAG gels were ~16 kPa at 1 Hz. As loading frequency increased, the 
average elastic compressive modulus values of both the pure PEG and PEG–GAG 
hydrogels increased to ~25 kPa (40 Hz, Fig. 7). Given the homogeneous and isotropic 
nature of PEG-based gels [122, 123], these average elastic compressive modulus values 
can be assumed to correspond to an elastic shear modulus of ~8 kPa for both the pure 
PEG and PEG– GAG gels.  
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Table 3. Hydrogel Water Uptake and Relative Mesh Size. 
 Water Uptake (S)
 a
 Relative Mesh Size
a,b
 
CSC 1.38 ± 0.02 1.01 ± 0.03 
HS 1.38 ± 0.01 1.00 ± 0.01 
HA 1.39 ± 0.01 1.00 ± 0.04 
 
aEight specimens were tested for both water uptake and relative mesh size assessments.  
bA relative mesh size of 1.00 corresponds to an average mesh size of ~18 nm [123]. 
 
 
As the loading frequency increased, the differences in damping ratios between 
the GAG-containing and non-GAG-containing gels increased, with the damping ratios of 
the PEG–CSC, PEG–HS, and PEG–HA gels being significantly greater than that of the 
PEG gels at 40 Hz (P = 0.0129, P = 0.046, and P = 0.013, respectively). Specifically, the 
damping ratios of the PEG–GAG hydrogels were ~0.8 at 40 Hz, whereas pure PEG gels 
displayed a damping ratio of ~0.55 at 40 Hz. Elastic shear modulus and damping ratio 
ranges for the vocal fold lamina propria at similar strains and loading frequencies are 
0.1–7 kPa and 0.6–2, respectively [125, 126]. Thus, conjugation of GAG into PEG 
networks allowed the hydrogels to more closely approach ‘‘average’’ lamina propria 
mechanical properties, at least in terms of observed damping ratios.  
Mechanical property assessments at the study end-point indicated that the initial 
mechanical properties were maintained over 18 days of culture (Table 4). Similarly, the 
24 h and 18 day thickness and mass data corresponded to negligible alterations in gel 
volume with time (Table 4). Thus, the bulk modulus, thickness, and gel mass 
assessments indicated that the PEG–GAG gels retained the slow degradation rate and 
resistance to cell-mediated contraction characteristic of pure PEG hydrogels [16].  
 
59 
 
Table 4. Hydrogel Modulus, Thickness, and Mass Assessmentsa. 
 
Elastic Compressive  
Modulus (kPa) at 1 Hz 
Thickness 
(mm) 
Mass of 8 mm Discs (mg)  
 24 h 18 days 24 h 18 days 24 h 18 days 
CSC 16.4 ± 2.7 19.1 ± 1.3 1.15 ± 0.04 1.16 ± 0.04 57.6 ± 0.9 59.5 ± 3.0 
HS 17.4 ± 2.1 18.3 ± 2.5 1.15 ± 0.05 1.14 ± 0.07 57.6 ± 0.4 59.4 ± 3.4 
HA 16.7 ± 2.0 17.5 ± 1.7 1.16 ± 0.03 1.17 ± 0.02 58.1 ± 0.2 58.7 ± 5.3 
 
aData were collected on the following numbers of cell-laden samples per formulation: Elastic 
compressive modulus, n = 7-8 (24 h) and n = 3-5 (18 days); thickness, n = 7-8 (24 h) and n=3-5 (18 days); 
mass of discs, n = 8 (24 h) and n = 8-11 (18 days). 
 
 
3.4.2. Cell Density and ECM Deposition  
 
Scarring is characterized by altered cell densities as well as altered deposition 
and contraction of ECM constituents. For instance, increases in collagen I, collagen III, 
and fibronectin expression have been associated with vocal fold scar formation [109]. In 
addition, the density of the elastic microfibril, fibrillin-1, has been observed to be 
significantly reduced in normal and hypertrophic dermal scars relative to normal skin 
[127]. In the present study, end-point cell densities within each hydrogel formulation 
were 65–70% of the initial seeding density, as is typical for cells photo-encapsulated 
within PEGDA hydrogels [128]. Similarly, hydroxyproline assessments indicated that 
total collagen production was consistent across hydrogel formulations (Fig. 8A).  
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Fig. 7. (A) The elastic compressive modulus and (B) damping ratio of the various PEG–GAG 
formulations compared with pure PEG gels. For each formulation, 7–8 cell-laden gels were tested. *P < 
0.05, significant difference for each PEG–GAG gel compared with the PEG hydrogel controls at 40 Hz. 
 
 
Biochemical and histological assays also suggested that elastin deposition per 
cell could not be distinguished among gel types (Fig. 8A and B). However, fibrillin-1 
levels were significantly greater in HS (P = 0.001) and HA (P = 0.034) hydrogels than in 
CSC gels (Fig. 8B), and fibronectin synthesis was higher in CSC than in HA gels (P = 
0.044, Fig. 9). Similarly, collagen I expression was significantly greater in CSC gels 
relative to HA (P = 0.002) and HS (P = 0.021) hydrogels, whereas collagen III 
expression was higher in HA gels than in CSC (P < 0.001) and HS (P = 0.001) 
hydrogels. Quantitative comparison of the present collagen I and collagen III unit 
magnitude intensity vectors (Fig. 9) with the total collagen vector (Fig. 8) indicated 
collagen I: collagen III ratios of approximately 13, 3, and 0.7 in the CSC, HS, and HA 
formulations, respectively. Representative images for collagen III staining are given in 
Fig. 10 and display the pericellular localization observed for each of the examined ECM 
proteins [12, 16].  
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Fig. 8. Total collagen and elastic fiber production across hydrogel formulations. (A) Average total 
collagen (based on hydroxyproline measures) and elastin (based on ELISA assessments) per cell. (B) 
Semi-quantitative histological assessments of elastin and fibrillin-1. For the purposes of comparison, the 
elastin and fibrillin-1 cumulative staining intensity vectors were normalized to unit magnitude. 
*Significantly different from CSC hydrogels, P < 0.05. 
 
 
3.4.3. Cell Phenotype and Signaling  
 
Scarring and contracture are often promoted by resident fibroblasts taking on 
contractile, myofibroblast-like phenotypes [129]. Therefore, vocal fold fibroblast 
expression of the myofibroblast marker SM-α-actin was evaluated across hydrogel 
formulations (Fig. 11). Levels of SM-α-actin were lower in HA hydrogels relative to 
CSC (P < 0.001) and HS (P < 0.001) gels. To gain an insight into the intracellular 
signaling underlying observed vocal fold fibroblast phenotype and ECM production, 
signaling molecules activated by GAG interactions with cell surface receptors CD44 and 
RHAMM were investigated. As shown schematically in Fig. 12, GAG interactions with 
these receptors activate a number of signaling molecules, including NFκB, ERK1/2, and 
PLC-c1, which in turn modulate cell gene expression [78-80]. In the present study, no 
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significant differences in pPLC-γ1 levels were observed among formulations (Figs. 10 
and 11). However, NFκB-p50 levels were significantly higher in HS gels relative to HA 
(P < 0.001) and CSC (P < 0.001) gels (Fig. 11), and NFκB-p65 levels were greater in 
CSC hydrogels than in HA gels (P = 0.041). In addition, pERK1/2 levels were lower in 
HS gels relative to CSC hydrogels (P = 0.036).  
 
3.5. Discussion  
 
The present study examined the impact of CSC and HS relative to HA on vocal 
fold fibroblast ECM production and phenotype with the aim of improving the design of 
implants for the treatment of SLP scarring. For an implant to restore scarred vocal fold 
SLP and/or to inhibit further SLP fibrosis, it is critical that the scaffold not trigger 
fibrotic vocal fold fibroblast behaviors, such as the increased deposition of total collagen 
[21]. In the current work, vocal fold fibroblasts in hydrogels containing CSC and HS 
displayed similar levels of total collagen relative to vocal fold fibroblasts in gels 
containing HA. Given that HA has previously been associated with a reduction in 
fibrotic response for a range of tissue types [13, 112, 130], the similarity in total collagen 
production between CSC, HS, and HA gels may be advantageous in terms of SLP 
restoration. That said, marked differences in the relative production of collagens I and III 
were observed among hydrogel formulations, with CSC having the highest collagen I: 
collagen III ratio and HA having the lowest collagen I: collagen III ratio. As previously 
discussed, comparison of the present total collagen and collagen type data indicated that 
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the collagen I: collagen III ratio varied with formulation, from ~12 in the CSC gels to 
~0.7 in the HA gels. Since the ratio of collagen I to collagen III in the vocal fold SLP is 
estimated to be less than 1.5 [93, 131], the current results suggest that the HA 
formulation resulted in collagen compositions most mimetic of normal SLP. 
In normal human vocal fold lamina propria, fibrillin-1 tends to be enriched in the 
pliable SLP, whereas elastin is essentially absent in this layer [102]. Fibrillin-1 has 
therefore been hypothesized to play a key role in SLP elasticity during phonation [20]. 
Although elastin deposition was similar across the PEG–GAG gel formulations, the HS 
hydrogels appeared to support the highest fibrillin- 1: elastin ratio, a feature which may 
be desirable for lamina propria regeneration. However, in the absence of quantitative 
measures of fibrillin-1, definitive statements regarding which PEG–GAG formulation 
supports a more appropriate fibrillin-1: elastin ratio cannot be made. In contrast to 
elastin, fibronectin was moderately increased in CSC hydrogels relative to HA gels. 
Since fibronectin expression has been consistently observed to be heightened in scarred 
vocal fold lamina propria [109], the increased fibronectin levels associated with CSC 
gels may be unfavorable for vocal fold scar treatment.  
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Fig. 9. Semi-quantitative histological assessments of collagen type and fibronectin production across 
hydrogel formulations. For the purposes of comparison, the cumulative staining intensity vectors for each 
antibody were normalized to unit magnitude. *Significantly different from CSC hydrogels, P < 0.05; 
#significantly different from HS hydrogels, P < 0.05. 
 
 
Expression of the myofibroblast marker SM-α-actin decreased significantly from 
CSC to HS and from HS to HA hydrogels. Given the role of myofibroblasts in scar 
contraction and abnormal ECM synthesis [129], these results indicate that CSC and HS 
hydrogels may stimulate undesirable vocal fold fibroblast phenotypes. To gain an insight 
into the internal cellular signaling underlying the observed vocal fold fibroblast 
phenotype and ECM production, signaling molecules activated by GAG interactions 
with the cell surface receptors CD44 and RHAMM were investigated. Although the 
signaling cascades initiated by GAGs and/or GAG-associated molecules (such as growth 
factors) [132] are complex, CD44- and RHAMM-activated intermediates were selected 
for investigation due to the fact that each GAG under investigation directly interacts with 
one or both of these receptors. Specifically, both HA and HS actively bind RHAMM 
[133], whereas both HA and CSC interact with CD44 [133, 134] (although HS and CSC 
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have over 10-fold lower affinities for RHAMM and CD44, respectively, than HA [134, 
135]).  
Comparison of the SM-α-actin and signaling data suggests that the increased 
levels of SM-α-actin in CSC gels may be correlated with increased NFκB-p65- and/or 
pERK1/2-related signaling. Previous research has shown that expression of SM-α-actin 
by dermal fibroblasts is regulated in part by activation of the ERK1/2 pathway [136]. 
Similarly, ERK1/2 activation has been associated with increased fibronectin expression 
by kidney myofibroblasts [137]. For HS hydrogels, the higher SM-α-actin levels relative 
to HA gels may also be correlated with an increase in NFκB-p50, a transcription factor 
which plays important roles in inflammatory and immune responses. This would be 
consistent with a previous study of myofibroblasts which found that suppressing NFκB-
p50 activation reduced expression of SM-α-actin as well as of collagen I [138].  
 
 
 
 
Fig. 10. Representative images of CSC, HS, and HA hydrogel sections immunostained for collagen III 
and PLC-γ1. The scale bar in the lower right-hand image equals 40 lm and applies to all images. 
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Fig. 11. Semi-quantitative histological assessments of SM-α-actin, pERK1/2, NFκB-p50, NFκB-p65, and 
pPLC-γ1 expression across hydrogel formulations. For the purposes of comparison, the cumulative 
staining intensity vectors for each antibody were normalized to unit magnitude. *Significantly different 
from CSC hydrogels, P < 0.05; #significantly different from HS hydrogels, P < 0.05. 
 
 
Several limitations of the present study merit comment. The tight cross-link 
density and slow degradation rate of PEGDA gels induced the associated cells to take on 
oval/stellate morphologies, despite the presence of the cell adhesion ligand RGDS [12, 
16]. These morphologies are non-native for vocal fold fibroblasts, which are normally 
elongated. However, a previous study has demonstrated that vocal fold fibroblasts 
encapsulated within  PEGDA gels responded to matrix-mediated stimuli with similar 
trends (at least in terms of relative collagen, elastic fiber, and SM-α-actin expression) as 
vocal fold fibroblasts encapsulated in hydrogels permissive of more elongated cell 
morphologies [16]. An additional limitation of the present work results from the analysis 
of only a single concentration of each GAG type. Furthermore, the potential impact of 
the proteoglycan core protein or varying GAG chain length in modulating cellular 
interpretation of the applied GAG signals was not accounted for. Similarly, CSC and HS 
interact with a range of growth factors [139-143], and the potential effects of these 
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factors on observed cell behavior were not assessed. In terms of analysis methods, many 
of the present conclusions are based on semiquantitative immunostaining analyses and 
thus the results should be interpreted with caution. This is particularly true for the 
activated transcription factors examined, since the immunostaining assessments did not 
distinguish between nuclear and cytoplasmic proteins.  
That said, the cumulative ECM and phenotypic data indicate that the PEG–HA 
gels may be the most appropriate for vocal fold SLP regeneration of the formulations 
examined, at least for the GAG molecular weights investigated. Future studies will 
therefore focus on PEG–HA hydrogels and will explore a broader range of PEGDA 
molecular weights and concentrations in order to further improve the correspondence 
between the dynamic mechanical response of PEG–HA gels and that of the vocal fold 
lamina propria. 
 
 
 
 
Fig. 12. Schematic of RHAMM and CD44 signaling and associated signaling intermediates, adapted 
from Turley et al. [80]. 
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CHAPTER IV 
REGULATION OF SMOOTH MUSCLE CELL PHENOTYPE BY 
GLYCOSAMINOGLYCAN IDENTITY* 
 
 
4.1. Overview 
 
The retention of lipoproteins in the arterial intima is an initial event in early 
atherosclerosis and occurs, in part, through interactions between negatively charged 
GAGs and the positively charged residues of apolipoproteins. Smooth muscle cells 
(SMCs) which infiltrate into the lipoproteinenriched intima have been observed to 
transform into lipid-laden foam cells. This phenotypic switch is associated with SMC 
acquisition of a macrophage-like capacity to phagocytose lipoproteins and/or of an 
adipocyte-like capacity to synthesize fatty acids de novo. The aim of the present work 
was to explore the impact of GAG identity on SMC foam cell formation using a scaffold 
environment intended to be mimetic of early atherosclerosis. 
 
 
 
 
 
 
 
 
_____ 
*Reprinted with permission from Influence of “Regulation of smooth muscle cell phenotype by 
glycosaminoglycan identity” by Xin Qu, Andrea Carolina Jimenez-Vergara, Dany J. Munoz-Pinto, Diana 
Ortiz, Rebecca E. McMahon, Deissy Cristancho, Silvia Becerra-Bayona, Viviana Guiza-Arguello, K. Jane 
Grande-Allen, Mariah S. Hahn, 2010, Acta Biomaterialia 7 (2011) 1031–1039, Copyright 2010, Acta 
Materialia Inc. Published by Elsevier Ltd. 
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In these studies, we focused on CSC, DS, and an intermediate molecular weight 
hyaluronan (HAIMW, ~400 kDa), the levels and/or distribution of each of which are 
significantly altered in atherosclerosis. DS hydrogels were associated with greater SMC 
phagocytosis of apolipoprotein B than HAIMW gels. Similarly, only SMCs in DS 
constructs maintained increased expression of the adipocyte marker A-FABP relative to 
HAIMW gels over 35 days of culture. 
The increased SMC foam cell phenotype in DS hydrogels was reflected in a 
corresponding decrease in SMC myosin heavy chain expression in these constructs 
relative to HAIMW gels at day 35. In addition, this DS-associated increase in foam cell 
formation was mirrored in an increased SMC synthetic phenotype, as evidenced by 
greater levels of collagen type I and glucose 6-phosphate dehydrogenase in DS gels than 
in HAIMW gels. Combined, these results support the increasing body of literature that 
suggests a critical role for DS-bearing proteoglycans in early atherosclerosis.  
 
4.2. Introduction 
 
Coronary artery disease is a leading cause of death in the USA [144] and 
develops when excess cellular and ECM components build up in the coronary arteries 
through the process of atherosclerosis [22-24]. Until recently it was generally believed 
that the extracellular lipids associated with early atherosclerosis originated from dead 
foam cells derived from invading macrophages. However, it is now recognized that this 
early accumulation of lipids precedes macrophage infiltration and instead arises 
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primarily from enhanced lipoprotein retention by the ECM of the arterial intima [22-24]. 
In fact, recent studies indicate that ionic interactions between the negatively charged 
GAG side-chains of intimal proteoglycans (PGs) and the positively charged 
apolipoprotein residues of low density lipoproteins (LDL) are critical to early 
atherosclerotic lipid retention [25-27]. As arterial LDL loading increases in 
atherogenesis, macrophages and SMCs increasingly infiltrate into the intima, followed 
by the appearance of foam cells [22]. Although foam cells were long considered to arise 
exclusively from macrophages, it is now known that SMCs form a significant portion of 
the foam cell population [145, 146]. The transition of SMCs to foam cells is marked by 
the acquisition of macrophage-like behaviors, such as scavenger– receptor uptake of 
LDL [147, 148], and/or by the acquisition of adipocyte-like properties, including 
expression of adipocyte fatty acid binding protein (A-FABP) [146]. Although it is 
recognized that GAG retention of lipoproteins is a key event in SMC foam cell 
formation [22], the extent to which specific GAG types contribute to this process is 
relatively poorly understood. Thus, the present work was designed to explore the impact 
of GAG identity on SMC phenotype using a scaffold environment intended to be 
mimetic of early atherosclerosis. Specifically, the effects of CSC, DS, and an 
intermediate molecular weight hyaluronan (HAIMW, ~400 kDa) were examined, as the 
levels and/or distribution of each of these GAG types are altered in early atherosclerosis 
[22, 149-154].  
To generate culture conditions mimetic of early atherosclerosis, PEGDA 
hydrogel was selected as the base scaffold into which the desired GAG signals were 
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conjugated. PEGDA gels have several properties which make them appropriate for the 
present studies. First, pure PEGDA hydrogels function as biological ‘‘blank slates’’ in 
that they are intrinsically resistant to protein adsorption and cell adhesion [70]. Thus, 
hybrid PEGDA–GAG gels permit the defined investigation of GAG identity on SMC 
behavior. In addition, the slow degradation rate and high cross-link density of PEGDA 
gels force encapsulated cells to take on rounded/stellate morphologies with limited cell–
cell interactions [16, 72]. These particular characteristics of PEGDA hydrogels are 
generally considered undesirable for the study of normal SMC function. However, they 
are appropriate for atherosclerotic mimetic environments, since atherosclerosis-induced 
changes are associated with SMCs taking on rounded/stellate morphologies [155-157] 
with limited intercellular gap junctions [158]. Finally, the dense cross-linking and slow 
degradation rate of PEGDA gels prevent cell-mediated hydrogel contraction and the 
associated changes in scaffold material properties which can confound interpretation of 
cell responses [16]. 
        In the present work, porcine SMCs were encapsulated in PEGDA hydrogels 
containing 0.1 wt.% GAG, a concentration selected to be consistent with GAG levels in 
arterial tissue [150, 159]. A 10 wt.% 10 kDa PEGDA hydrogel was chosen for the base 
scaffold in order to mimic the modulus of lipid-rich regions of grade II atherosclerotic 
plaque [160]. Following 14 and 35 days of culture, SMC phenotype in each formulation 
was assessed biochemically and histologically. 
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4.3. Materials and Methods 
 
4.3.1. Polymer Synthesis Dnd Characterization  
 
4.3.1.1. PEGDA Synthesis  
 PEGDA was prepared as previously described [117] by combining 0.1 mmol ml-
1 dry PEG (10 kDa, Fluka), 0.4 mmol ml-1 acryloyl chloride, and 0.2 mmol ml-1 
triethylamine in anhydrous DCM and stirring under argon overnight. The resulting 
solution was washed with 2 M K2CO3 and separated into aqueous and DCM phases to 
remove HCl. The DCM phase was subsequently dried with anhydrous MgSO4, and 
PEGDA was precipitated in diethyl ether, filtered, and dried under vacuum. The extent 
of PEG diacrylation was determined by 1H NMR to be ~75%. 
 
4.3.1.2. Synthesis of Methacrylate-Derivatized CSC and DS  
In order to conjugate specific GAGs into the PEGDA-based hydrogel networks, 
each GAG type was methacrylate-derivatized according to standard protocols [81]. CSC 
(~50 kDa, 6.4 wt.% sulfur, Sigma) and DS (~41.5 kDa, 6.1 wt.% sulfur, Sigma) were 
selected to have molecular weights (MWs) consistent with those observed in 
atherosclerotic tissue [149, 159]. The respective sulfur contents of these GAG chains 
indicated that, on average, the CSC and DS disaccharide units had a charge density 
consistent with mono-sulfation. The GAGs were dissolved in deionized dIH2O to 
achieve a 1 wt.% final concentration, and the pH of each solution was adjusted to 8.0. A 
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10-fold molar excess of methacrylic anhydride (Polysciences) was added per 
disaccharide unit. Each reaction was allowed to proceed under constant stirring at 4 °C, 
with the solution pH being maintained at ~8.0 by periodic addition of 5 M NaOH. The 
product of each reaction was precipitated twice using chilled 95% ethanol, dialyzed 
against dIH2O for 48 h, and lyophilized. The extent of methacrylate-derivatization was 
characterized by 1H NMR to be ~1.0–1.6%. These levels of methacrylate-derivatization 
have been previously shown to negligibly alter observed cell-GAG interactions [16, 81, 
118, 161-163].  
 
4.3.1.3. Synthesis of Methacrylate-Derivatized Intermediate Molecular Weight HA  
Recent studies indicate that atherosclerotic vessels contain two primary HA 
populations, one with MW > 1 x 10
3 kDa, which is also present within normal tissue, and 
a second with MW 340 kDa, which appears to be specific to atherosclerotic tissue [149, 
154]. To generate HA appropriate for the examination of atherosclerotic conditions, high 
MW HA (HAHMW, Streptococcus equi, MW ~1.65 x 10
3 kDa, Fluka) was first 
methacrylate derivatized as above. The purified product was then dissolved at 1 mg ml-1 
in phosphate- buffered saline (PBS) containing 0.05% sodium azide and 5U ml-1 
hyaluronidase IV-S (H3884, Sigma). Following incubation at 37 °C overnight, the 
enzyme was heat inactivated. The resulting digestion product (HAIMW-MA) was dialyzed 
against dIH2O for 48 h and lyophilized. The mean MW of the isolated HAIMW-MA was 
determined to be ~400 kDa, with a polydispersity of ~1.3, using gel permeation 
chromatography (Viscotek).  
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4.3.1.4. Synthesis of Acrylate-Derivatized Cell Adhesion Peptide  
Cell adhesion peptide RGDS (American Peptide) was reacted with acryloyl-
PEG-N-hydroxysuccinimide (ACRL-PEG-NHS, 3.4 kDa, Nektar) at a 1:1 M ratio for 2 
h in 50mM sodium bicarbonate buffer, pH 8.5 [20]. The product (ACRL-PEG-RGDS) 
was purified by dialysis, lyophilized, and stored at -20 °C until use.  
 
4.3.2. Characterization of Hydrogel Properties  
 
4.3.2.1. Hydrogel Initial Water Uptake  
To compare initial hydrogel water uptake across formulations, the initial weight 
(Wi) of each gel was determined immediately following polymerization, after which the 
gels were submerged in media. After 24 h, the swollen weight (Ws) of each gel was 
measured. The equilibrium water uptake (S) was calculated as: S 
 s
 i
. This information 
was used to estimate the increase in hydrogel volume due to swelling, data which were 
then used to compare post-swelling GAG levels across gels.  
 
4.3.2.2. Average Mesh Size  
 PEGDA hydrogel mesh size cannot be visualized using standard techniques such 
as conventional SEM [164]. In the present study, hydrogel mesh size was characterized 
via a series of dextran diffusion experiments based on an adaptation of the methodology 
of Watkins et al. [120]. To avoid charge–charge interactions between the diffusing 
dextrans and the GAG chains tethered to the hydrogel network, fluorescently labeled, 
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charge-neutral dextrans were employed. In brief, PEGDA-GAG hydrogels were 
prepared and allowed to swell overnight at 37 °C in PBS containing 0.05% azide (PBS–
azide). 1 cm diameter discs were cored from each hydrogel formulation. Fluorescently 
labeled, charge-neutral dextrans (40 and 70 kDa, Invitrogen) were dissolved at 0.05 mg 
ml-1 in HEPES-buffered saline (HBS) (10 mM HEPES, 150 mM NaCl, pH 7.4) 
containing 0.05% azide and added at 1 ml per hydrogel disc (3 discs per dextran MW). 
Dextran solutions were allowed to diffuse into the hydrogels for 24 h at 37 °C. Each gel 
disc was subsequently gently blotted and transferred to 1 ml of fresh PBS–azide. 
Dextran that had penetrated into the hydrogels was then permitted to diffuse out into the 
surrounding solution at 37 °C. After 24 h, the fluorescence of the PBS– azide solution 
surrounding each disc was measured at excitation/ emission wavelengths of 530/590 nm. 
Dextran standard curves were used to convert each fluorescence signal to a 
concentration. For each hydrogel formulation, the measured concentration readings for 
each dextran MW were divided by the gel thickness and then plotted versus dextran 
hydrodynamic radius [121]. The area (A) under the resulting curve served as a 
quantitative indicator of hydrogel permissivity over the hydrodynamic radii range 
assayed. For the purposes of comparison, the calculated area values for CSC and DS gels 
were normalized to that of the HAIMW gels to yield relative mesh size values.  
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4.3.2.3. Hydrogel Permissivity to LDL  
To confirm the ability of LDL molecules to diffuse into the hydrogel networks, 
three gels from each formulation were exposed overnight at room temperature to 50 lg 
ml-1 of fluorescently labeled LDL (Invitrogen) in PBS. After 24 h, the levels of LDL 
which had diffused into the hydrogel networks were examined using confocal 
microscopy (Leica). The resulting confocal image series were volume-rendered using 
Osirix freeware and compared against control gels which had not been exposed to LDL.  
 
4.3.2.4. Comparison of GAG LDL Retention  
To assess differences in the LDL-binding capacity of the various GAG-laden 
hydrogels, samples which had been exposed overnight to fluorescently labeled LDL 
were transferred to fresh PBS–azide. Over a period of 24 h, the PBS solution 
surrounding each gel was exchanged twice, after which the hydrogels were transferred to 
fresh PBS for fluorescence imaging.  
 
4.3.3. Cell Culture  
 
Cryopreserved aortic SMCs (Cell Applications) isolated from pigs, a common 
animal model for vascular SMC physiology [165, 166], were thawed and expanded in 
monolayer culture between passages 4–8. Prior to encapsulation, cells were maintained 
at 37 °C in 5% CO2 in DMEM (Hyclone) supplemented with 10% FBS (Hyclone), 1 ng 
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ml-1 basic fibroblast growth factor (BD Biosciences), 100 mU ml-1 penicillin and 100 mg 
l-1 streptomycin (Hyclone).  
 
4.3.4. Cell Encapsulation and Hydrogel Maintenance  
 
Hydrogels were fabricated by preparing precursor solutions containing 100 mg 
ml-1 10 kDa PEGDA, 1 mg ml-1 methacrylatederivatized GAG, and 1 lmol ml-1 ACRL-
PEG-RGDS in HBS. The 100:1 weight ratio of PEGDA to GAG was chosen to ensure 
that the degradation rate, modulus, and initial mesh structure of each hydrogel network 
would be dominated by PEGDA [19]. A 300 mg ml-1 solution of UV photoinitiator 2,2-
dimethoxy-2-phenyl acetophenone in N-vinylpyrrolidone was added at 1% to each 
precursor solution. SMCs were harvested and resuspended in the filter-sterilized 
precursor solutions at ~1 x 106 cells ml-1. The cell suspensions were then poured into 
molds composed of two glass plates separated by 0.5 mm polycarbonate spacers and 
polymerized by 2 min exposure to longwave UV light (Spectroline, ~6 m Wcm-2, 365 
nm). The hydrogel slabs were transferred to Omnitrays (Nunc) fitted with four sterile 
polycarbonate bars to simultaneously prevent gel flotation and prevent gel contact with 
the tray bottom. Hydrogels were immersed in DMEM supplemented with 10% FBS, 100 
U ml-1 penicillin, and 100 mg l-1 streptomycin and maintained at 37 °C in 5% CO2. The 
FBS lot used for the present studies contained ~50 mg dl-1 LDL according to the 
manufacturer’s quality control assays.  
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4.3.4.1. Hydrogel Mechanical Properties and Contraction  
Following initial swelling, three 8 mm diameter samples were cored from each 
hydrogel. The thickness of each disc was measured using a digital caliper. These 
thickness measures served both as gage lengths for mechanical testing as well as 
indicators of hydrogel degradation and/or SMC-mediated gel compaction with time. 
Following application of a 0.01 N preload, each hydrogel was subjected to cyclic 
unconstrained compression (~10% cyclic strain) at 1 Hz using an Instron 3342. The 
dynamic compressive modulus of each hydrogel formulation was extracted from the 
resulting stress–strain data.  
 
4.3.5. End-Point Hydrogel Analyses 
  
On days 14 and 35 of culture, a series of 8 mm diameter samples were collected 
from each hydrogel formulation for mechanical, biochemical, and histological analyses. 
Mechanical samples were tested as described above.  
 
4.3.5.1. Collagen and Elastin Analyses  
Samples harvested for biochemical analyses were transferred to screw cap vials, 
weighed, flash frozen in liquid nitrogen, and stored at -80 °C until time of analysis. The 
weight of each 8 mm disc was used as a second indicator of gel degradation and/or 
compaction, since the reduction in gel volume associated with both of these processes 
would be reflected in a mass loss, assuming lack of commensurate new matrix 
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deposition [16]. Hydrogel samples were digested for 72 h at 37 °C in 1 ml of 0.12 M 
NaOH per 0.2 g hydrogel wet weight [83, 84]. DNA, total collagen, and elastin were 
then analyzed using established protocols. For each assay, the standards used were 
subjected to the same association with PEGDA and GAG and to the same digestion 
conditions as the samples. The resulting collagen and elastin data were normalized to 
cell number.  
 
DNA Analysis. Aliquots of the hydrolyzed samples (n = 12 per formulation) were 
neutralized and their DNA content determined using the Invitrogen PicoGreen assay 
[84]. DNA measures were translated to cell number using a conversion factor of 6.6 pg 
DNA per cell [85]. Calf thymus DNA (Sigma) served as a standard. 
 
Collagen Analysis. The amino acid hydroxyproline was quantified as an indirect 
measure of total collagen. In brief, aliquots (n = 4–6 per formulation) collected for 
collagen quantitation were hydrolyzed for 18 h at 110 °C in 6 M HCl. Each sample was 
then dried on a Labconco Centrivap to remove HCl, resuspended in dIH2O, and passed 
through a charcoal-packed centrifugal microcolumn (Nunc) to remove caramelized 
sugars. The resultant samples were reacted with chloramine T and p-
dimethylbenzaldehyde reagents [83, 84]. Sample absorbance was read at 550 nm relative 
to that of L-4-hydroxyproline (Sigma). Total collagen content was estimated from 
measured grams of hydroxyproline by dividing by 0.13 [124].  
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Elastin Analysis. Elastin production was measured using indirect ELISA [86]. 
NaOH digested samples (n = 9–14 per formulation) were neutralized and further 
digested with 0.25 M oxalic acid at 100 °C overnight. Oxalic acid was removed from the 
samples and exchanged for PBS using Microcon YM-3 centrifugal filters (Millipore). 
100 μl of the resulting samples were applied to a high binding multiwell plate for 3 h at 
room temperature. After blocking the plate with bovine serum albumin (BSA), adsorbed 
elastin fragments were detected by applying elastin antibody (BA-4, Santa Cruz 
Biotechnology, [SCBT]) followed by donkey anti-mouse HRP secondary antibody 
(SCBT) and 2,2’-azino-bis(3-ethylbenzthiazo-line-6-sulphonic acid). Absorbance was 
read at 410 nm, with bovine aortic elastin (Sigma) serving as a standard.  
 
4.2.5.2. GAG Analyses  
Quantification of individual GAG types as well as changes in these GAG types 
requires specialized techniques, which generally rely on identifying specific GAG 
classes based on their characteristic component disaccharides. Given the anticipated 
levels of new GAG synthesis (~5 μg (g gel)-1 = ~50 lg (g PEG)-1) [72], the high 
sensitivity technique known as fluorescence assisted carbohydrate electrophoresis 
(FACE) was employed and GAG type assessments were limited to HA, DS, and CSC 
disaccharide units.  
To separate newly synthesized GAGs from the GAG chains covalently linked to 
the PEGDA hydrogel networks, a two step degradation process was employed. The first 
phase of this process was intended to release newly deposited GAGs, while the second 
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step was intended to release GAGs conjugated to the hydrogel network. In brief, 
harvested hydrogel samples were sliced into a series of 35 lm sections using a 
cryomicrotome, after which these sections were exposed to 1 mg ml-1 proteinase K 
(Worthington Biochemical) in PBS at 37 °C. Sectioning increased the surface area for 
enzymatic action, allowing the proteinase K to release GAGs bound to either 
proteoglycan core proteins or to cell receptors. However, since the covalent bonds 
linking the methacrylate-derivatized GAGs to the PEGDA chains are not labile by 
proteinase K, the GAGs tethered to the hydrogel networks were not released by this 
treatment. Following 24 h of digestion, the samples were heated to inactivate the 
proteinase K, after which they were centrifuged and the supernatant collected. The gel 
sections were subsequently rinsed with PBS, and the wash solution was combined with 
the initial proteinase K supernatant. The gels sections were then immersed in 0.1 M 
NaOH for 24 h at 37 °C to induce hydrolysis of the hydrogel structure and the release of 
conjugated GAG chains.  
Each proteinase K supernatant and NaOH-treated sample was exposed to 0.3 mU 
μl-1 chondroitinase ABC (Proteus vulgaris, Sigma) for 3 h at 37 °C, followed by 
exposure to 0.3 mU μl-1 chondroitinase ACII (Flavobacterium heparinum, Seikagaku 
America) overnight at 37 °C [43,44]. This enzymatic treatment digested chains of HA, 
CSC, and DS into their component disaccharides, which can be considered to be 
primarily ΔDi-HA, ΔDi-6S, and ΔDi-4S, respectively. The chondroitinase ABC/ACII 
treated samples were then dried, fluorotagged with 2-aminoacridone HCl (AMAC, 
Invitrogen) [167], and mixed with glycerol. These samples were subsequently 
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electrophoresed on monosaccharide gels prepared as previously described [167]. 
Negative control samples of pure AMAC were run on each gel, and enzyme digestion 
products were identified by correspondence to bands in disaccharide standard lanes. The 
gel bands were imaged using a Kodak GelLogic station and analyzed using Image J 
software. The quantity of each disaccharide was determined from the integrated optical 
density of the appropriate band, internal maltriose standards, and sample volume 
information [20]. The measured disaccharide values were then normalized to sample 
PEG content, which was quantified by iodine staining of the electrophoresed, NaOH-
treated samples as per Suggs et al. [168].  
 
4.3.5.2. Histological Analyses  
Samples harvested for histological analyses were fixed in 10% formalin for 30 
min, embedded in Tissue-Tek freezing medium, and frozen at -80 °C. 35 μm sections 
were cut using a cryomicrotome.  
 
Immunostaining. SMC ECM production and phenotype were analyzed for each 
gel sample using standard immunohistochemical techniques. All immunostaining steps 
took place at room temperature unless otherwise noted. Rehydrated sections were 
blocked with peroxidase for 10 min, followed by 10 min exposure to Terminator block 
(Biocare Medical). Primary antibodies for elastin (BA-4, SCBT), collagen type I 
(Rockland Immunochemicals), or collagen type III (Rockland Immunochemicals), which 
had been diluted in PBS containing 0.05% Tween 20 and 3% BSA, were then applied for 
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1 h. Primary antibodies for smooth muscle myosin heavy chain (MHC) (G-4, SCBT), 
calponin h1 (CALP, SCBT), A-FABP (C-15, SCBT), and apolipoprotein B (apoB) 
(ab20737, Abcam) were similarly applied to construct sections for 1 h, except that 
rehydrated sections were permeabilized with PBS containing 0.5% Triton X-100 for 10 
min prior to Terminator application. Bound primary antibody was detected using 
alkaline phosphatase-conjugated secondary antibody (Jackson Immunochemicals) 
followed by application of the chromogen Ferangi Blue (Biocare Medical) or using 
horseradish peroxidase-conjugated secondary antibody followed by application of the 
chromogen AEC (LabVision). Based on observed differences in SMC behavior in 
HAIMW and DS gels, day 14 hydrogel samples were also immunostained for the 
metabolic marker glucose 6-phosphate dehydrogenase (G6PD) (ab61704, Abcam) and 
ECM protein osteocalcin (M-15, SCBT) as per the above procedure. 
 
Semi-quantitative Assessments. For intracellular markers (calponin h1, MHC, A-
FABP, apoB, and G6PD), cell counts were carried out as semi-quantitative analyses of 
the immunostaining results. These counting assessments were conducted by two 
independent observers on two or three sections per sample of each PEGDA-GAG 
formulation (~500–3000 cells) according to established methods [53, 87-89]. For each 
cell i in a given section, a staining intensity di was recorded on a scale of 0–3, 0 
representing no staining and 3 representing the highest intensity observed among all gel 
formulations for that antibody. The cumulative staining intensity d for a given antibody 
in a particular section was calculated using the equation: d 
 di
total cell number
. In addition, 
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since deposited ECM tended to remain localized around the parent cells in each hydrogel 
formulation, as is characteristic for PEGDA gels [73, 90, 169], the relative levels of 
osteocalcin, collagen type I, collagen type III, and elastin among hydrogel formulations 
were also evaluated by cell counts as per the above procedure. For the purposes of 
comparison, the resulting average cumulative staining intensities for CSC and DS gels at 
a given time point were normalized to the corresponding HAIMW average cumulative 
staining intensity. 
 
4.3.6. Statistical Analyses  
 
Data are reported as means ± standard error of the mean. Comparison of sample 
means was performed by one-way ANOVA and Tukey’s post-hoc test (SPSS software), 
P  <  0.05.  
 
4.4. Results  
  
4.4.1. Hydrogel Material Properties  
 
4.4.1.1. Hydrogel Swelling, LDL Permissivity, and Binding Affinity  
In order to specifically attribute differences in SMC behavior across hydrogel 
formulations to initial differences in gel GAG composition, it was important that the 
remaining hydrogel material properties could be considered consistent across gels. The 
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‘‘bulk’’ material properties of each gel formulation were therefore characterized and 
compared. The initial water uptake S of each gel following polymerization was similar 
(CSC, 1.42 ± 0.02; DS, 1.38 ± 0.03; HAIMW, 1.43 ± 0.02), indicating that gel equilibrium 
hydration could be considered consistent across formulations. The ability of LDL to 
diffuse through and bind to the GAG-laden hydrogel networks was also characterized by 
exposing the swollen gels fluorescently labeled LDL, examining the equilibrium levels 
of LDL diffusion, and then assessing LDL retention when the external LDL solution was 
removed. Fig. 13 demonstrates the ability of LDL to partition into and diffuse evenly 
throughout the GAG-laden hydrogels. When the observed LDL fluorescence intensities 
within the hydrogel networks were quantified against known LDL standards, each 
hydrogel demonstrated similar permissivity to LDL (Table 5). This result was 
anticipated based on the similarity in bulk average mesh size across hydrogel 
formulations, as determined by the equilibrium diffusion of a set of neutral dextrans 
(Table 5), and based on previous reports indicating that the average mesh size of 10% 10 
kDa PEGDA hydrogels could be considered to be roughly twice the average 
hydrodynamic radius of LDL [12, 72]. Comparison of LDL retention by the GAG-
containing hydrogels following the exchange of the external LDL solution with PBS 
indicated that each GAG-laden gel had a similar average capacity to bind LDL (Table 5). 
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Table 5. Hydrogel Relative Mesh Size, LDL Permissivity, and LDL Retention. 
 
 
4.4.1.2. Assessments of Alterations in GAG Levels and Gel Material Properties  
Comparison of the initial and end-point mechanical data (Table 6) suggested that 
the bulk gel modulus could be considered indistinguishable across formulations at each 
time point. Similarly, the initial and end-point gel thickness and mass data corresponded 
to a negligible reduction in gel volume with time (Table 6). FACE analysis of the GAGs 
within hydrolyzed day 0 gels indicated ~100% conjugation of methacrylate-derivatized 
GAG to the hydrogel networks at the time of polymerization (~11 mg GAG (g PEG)-1 =  
~1.1 mg ml-1 precursor solution = ~ 0.79 mg g-1 swollen gel, Table 7). Furthermore, the 
levels of GAGs conjugated to the gel networks at day 14 were not substantially altered 
from day 0 values. Although the levels of network-conjugated GAGs appeared to have 
decreased by day 35 relative to time 0 values, these differences were not statistically 
significant (Table 7). Cumulatively, the bulk modulus, thickness, gel mass, and 
conjugated GAG assessments indicated that the PEGDA–GAG gels retained the slow 
degradation rate and resistance to cell-mediated contraction characteristic of pure 
PEGDA hydrogels [84, 90-92]. 
To assess potential alterations in the GAG types experienced by encapsulated 
cells due to newly synthesized GAGs, FACE analyses were performed on GAGs 
Gel 
Type Relative Mesh Size 
LDL Diffusion into 
Network (µg/g) 
LDL 
Retained (µg/g) 
CSC 1.01 ± 0.01 7.52 ± 0.20 0.052 ± 0.028 
DS 1.02 ± 0.01 7.37 ± 0.40 0.043 ± 0.013 
HAIMW 1.00 ± 0.01 7.52 ± 0.16 0.046 ± 0.019 
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released from thin hydrogel sections following exposure to proteinase K. These newly 
synthesized GAGs were primarily comprised of ΔDi-6S disaccharides (a primary 
component of CSC) (data not shown) in each hydrogel type, and were measured at 
between 0.012 and 0.052 mg (g PEG)-1, which is equivalent to ~0.0008–0.0038 mg 
GAG per g swollen gel (Table 7). 
 
 
 
 
Fig. 13. Representative side views of 3D renderings of two, confocal image series taken of PEGDA–
GAG hydrogels. The upper image is of a hydrogel that had been immersed in a fluorescently labeled LDL 
solution for 24 h prior to imaging. The external LDL solution is apparent at the upper and lower borders of 
the gel. The lower image is of a control hydrogel immersed in PBS, rather than LDL, for 24 h prior to 
imaging. The upper and lower images were generated and rendered using the same microscope and 
software settings to ensure that the grayscale intensities of the hydrogel side views could be compared. 
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Table 6. Hydrogel Modulus, Thickness, and Mass Assessments. 
Gel 
Type 
Modulus (kPa) Thickness (mm) Mass of 8 mm Discs (mg) 
initial final initial final initial final 
CSC 81.6 ± 3.4 86.6 ± 1.7 0.56 ± 0.01 0.59 ± 0.01 28.4 ± 0.3 29.4 ± 0.3 
DS 79.1 ± 2.3 83.0 ± 12.2 0.55 ± 0.01 0.55 ± 0.01 27.6 ± 0.5 27.8 ± 0.4 
HAIMW 80.4 ± 3.6 81.5 ± 12.0 0.57 ± 0.01 0.56 ± 0.01 28.7 ± 0.4 28.1 ± 0.5 
 
 
4.4.2. SMC Collagen and Elastin Deposition  
 
To gage the extent to which encapsulated SMCs were taking on a synthetic 
phenotype, elastin and collagen production was analyzed biochemically and 
histologically at days 14 and 35. As expected for PEGDA gels [73], staining for elastin 
and individual collagen types was confined to the immediate pericellular space in each 
formulation (Fig. 14), enabling reliable semi-quantitative histological analyses of these 
ECM proteins. Day 14 histological and biochemical data suggested that DS may enhance 
elastin production relative to HAIMW and CSC (Fig. 15A). However, for both assessment 
methods, no statistical differences between elastin levels among hydrogel types were 
observed. In contrast, day 14 hydroxyproline measures indicated that total collagen 
levels were significantly higher in DS gels relative to HAIMW gels (P = 0.014, Fig. 3B). 
Analysis of individual collagen types demonstrated that collagen type I deposition was 
significantly greater in DS gels than in CSC gels (P = 0.036), whereas collagen type III 
was significantly greater in HAIMW gels relative to CSC hydrogels (P = 0.020) (Fig. 3B). 
Comparison of the collagen type I and type III trends with that of total collagen 
suggested that collagen type I was the dominant collagen being produced by the 
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encapsulated SMCs. By day 35, differences in elastin production among formulations 
were no longer apparent (Fig. 15C), although the day 14 trends in collagen type I were 
maintained at this time point (Fig. 15D). In particular, collagen type I deposition on day 
35 was greater in DS gels than HAIMW gels (P = 0.050). As shown in the notations 
associated with Fig. 15, total collagen and total elastin levels per cell remained 
essentially unaltered from day 14 to day 35, indicating that the cells had reached a 
steady-state betweenthe productionand degradation of these molecules.  
 
 
 
Fig. 14. Representative images of day 14 CSC, DS, and HAIMW hydrogel sections immunostained for 
elastin and A-FABP. The scale bar in the upper left image represents 40 μm and applies to all images.The 
noted values for the immunostaining assessments are unitless, but represent both average intensity (on a 
scale of 1–3) as well as the cell fraction positively stained. 
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Table 7. Results from FACE-Based GAG Analyses. 
 
 
4.4.3. SMC Phenotype  
 
SMC acquisition of adipocyte-like or macrophage-like characteristics was 
similarly examined (Fig. 16). On day 14, SMC uptake of LDL (as evidenced by 
intracellular apoB) was higher in DS gels relative to HAIMW gels (P = 0.026) (Fig. 16A). 
In addition, expression of the late-term adipogenic marker A-FABP was significantly 
greater in CSC (P = 0.034) and DS (P = 0.018) gels than in HAIMW gels (Figs. 14 and 
16A). Similarly, day 35 apoB uptake (P = 0.05) and A-FABP expression (P = 0.015) 
continued to be greater in DS gels relative to HAIMW gels (Fig. 16C). The degree to 
which encapsulated cells displayed markers associated with a mature, contractile SMC 
phenotype was also investigated through analysis of calponin h1 and MHC expression. 
On day 14, calponin h1 levels were greater in DS gels relative to both CSC (P = 0.021) 
and HAIMW (P = 0.011) constructs (Fig. 16B). In contrast, MHC measures indicated that 
both DS (P = 0.011) and HAIMW (P = 0.039) better supported a contractile phenotype 
than CSC.  
 
 
 
GAG Source Gel Type 
Initial  
(mg/g PEG) 
Day 14  
(mg/g PEG) 
Day 35  
(mg/g PEG) 
Conjugated CSC, DS,  HAIMW 11.7  ± 3.0 10.7 ± 3.6 7.0 ± 1.2 
Synthesized 
CSC  0.015 ± 0.003 0.012 ± 0.008 
DS  0.051 ± 0.023 0.018 ± 0.006 
HAIMW  0.052 ± 0.027 0.013 ± 0.006 
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Fig. 15. ECM deposition across formulations. (A and C) Relative elastin production by both biochemical 
and histological assessments on days 14 and 35, respectively. (B and D) Relative total collagen, collagen 
type I and collagen type III production on days 14 and 35, respectively. *Significantly different from CSC 
hydrogels, P < 0.05. #Significantly different from DS hydrogels, P < 0.05. CSC and DS data at each time 
point have been normalized to the corresponding HAIMW data, the average values for which are noted 
above the HAIMW formulation where applicable. For the elastin and collagen biochemical data, the units of 
the noted values are in micrograms per cell. 
 
 
By day 35, calponin h1 expression had leveled out among formulations, and the 
MHC trends had shifted, with HAIMW gels supporting greater MHC expression than 
either DS (P = 0.050) or CSC (P = 0.048) gels (Fig. 16D). Due to the observed 
differences between the apoB and A-FABP profiles of HAIMW and DS gels, day 14 
hydrogel samples were also immunostained for G6PD and osteocalcin in order to gain 
further insight into the cell responses within these gels. G6PD is a key metabolic enzyme 
92 
 
associated with a primarily anabolic pathway essential in the regulation of oxidative 
stress [170, 171], one of the stressors in atherosclerosis. In addition, osteocalcin is an 
ECM protein produced by foam cells in calcific plaques. As shown in Fig. 17, both 
G6PD (P < 0.001) and osteocalcin (P = 0.010) were elevated in DS gels relative to 
HAIMW hydrogels.  
 
4.5. Discussion  
 
The aim of the present study was to examine the impact of GAG type on SMC 
acquisition of adipocyte-like or macrophage-like characteristics within an environment 
mimetic of early atherosclerosis. The results from the aforementioned apoB and A-
FABP analyses suggest that DS gels support greater foam cell formation than HAIMW 
hydrogels.  
To assess the extent to which SMC acquisition of foam cell characteristics was 
correlated with a transition towards a synthetic phenotype, SMC collagen and elastin 
production were evaluated. No significant differences in SMC elastin deposition were 
observed over the course of the present study. This result is in agreement with the 
literature, which indicates that, although changes in elastin levels are at times observed 
in atherosclerotic lesions, these alterations are generally not consistent in their 
directionality [172]. Instead, changes in elastic fiber structure characterize 
atherosclerotic vessels [172]. Regarding collagen, DS gels displayed greater deposition 
of collagen type I than CSC and HAIMW gels on day 14 and day 35, respectively. The 
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literature indicates that SMC synthesis of total collagen in general, and of collagen type I 
in particular, is up-regulated in early atherosclerotic lesions [145, 173, 174]. In addition, 
levels of the anabolic enzyme G6PD were elevated in DS gels relative to CSC and 
HAIMW hydrogels, at least at day 14. Thus the present data suggest that DS induces a 
more synthetic SMC phenotype than CSC or HAIMW, in agreement with the increased 
foam cell transition observed for DS relative to HAIMW.  
 
 
 
Fig. 16. Evaluation of SMC foam cell versus contractile phenotypes. (A and B) Relative expression of 
markers of a SMC contractile apparatus on days 14 and 35, respectively. (C and D) Relative apoB uptake 
and A-FABP expression on days 14 and 35, respectively. *Significantly different from CSC hydrogels, P 
< 0.05. #Significantly different from DS hydrogels, P < 0.05. CSC and DS data at each time point have 
been normalized to the corresponding HAIMW data, the average values for which are noted above the 
HAIMW formulation, where applicable. The noted values for the immunostaining assessments are unitless 
but represent both average intensity (on a scale of 1–3) as well as the cell fraction positively stained. 
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Fig. 17. Relative G6PD and osteocalcin expression on day 14. *Significantly different from CSC 
hydrogels, P < 0.05. #Significantly different from DS hydrogels, P < 0.05. 
 
 
The increase in SMC acquisition of synthetic and foam cell phenotypes in DS 
gels was not, at least initially, marked by a corresponding decrease in SMC contractile 
marker expression. Specifically, day 14 calponin h1 levels were greater in DS gels 
relative to HAIMW gels. Only day 35 MHC measures suggested that the increased foam 
cell phenotype associated with SMCs in DS gels was being mirrored in decreased 
expression of a contractile phenotype. An increase in SMC contractile marker expression 
in early atherogenesis followed by a down-regulation of these markers in later 
atherosclerotic stages has previously been documented. For instance, a recent study of 
SMCs in the aortic arch of LDL receptor knockout mice revealed increased MHC 
expression in high cholesterol mice by day 28, coincident with the SMC proliferation 
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and ECM remodeling associated with early atherosclerosis [175]. However, by day 98 
SMC MHC expression in the advancing atherosclerotic lesions had decreased [175]. 
The apparent link between DS and SMC foam cell formation suggested by the 
present results is in agreement with the current literature. Specifically, biglycan (a 
CS/DS-containing small leucine- rich proteoglycan) has been the focus of several recent 
studies of proteoglycan involvement in early atherosclerotic lipid deposition [22, 23, 25, 
176-178]. However, the above comparisons with in vivo data must be interpreted with 
caution due to the simplified in vitro system used here.  
Several limitations of the present manuscript merit comment. Although we 
mimicked the cell morphology and limited intercellular junctions associated with SMCs 
within atherosclerotic lesions, we did not reproduce several other aspects of early 
atherogenesis. Specifically, the proliferation and migration associated with SMC 
responses to arterial wall injury were not mirrored. Indeed, SMC proliferation and 
migration were essentially prevented by the same PEGDA hydrogel properties which 
allowed us to induce rounded/stellate SMC phenotypes. Furthermore, the origins of 
SMC rounding in atherosclerotic environments, which are linked to changes in ECM 
composition and SMC integrin profiles, were not recapitulated [156]. The present work 
also did not fully replicate the complex cascade of events/interactions between several 
cell types, growth factors, cytokines, and ECM molecules which ultimately lead to the 
formation of atheromatous plaques [27, 179]. Similarly, the role of the proteoglycan core 
protein in modulating SMC responses to CSC or DS signals was not accounted for. 
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  Finally, as previously discussed, the interaction of LDL with GAG chains is ionic 
in nature [177]. Thus, GAG chain length and charge densities are determining factors in 
the levels of bound lipid per chain [177, 178]. Although we have attempted to mimic the 
GAG chain lengths associated with atherosclerotic vessels in the present work, the CSC 
and DS chains conjugated to the hydrogel networks may not have charge densities 
appropriate to the atherogenic environment [180]. That said, we have reported the sulfur 
levels within the DS and CSC chains employed here, which should allow appropriate 
comparison with future work. 
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CHAPTER V 
APPROACH FOR FABRICATING TISSUE ENGINEERED VASCULAR 
GRAFTS WITH STABLE ENDOTHELIALIZATION* 
 
 
5.1. Overview 
 
A major roadblock in the development of TEVGs is achieving construct 
endothelialization that is stable under physiological stresses. The aim of the current 
study was to validate an approach for generating a mechanically stable layer of ECs in 
the lumen of TEVGs. To accomplish this goal, a unique method was developed to 
fabricate a thin EC layer using PEGDA as an intercellular ‘‘cementing’’ agent. This EC 
layer was subsequently bonded to the lumen of a tubular scaffold to generate a bi-
layered construct. The viability of bovine aortic endothelial cells (BAECs) through the 
‘‘cementing’’ process was assessed. ‘‘Cemented’’ EC layer expression of desired 
phenotypic markers (AcLDL uptake, VE-cadherin, eNOS, PECAM-1) as well as of 
injury-associated markers (E-selectin, SM22α) was also examined.  
 
 
_____ 
*Reprinted with permission from Influence of “Approach for Fabricating Tissue Engineered Vascular 
Grafts with Stable Endothelialization” by Andrea Carolina Jimenez-Vergara, Viviana Guiza-Arguello, 
Silvia Becerra-Bayona, Dany J. Munoz-Pinto, Rebecca E. Mcmahon, Anabel Morales,  Lynnette Cubero-
Ponce, and Mariah S. Hahn, 2010, Annals of Biomedical Engineering, Vol. 38, No. 9, September 2010, 
Copyright 2010, 2010 Biomedical Engineering Society. 
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These studies indicated that the ‘‘cementing’’ process allowed ECs to maintain high 
viability and expression of mature EC markers while not significantly stimulating 
primary injury pathways.  
The stability of the ‘‘cemented’’ EC layers under abrupt application of high shear 
pulsatile flow (~11 dyn cm-2, Pavg ~ 95 mmHg, ΔP ~ 20 mmHg) was evaluated and 
compared to that of conventionally ‘‘seeded’’ EC layers.  hereas the ‘‘cemented’’ ECs 
remained fully intact following 48 h of pulsatile flow, the ‘‘seeded’’ EC layers 
delaminated after less than 1 h of flow.  
Furthermore, the ability to extend this approach to degradable PEGDA 
‘‘cements’’ permissive of cell elongation was demonstrated. Combined, these results 
validate an approach for fabricating bi-layered TEVGs with stable endothelialization.  
 
5.2. Introduction 
 
In 2006, ~448,000 coronary artery bypass procedures were performed in the US 
alone [181]. Autologous saphenous veins and mammary arteries are currently the 
preferred graft materials for these small-caliber vessels (<6 mm ID), but many patients 
lack usable autologous tissue [182]. Prostheses formed from synthetic materials, such as 
polytetrafluoroethylene or polyethylene terephthalate, which are suitable as peripheral 
vessel grafts, fail as small-caliber vessel replacements due to their thrombogenicity, 
relatively poor elasticity, and low compliance [183]. Tissue engineering represents a 
potential alternate source of functional coronary artery grafts [184-186]. 
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Coronary arteries consist of three layers: the intima—coated on the luminal 
surface by an endothelial cell (EC) monolayer; the media—composed of SMCs in a 
collagen and elastin-rich ECM; and the adventitia—a loosely organized layer maintained 
by fibroblasts. The medial layer is considered to be primarily responsible for vascular 
tone and for vessel elasticity under physiological loading conditions [187]. Furthermore, 
an intact endothelial layer is considered to be critical to the long-term inhibition of 
thrombosis and hyperplasia [188]. Arterial TEVGs will therefore likely require both 
functional medial and intimal layers [183].  
Achieving TEVG endothelialization that is stable under physiological loading 
conditions is challenging, and engineered EC layers frequently delaminate upon 
exposure to high shear pulsatile flow [28, 29]. A range of methods have been employed 
to enhance stable vascular graft endothelialization, including specialized EC seeding 
methods [29] and luminal coatings (e.g., fibronectin, collagen) [30]. However, only 
moderate long-term success has been attained with these approaches. Another recent 
study achieved stable EC presence under prolonged (14 day) TEVG mechanical 
conditioning by encapsulating ECs within ~1 mm thick hydrogel layers [117]. Although 
this experimental design prevented EC loss due to physiological conditioning, the 3D 
arrangement of ECs likely induced non-physiological behaviors.  
The aim of the current study was to validate an approach for generating a thin, 
mechanically stable layer of ECs in the lumen of TEVGs. To accomplish this goal, a 
unique method was developed to fabricate bonded EC layers using PEGDA as a 
‘‘cementing’’ agent between adjacent ECs.  PEGDA was selected for use since its 
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photoactivity not only enabled the bonding of ECs into a continuous layer but also 
facilitated the generation of bi-layered TEVGs. In addition, the non-thrombogenic nature 
[189] and broadly tunable material properties (including modulus [92] and degradation 
rate [189, 190]) of  PEGDA gels are well-established, giving the resulting constructs 
potential utility in both the in vitro and in vivo scenarios. 
 In the present study, we examined the viability of bovine aortic endothelial cells 
(BAECs) through the ‘‘cementing’’ process. ‘‘Cemented’’ EC layer expression of 
quiescent phenotypic markers and of inflammatory/damage-associated markers was also 
investigated. Finally, the stability of the ‘‘cemented’’ EC layers under abrupt application 
of high shear pulsatile flow (~11 dyn cm-2, Pavg ~ 95 mmHg, ΔP ~ 20 mmHg) was 
evaluated and compared to that of conventionally ‘‘seeded’’ EC layers. 
 
5.3. Materials and Methods 
 
5.3.1. Polymer Synthesis 
  
  PEGDA was prepared as previously described [191] by combining 0.1 mmol ml-1 
dry PEG (6 kDa, Sigma), 0.4 mmol ml-1  acryloyl chloride, and 0.2 mmol ml-1  
triethylamine in anhydrous DCM and stirring under argon overnight at 4 °C. The 
resulting solution was washed with 2 M K2CO3 and separated into aqueous and DCM 
phases to remove HCl. The DCM phase was subsequently dried with anhydrous MgSO4, 
and PEGDA was precipitated in diethyl ether, filtered, and dried under vacuum.  
101 
 
Cell adhesion peptide RGDS (American Peptide) was conjugated to acryloyl-
PEG-N-hydroxysuccinimide (ACRL-PEG-NHS, 3.4 kDa, JenkemUSA) at a 1:1 molar 
ratio for 2 h in 50 mM sodium bicarbonate buffer, pH 8.5.9 The product (ACRL-PEG-
RGDS) was purified by dialysis, lyophilized, and stored at 220 °C until use.  
 
5.3.2. Cell Culture  
 
Cryopreserved bovine aortic ECs (BAECs, Cell Applications) at passage 4 were 
thawed and expanded at 37 °C and 5% CO2. During expansion, cells were cultured in 
Dulbecco’s Modified Eagle’s Media (DMEM, Hyclone) containing 10% iron-
supplemented bovine calf serum (BCS, Hyclone), 100 mU ml-1 penicillin, and 100 mg l-1 
streptomycin (Hyclone).  
 
5.3.3. Fabrication of Bi-layered Tubular Hydrogel Constructs  
 
5.3.3.1. Fabrication of Conventionally ‘‘Seeded’’ Control 
Hydrogels RGDS-containing PEGDA hydrogels with a ‘‘seeded’’ EC luminal 
layer were prepared by conventional methods. In brief, a precursor solution containing 
0.1 g ml-1  PEGDA and 2 mM ACRL-PEG-RGDS was prepared in HBS-TEOA (10 mM 
HEPES, 150 mM NaCl, 115 mM triethanolamine, pH 7.4). Ten microliters of 
photoinitiator solution (300 mg ml-1 of UV photoinitiator 2,2-dimethoxy-2-phenyl-
acetophenone (Sigma) in N-vinylpyrrolidone (Sigma)) were then added per mL of 
102 
 
mixture. The resulting solution was sterilized using a 0.22 ml PES filter, pipetted into 
tubular molds (3 mm ID, 5 mm OD), and polymerized by 6 min exposure to longwave 
UV light (365 nm, ~10 mW cm-2, UVP model B-100SP).  
Following overnight immersion in media, the polypropylene joints that would be 
used to mount the constructs onto the pulsatile flow bioreactor system were inserted into 
each gel end. BAECs at passage [84, 187] were seeded onto the luminal surface of the 
gels in four sequential steps. At each step, BAECs were resuspended in DMEM 
containing 10% BCS and injected into the lumen of each construct at 120,000 cells per 
cm2. Following 1 h incubation at 37 °C, the gel was rotated 90° and the seeding process 
was repeated. The ‘‘seeded’’ constructs were maintained in DMEM containing 10% 
BCS and 1% PSA (PSA: 10 U ml penicillin, 10 g l streptomycin, and 25 mg l-1 
amphotericin; Mediatech).  
 
5.3.3.2. Fabrication of ‘‘Cemented’’ Hydrogels 
Constructs with ‘‘cemented’’ EC layers were prepared by a unique sequential 
polymerization process. In brief, a precursor solution containing 0.1 g ml-1   PEGDA and 
2 mM ACRL-PEG-RGDS in HBS-TEOA was first prepared. Ten microliters of 
photoinitiator solution were then added per mL of mixture, and the resulting solution 
was sterilized by filtration.  
BAECs at passage [84, 187] were harvested and resuspended at high density (125 
x 106 cells ml-1) in the PEGDA precursor solution. Fifty microliters of the resulting 
mixture were spread evenly onto a 3 mm OD glass rod over a 5.5 cm length. This EC-
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PEGDA coating was then dried as a thin layer by 8 min application of a sterile airstream. 
During airstream application, the rod was held horizontally and constantly rotated to 
facilitate the fabrication of an even coating (Fig. 18).  
Each EC-coated rod was inserted as the inner mandrel of a double-walled 
cylindrical mold, the outer wall of which was composed of a hollow UV transparent 
plastic cylinder (5 mm ID).  PEGDA precursor solution was gently pipetted into the 
cylindrical molds and polymerized by exposure to UV light (365 nm, ~10 mW cm-2, 
UVP model B-100SP) for 6 min. The resulting bi-layered hydrogels were then removed 
from their molds and transferred to DMEM containing 10% BCS and 1% PSA.  
‘‘Seeded’’ and ‘‘cemented’’ controls fabricated using enzyme-degradable 
hydrogels were prepared as described above, except that  PEGDA containing the 
collagenase-labile peptide sequence APQGIAGQK was used for the ‘‘cementing’’ 
solution rather than pure  PEGDA.  
 
5.3.3.3. Fabrication of ‘‘Encapsulated’’ Hydrogel 
Controls PEGDA hydrogels containing ECs encapsulated per conventional 
methods were also fabricated. A precursor solution containing 0.1 g ml-1 PEGDA and 2 
mM ACRL-PEG-RGDS in HBS-TEOA was prepared. Ten microliters of photoinitiator 
solution were then added per mL of mixture, and the resulting solution was sterilized by 
filtration. Harvested ECs were then added directly to the precursor solution to achieve a 
cell number per total gel volume equivalent to that employed for the ‘‘cemented’’ layer 
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gels. The resulting EC suspension was pipetted into a set of molds and polymerized by 6 
min exposure to UV light.  
 
5.3.4. Analyses Conducted within 24 h of Endothelial Layer Fabrication  
 
5.3.4.1. Analyses of Cell Death and Metabolic Activity 
The cytotoxicity of the ‘‘cementing’’ process was assessed by measuring lactate 
dehydrogenase (LDH) levels released by ‘‘cemented’’ ECs at 1 and 24 h 
postpolymerization. Immediately following polymerization, hydrogels with ‘‘cemented’’ 
EC layers (n = 9) were cut into a series of 4-mm long ring segments. Each segment was 
then rapidly transferred to fresh cell culture media. After 1 h, LDH levels in the media 
surrounding each segment were measured using the LDH Cytotoxicity kit (Roche). 
Since the construct segments were transferred to media immediately following 
polymerization and without pre-rinsing, any LDH released due to cell membrane 
damage incurred during the ‘‘cementing’’ process would be represented in this initial 1 h 
measure.  
Following the 1 h LDH time point, the media in each construct was exchanged 
with fresh media. At 24 h, 6 of the 9 ‘‘cemented’’ construct segments were allocated for 
LDH cytotoxicity assays, and the remaining three gels were allocated for mitochondrial 
activity analyses. For the LDH samples, the media surrounding each gel segment was 
collected and analyzed as above. Mitochondrial activity was assessed using the Vybrant 
Metabolic Assay (Invitrogen) per manufacturer protocol. For both the LDH and Vybrant 
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Assays, cells exposed to encapsulation within PEGDA gels but not to pre-drying were 
used as controls.  
 
5.3.4.2. Mechanical Assessment 
Mechanical analyses were conducted using a modification of the circumferential 
property testing technique validated in Johnson et al.[192] and Hiles et al.[193] In brief, 
the dimensions of ring segments 2–4 cm in width were measured using digital calipers. 
These measures served as dimension inputs for subsequent stress and strain calculations 
and as swelling indicators. Each ring was mounted onto an Instron 3342 by threading 
opposing stainless steel hooks through the segment lumen. The hooks were then 
uniaxially separated at a rate of 6 mm min-1 until construct failure. As hook separation 
increased, the mounted ring was drawn into an increasingly oblong oval conformation. 
Johnson et al. confirmed that the force applied by the hooks to this oblong oval could be 
approximated as being equally distributed between two parallel rectangles, each with 
sides equal to the width and wall thickness, hv, of the ring. The gauge length, lg, was 
taken to be the inner diameter, Dv, of the unstretched ring plus hv, and the elastic 
modulus, E, of each sample was defined as the slope of the resulting stress–strain curve 
at a reference stress of 20 kPa [84]. Samples remained immersed in PBS until 
immediately prior to mechanical analyses, and testing was completed rapidly to avoid 
sample dehydration.  
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5.3.5. Analyses Conducted 3 Days Following Endothelial Layer Fabrication  
 
Three days following endothelial layer fabrication, a set of ‘‘seeded’’ EC layer 
constructs and a set of ‘‘cemented’’ EC constructs were harvested. Acetylated low 
density lipoprotein (AcLDL) uptake analyses as well as antibody-based assessments of 
various functional and injury-associated EC markers were then performed.  
 
5.3.5.1. AcLDL Uptake 
To assess the ability of ‘‘cemented’’ ECs to uptake AcLDL, harvested constructs 
(n = 6 per treatment group) were rinsed three times with PBS. All segments were 
exposed to 5 μg ml-1  AcLDL-AlexaFluor 488 (Invitrogen) in DMEM containing 1 mM 
Ca2+ and 1 mM Mg2+ for 4 h at 37 °C. Negative control segments were immersed in 
formalin to induce cell death prior to AcLDL exposure. Following AcLDL application, 
segments were rinsed extensively in PBS and imaged using a fluorescence microscope 
(Zeiss Axiovert).  
 
5.3.5.2. Competitive ELISA 
Analyses Competitive ELISA assays were conducted to quantitatively compare 
the expression of various indicators of EC functionality or EC damage across treatment 
groups.  
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Protein Isolation. Proteins from ‘‘seeded’’ and ‘‘cemented’’ EC samples (n   3–
6 per treatment group) were isolated using a modification of a procedure validated by 
Hummon et al. [194]. In brief, each construct segment was homogenized in Trizol 
(Invitrogen), after which chloroform was added per manufacturer protocol. The 
associated phenol-chloroform phase was mixed with ethanol to precipitate DNA. The 
resulting phenol–ethanol phase was then transferred to 3.4 kDa SnakeSkin dialysis 
membranes (Pierce, Rockford). The solutions were dialyzed for ~60 h at 4 °C against an 
aqueous solution of 0.1% sodium dodecyl sulfate (SDS), with buffer exchange every 
~18–20 h. The resultant protein mass [194] was collected and resuspended in PBS 
containing 0.5% SDS and 1% Triton X-100.  
 
 ELISA Technique. Primary antibodies and their corresponding peptide antigens 
were purchased from SCBT. High binding EIA 96 well plates (Costar) were coated 
overnight at 4 °C with 2 ng per well of peptide for endothelial nitric oxide synthase 
(eNOS, C-20), vascular endothelial (VE)-cadherin (C-19), platelet/endothelial cell 
adhesion molecule-1 (PECAM-1, M-20), smooth muscle 22α (SM22α, P-15), or E-
selectin (C-20). The coated wells were then blocked with bovine serum albumin (BSA). 
Peptide standards and resuspended protein samples were diluted in PBS containing 3% 
BSA and 0.05%Tween 20 and incubated with primary antibody for 1 h at room 
temperature prior to transfer to the coated wells. The plate was then incubated for 1 h at 
room temperature with continuous gentle mixing, after which HRP-conjugated 
secondary antibody (Jackson Immunochemicals) was applied to each well. Levels of 
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antigen in each sample were evaluated indirectly via measuring the amount of secondary 
antibody bound to each well. This was quantified by the addition of 2,2’-azino-bis(3- 
ethylbenzthiazoline-6-sulphonic acid) and subsequent absorbance measurements at 410 
nm. ELISA results were normalized to sample total protein as determined using the 
CBQCA assay (Invitrogen) per manufacturer protocol. Samples were measured in 
duplicate.  
 
5.3.5.3. Histological Analyses 
Construct segments reserved for immunostaining were fixed in formalin for 30 
min. Each sample was then transferred to Tissue-Tek freezing media, snap frozen, and 
cut into 20 μm sections using a cryotome. Rehydrated sections were blocked with 
peroxidase (Biocare Medical) for 10 min followed by 10 min exposure to Terminator 
block (Biocare Medical). Primary antibodies diluted in HBS (10 mM HEPES, 150 NaCl, 
pH 7.4) containing 3% BSA and 0.05% Tween 20 were then applied to the sections for 1 
h. Bound primary antibody was detected using AP-conjugated secondary antibody 
(Jackson Immunochemicals) diluted in HBS containing 3% BSA and 0.05% Tween 20 
followed by application of the chromogen Ferangi Blue (Biocare Medical). Stained 
sections were imaged using a Zeiss Axiovert 200 microscope.  
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5.3.6. Stability Under Physiological Stress Application  
 
Three days following endothelial layer fabrication, remaining ‘‘seeded’’ 
constructs (n   3) and BAEC ‘‘cemented’’ constructs (n   3) were mounted onto the 
inner ports of a custom pulsatile flow bioreactor graft chamber [117]. 
 
5.3.6.1. Bioreactor Flow Loop  
EC layer stability under pulsatile flow conditions was evaluated using a 
modification of the bioreactor system described in Bulick et al. [117]. In brief, a 
peristaltic pump drew media from a reservoir, generating the desired flow rate of media 
through the system. The media flow was then passed through a compliance chamber, and 
a CellMax pump (Spectrum Labs) was used to overlay the desired pulsatile waveform. 
The flow was then passed through the constructs. Pressure profiles were monitored 
immediately upstream and downstream of each construct using sterile transducers (Merit 
Medical) equipped with inlet and outlet valves. After exiting the constructs, the media 
was passed back to the media reservoir, completing the flow circuit. Both the graft 
chamber and the media reservoir were fitted with vent ports to maintain both chambers 
at atmospheric pressure and to allow for gas exchange. The elasticity of the hydrogels 
themselves acted to maintain the constructs on the graft chamber fittings during 
pulsation, preventing media leakage from the higher pressure construct lumens into the 
surrounding, lower pressure graft chamber bath.  
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5.3.6.2. Mechanical Stimulation Regimen  
The graft chambers into which the constructs had been mounted were connected 
to the flow loops described above. The graft chamber bath was filled with DMEM 
supplemented with 10% BCS and 1% PSA. The inner flow loop was filled with DMEM 
containing 10% BCS and 1% PSA as well as 1.75% dextran 70 (Pharmacosmos) to 
increase media viscosity. Flow was initiated at 22 ml min-1 per construct. After 2 min, 
the flow was increased to 75 ml min-1 per construct. Following an additional 5 min, flow 
through each construct was ramped to 180 mL/min, and the mean pressure (Pavg) in each 
construct lumen was adjusted to ~95 mmHg using the pressure transducer valves.  
Visual inspection indicated that the EC layers on the ‘‘seeded’’ constructs were 
no longer present following 1 h of full flow. Flow was therefore slowly ramped down in 
both the ‘‘seeded’’ and ‘‘cemented’’ construct chambers at this time point. Grafts were 
gently dismounted and images were taken of each construct lumen, after which the grafts 
were remounted and flow reinitiated as described above. Following 1 h of stable 
application of full flow conditions, pulsation (120 beats per minute [bmp], DP ~ 20 
mmHg) was initiated. Continuous pulsatile flow was applied for 48 h, after which each 
flow loop was dismantled and constructs were harvested for imaging and histological 
analyses. Samples collected for immunostaining were processed as described above.  
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5.3.6.3. Shear Stress Estimates and Viscosity  
Measures Rigorous estimates of the wall shear stress, τw, experienced by the ECs 
under the above pulsatile flow conditions can be obtained from the mathematical 
descriptions of pulsatile flow in rigid pipes developed by Womersley [195, 196] and the 
associated dimensionless Womersley number, α R√
  
μ
 ; where R = vessel inner radius, 
  = frequency of oscillation, q   media density, and μ = media viscosity. The magnitude 
of a is a indicator of the impact of pulsatile flow frequency relative to viscous effects. To 
calculate the Womersley number for the present system, the extent to which dextran 70 
increased the media viscosity had to be evaluated.  
The viscosity of DMEM containing 10% BCS, 1% PSA, and 1.75% dextran 70 
was determined using a Physica MCR 300 Modular Compact Rheometer fitted with a 
CP50-1 cone plate [197]. During testing, the temperature was held constant at 37 °C 
using a Peltier temperature controller. The change in media shear stress with increasing 
shear rate from 0.5 to 200 s-1 was monitored by the device and was used to calculate 
media viscosity. Through this technique, the viscosities of both dIH2O and of DMEM 
containing 10% BCS but no dextran were determined to be ~0.65 cP at 37 °C, in good 
agreement with previous literature [198]. In contrast, the viscosity of media containing 
1.75% dextran 70 was measured at 1.18 ± 0.17 cP.  
Thus, for R   0.16 cm and     4πs-1, α was approximately 5.2. This α value was 
mimetic of coronary and carotid arteries for which α = 3–10. In this a range, the Hagen–
Poiseuille equation can be assumed to provide a useful estimate of wall shear stress 
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[199]. Specifically, the Hagen–Poiseuille equation predicts that τ
w~
4μQ
πR3
; where Q = 
volumetric flow rate. In this case, τw ~ 11 dyn cm
-2, which is within the physiological 
range for coronary arteries [200]. 
 
5.3.6.4. Circumferential Strain  
Estimates To estimate the circumferential strain experienced by the constructs, 
the measured elastic moduli and vessel dimensions were input into the Bernoulli 
equation   ~
( P )R
hvE
; where R = inner vessel radius, hv = wall thickness, and E = construct 
modulus [201]. This equation has previously been shown to be in good agreement with 
actual strains experienced by  PEGDA constructs in the current bioreactor setup [84]. 
For the present hydrogel formulations (E ~ 67.0 kPa, hv ~ 0.1 cm, R ~ 0.16 cm) and 
pulsatile conditions (ΔP ~ 20 mmHg), Δ  ~ 0.064.  
 
5.3.7. Statistical Analyses  
 
All data are reported as mean ± standard error of the mean. Comparisons among 
hydrogel treatment groups were conducted using ANOVA and Tukey’s post-hoc test 
(SPSS software), p ≤ 0.05.  
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5.4. Results and Discussion 
 
The aim of the current study was to develop an approach for fabricating TEVGs 
with thin, mechanically stable endothelial linings. To achieve this objective, a unique 
method was developed to fabricate luminal EC layers using PEGDA as an intercellular 
‘‘cementing agent.’’ In this approach, ECs are suspended in an aqueous PEGDA 
solution which is dried as a thin coating onto the surface of a glass rod. The dried, 
PEGDA-EC layer is then simultaneously partially rehydrated, polymerized, and bonded 
to an outer hydrogel layer by the rapid addition of a second PEGDA precursor solution 
to the construct mold followed by immediate UV exposure. The resulting bi-layered 
hydrogel contains a dense luminal EC layer which is mechanically stable and which 
permits direct exposure of EC surfaces to the luminal environment. This ‘‘cementing’’ 
process is illustrated in detail in Fig. 18 and its associated legend.  
Due to the drying step associated with the fabrication of ‘‘cemented’’ EC layers, 
it was important to first assess the viability of ‘‘cemented’’ ECs. The cytotoxicity of the 
‘‘cementing’’ process was therefore assessed by measuring the levels of LDH released 
by ‘‘cemented’’ ECs at 1 and 24 h post-polymerization. Due to the method of construct 
handling and preparation, the 1 h LDH readings could be taken to represent the extent of 
immediate cell death induced by the ‘‘cementing’’ process. Interestingly, the levels of 
LDH released at 1 h from ‘‘cemented’’ ECs were statistically indistinguishable from the 
amount of LDH released from an equivalent number of cells encapsulated in PEGDA 
gels without a drying step. The 24 h LDH assay detected LDH released from the gels 
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between 1 and 24 h postpolymerization and served as a measure of apoptosis induced by 
the ‘‘cementing’’ process. As with the 1 h LDH assay, no statistically significant 
differences were observed between the LDH released at 24 h by ‘‘cemented’’ ECs 
relative to encapsulated ECs (Fig. 19).  
 
 
 
Fig. 18. A schematic of the ‘‘cemented’’ EC layer fabrication process. ECs suspended at high density in 
a PEGDA precursor solution are spread evenly over the length of a glass rod, and a sterile air-stream is 
applied under constant rod rotation to generate a dried EC-containing film. Each EC-coated rod is inserted 
as the inner mandrel of a tubular mold. A PEGDA precursor solution is rapidly, but gently, pipetted into 
the mold and polymerized immediately by exposure to longwave UV light. The brief time delay (seconds) 
between the addition of the outer PEGDA solution and the onset of UV-induced photopolymerization is 
sufficient to permit at least partial rehydration of the EC-containing film (as indicated by the loss of film 
opacity) but not to permit significant motion of associated ECs. The harvested gel contains a dense layer 
of ECs that are directly exposed to the luminal environment. Currently, the mechanism by which this 
process forces ECs to the rod surface to the exclusion of PEGDA is unclear. However, since EC surfaces 
are charged, it can be speculated that each cell in the coating solution can induce a local, opposing charge 
on the glass insulator surface if the cell and rod are brought into sufficiently close proximity. The drying 
process may induce this proximity. The resulting electrostatic interactions would encourage heightened 
contact between the cells and the glass rod, which may thereby force residual PEGDA solution between 
the cell and rod out into neighboring intercellular spaces. In contrast, cell surfaces facing the airstream 
remain covered in PEGDA, which may result in the formation of a protective film preventing cell 
dehydration as drying proceeds. This process can readily be expanded to include a second cell type (such 
as SMCs) in the outer PEGDA precursor solution. 
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Fig. 19. LDH release and mitochondrial activity assays intended to assess the cytocompatibility of the 
‘‘cementing’’ process relative to conventional encapsulation. The 1 and 24 h LDH release assays served as 
quantitative indicators of ‘‘cementing’’-induced necrosis and apoptosis, respectively. The 24 h 
mitochondrial activity assay assessed the retention of mitochondrial integrity following the ‘‘cementing’’ 
process. 
 
 
Similarly, cell mitochondrial activity assessments indicated no loss in viability 
due to the ‘‘cementing’’ process relative to cells exposed to standard PEGDA 
encapsulation conditions (Fig. 19). Combined, the LDH and mitochondrial activity 
results indicate that the PEGDA ‘‘cementing’’ process is of similar cytocompatibility as 
the conventional PEGDA ‘‘encapsulation’’ process, a method regarded as essentially 
non-cytotoxic. The mechanism underlying the relatively low cell death observed in the 
‘‘cemented’’ layers is currently unclear, although the presence of PEGDA in the 
‘‘drying’’ solution may underlie this result. It can be speculated that the PEGDA 
solution forms a film on the surface of the cells facing the airstream, thereby protecting 
the cells from desiccation during the drying process. 
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Fig. 20. Stability of ‘‘cemented’’ BAEC layers relative to ‘‘seeded’’ BAEC layers. Representative 
images of (a) ‘‘seeded’’ BAEC layers and (b) ‘‘cemented’’ BAEC layers 72 h post-fabrication and before 
the onset of flow. Representative images of (c) ‘‘seeded’’ BAEC layers following 1 h of 11 dyn/cm2 flow 
and (d) ‘‘cemented’’ BAEC layers following 48 h of continuous 11 dyn cm-2 flow and 6.4% cyclic 
circumferential strain. The scale bar in (a) applies to all images and equals 40 μm. 
 
 
The EC-layer drying process also required that the resulting bi-layered grafts be 
examined for tears that could potentially be induced by the significant 
postpolymerization swelling associated with PEGDA hydrogels. The ‘‘cemented’’ 
constructs were therefore carefully examined under DIC microscopy at high 
magnification (2009) for surface tears or fractures. As expected for 10 wt.% hydrogels 
prepared from 6 kDa  PEGDA, the inner diameter of both the ‘‘seeded’’ and 
‘‘cemented’’ constructs increased from the initial diameter set by the mandrel (3 mm) to 
~3.2 mm on swelling [202]. However, no tears were observed in any of the ‘‘cemented’’ 
grafts either before or after flow, as illustrated in the rightmost column of Fig. 20. In 
fact, the gel swelling proved beneficial in that it aided the gentle and rapid detachment of 
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the polymerized gel and associated EC layer from the glass mandrel. Thus, the 
‘‘cementing’’ process permitted the generation of intact bi-layered hydrogels.  
The stability of the ‘‘cemented’’ EC layers through 48 h of continuous 
application of pulsatile flow was also evaluated and compared to that of ‘‘seeded’’ EC 
layers. Constructs with ‘‘seeded’’ EC layers delaminated in less than 1 h at full flow 
(~180 ml min-1, Pavg ~ 95 mmHg), prior to initiation of pulsation (Figs. 20a and 20c). 
This rapid delamination occurred despite the relatively high levels of RGDS (2 mM) 
conjugated to the PEGDA gels to enhance ‘‘seeded’’ EC adhesion. In contrast, 
‘‘cemented’’ EC layers remained intact through the initiation of pulsation and a 
subsequent 48 h of full pulsatile flow (~180 ml min-1, ΔP ~ 20 mmHg; Figs. 26b and 
26d). Given the average ‘‘cemented’’ construct modulus of 67.0 ± 3.4 kPa and the 
applied DP, the cyclic circumferential strain experienced by the dynamic constructs was 
estimated to be ~6.4% by the Bernoulli equation. Similarly, the mean construct wall 
shear stress at full flow conditions was calculated to be ~11 dyn cm-2 using the Poiseuille 
assumption, as justified in ‘‘Materials and Methods’’. Thus, the ‘‘cemented’’ EC layers 
remained intact through extended application of physiological cyclic strains and shear 
stresses.  
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Fig. 21. Assessment of ‘‘cemented’’ BAEC layer uptake of AcLDL. Representative fluorescence images 
of (a) a conventional EC layer exposed to AlexaFluor 488-labeled AcLDL, (b) a ‘‘cemented’’ EC layer 
exposed to AlexaFluor 488-labeled AcLDL, and (c) a ‘‘cemented EC layer immersed in formalin to induce 
cell death prior to AcLDL application. (d, e, f) The brightfield images corresponding to (a), (b), and (c), 
respectively. The scale bar in (a) applies to all images and equals 40 μm. 
 
 
  ‘‘Cemented’’ and ‘‘seeded’’ BAEC constructs were further compared for 
expression of several functional and damage-associated EC markers. Uptake studies 
demonstrated that the ability of ‘‘cemented’’ ECs to internalize AcLDL was retained for 
at least 72 h post-‘‘cementing’’ (Fig. 21). Since only live ECs are capable of AcLDL 
endocytosis (Figs. 21b vs. 21c), these results also supported the high viability of 
‘‘cemented’’ ECs indicated by the LDH release and metabolic activity assays. 
Furthermore, competitive ELISA and immunostaining assays were used to evaluate the 
phenotype of the ‘‘cemented’’ ECs. Consistent with AcLDL uptake results, levels of 
eNOS (NOS3), an enzyme involved in the maintenance of vascular homeostasis [203], 
were similar in ‘‘cemented’’ ECs relative to ‘‘seeded’’ ECs at 72 h of culture (prior to 
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initiation of flow, Figs. 22, 23a, and 23b). These levels of eNOS were maintained by the 
‘‘cemented’’ ECs following 48 h of pulsatile flow (Figs. 22 and 23c). Expression of 
PECAM-1 and VE-cadherin, molecules associated with EC cell–cell adhesion or 
junction formation, followed more complicated trends (Figs. 22, 23d–23f, and 23g–23i, 
respectively). Specifically, levels of both markers appeared to be lower in the statically-
cultured, ‘‘cemented’’ EC layers relative to ‘‘seeded’’ layers, although these differences 
fell below statistical significance. However, ‘‘cemented’’ EC VE-cadherin levels 
significantly increased following exposure to pulsatile flow (p = 0.02), recovering to 
‘‘seeded’’ EC levels. 
 
 
 
Fig. 22. Quantitative comparison of the expression of functional and damage-associated markers by 
‘‘cemented’’ ECs relative to conventionally ‘‘seeded’’ ECs. ‘‘Cemented’’ EC phenotype was analyzed for 
both static and dynamic constructs. *indicates a significant difference with the corresponding measures for 
‘‘cemented’’ EC—no flow constructs, p < 0.05. 
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Fig. 23. Expression of mature- and injury-associated EC markers. Representative images of eNOS-
stained sections from (a) ‘‘seeded’’ EC layers (72 h post-fabrication), (b) ‘‘cemented’’ EC layers (72 h 
post-fabrication), and (c) ‘‘cemented’’ EC layers (after 48 h of pulsatile flow). Representative images of 
PECAM-1-stained sections from (d) ‘‘seeded’’ EC layers (72 h post-fabrication), (e) ‘‘cemented’’ EC 
layers (72 h post-fabrication), and (f) ‘‘cemented’’ EC layers (after 48 h of pulsatile flow). Representative 
images of VE-cadherin-stained sections from (g) ‘‘seeded’’ EC layers (72 h post-fabrication), (h) 
‘‘cemented’’ EC layers (72 h postfabrication), and (i) ‘‘cemented’’ EC layers (after 48 h of pulsatile flow). 
Representative images of SM22α-stained sections from (j) ‘‘seeded’’ EC layers (72 h post-fabrication), (k) 
‘‘cemented’’ EC layers (72 h post-fabrication), and (l) ‘‘cemented’’ EC layers (after 48 h of pulsatile 
flow). Representative images of E-selectin-stained sections from (m) ‘‘seeded’’ EC layers (72 h post-
fabrication), (n) ‘‘cemented’’ EC layers (72 h post-fabrication), and (o) ‘‘cemented’’ EC layers (after 48 h 
of pulsatile flow). The scale bar in (a) applies to all images and equals 40 μm. 
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Combined, the ELISA results suggest that the ‘‘cementing’’ process allows ECs 
to retain their ability to express mature EC markers and to respond to mechanical 
conditioning while not significantly stimulating primary injury pathways. However, 
despite the presence of adhesion peptide RGDS in the coating solution, ECs took on 
rounded or elliptical morphologies in the pure PEGDA ‘‘cemented’’ layers (Figs. 20, 21, 
and 23). These cell morphologies, which result from the dense crosslinking (~15–20 nm 
average mesh size)1 and relatively slow degradation rate of pure  PEGDA hydrogels (1–
2 years for ~95% degradation) [84, 90-92] are non-optimal for ECs, which natively take 
on elongated morphologies. We therefore extended the present method to utilize an 
enzyme-degradable PEGDA ‘‘cement’’ in place of pure PEGDA. As illustrated in Fig. 
24, the degradable ‘‘cement’’ permitted cells to take on more natural cell shapes via 
local, cell-based cleavage of the ‘‘cement’’ network [204]. 
 
 
 
 
Fig 24. Evaluation of the ability of ECs ‘‘cemented’’ using an enzyme-degradable PEGDA to alter their 
shape with time in culture. Representative images of (a) ECs ‘‘seeded’’ on the surface of an enzyme-
degradable PEGDA gel following 4 days of culture; (b) ECs ‘‘cemented’’ using degradable PEGDA 
following 1 day of culture; and (c) ECs ‘‘cemented’’ using degradable PEGDA following 4 days of 
culture. The scale bar in (a) applies to all images and equals 40 μm. 
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Collectively, the present results establish an approach for fabricating TEVGs 
with mechanically stable, physiologically relevant endothelialization. In addition, 
although a PEGDA hydrogel was used as the scaffold to which the ‘‘cemented’’ EC 
layer was bonded during construct fabrication, the EC- PEGDA coating can be 
conjugated to any protein-based scaffold containing sufficient levels of free cysteines 
(e.g., fibrin gels) [205, 206]. Therefore, the present method can be extended to 
generating stable, luminal EC layers on a range of TEVG scaffolds. 
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CHAPTER VI 
OSTEOGENIC POTENTIAL OF POLY(ETHYLENE GLYCOL)- 
POLY(DIMETHYLSILOXANE) HYBRID HYDROGELS* 
 
 
6.1. Overview 
 
Growth factors have been shown to be potent mediators of osteogenesis. 
However, their use in tissue engineered scaffolds not only can be costly but also can 
induce undesired responses in surrounding tissues. Thus, the ability to specifically 
induce osteogenic differentiation in the absence of growth factors through manipulation 
of scaffold material properties would be desirable for bone regeneration. Previous 
research indicates that addition of inorganic or hydrophobic components to organic, 
hydrophilic scaffolds can enhance MSC osteogenesis. However, the combined impact of 
scaffold inorganic content and hydrophobicity on MSC behavior has not been 
systematically explored, particularly in 3D culture systems.  
 
 
 
 
 
 
 
 
 
_____ 
*Reprinted with permission from Influence of “Osteogenic potential of poly(ethylene glycol)-
poly(dimethylsiloxane) hybrid hydrogels” by 7. D.J. Munoz-Pinto, A.C. Jimenez-Vergara, Y. Hou, H.N. 
Hayenga, M. Grunlan, M.S. Hahn, 2012, Tissue Engineering Part A , In press, Copyright 2012,  Mary Ann 
Liebert, Inc. 
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The aim of the present study was therefore to examine the effects of 
simultaneous increases in scaffold hydrophobicity and inorganic content on MSC 
osteogenic fate decisions in a 3D culture environment toward the development of 
intrinsically osteoinductive scaffolds. Mouse 10T½ MSCs were encapsulated in a series 
of novel scaffolds composed of varying levels of hydrophobic, inorganic 
poly(dimethylsiloxane) (PDMS) and hydrophilic, organic PEG. Following 21 days of 
culture, increased levels of osteoblast markers, runx2 and osteocalcin, were observed in 
scaffolds with increased PDMS content. Bone ECM molecules, collagen I and calcium 
phosphate, were also elevated in formulations with higher PDMS:PEG ratios. 
Importantly, this osteogenic response appeared to be specific in that markers for 
chondrocytic, smooth muscle cell, and adipocytic lineages were not similarly affected by 
variations in scaffold PDMS content. As anticipated, the increase in scaffold 
hydrophobicity accompanying increasing PDMS levels was associated with elevated 
scaffold serum protein adsorption. Thus, scaffold inorganic content combined with 
alterations in adsorbed serum proteins may underlie observed cell behavior.  
 
6.2. Introduction 
 
MSC differentiation is known to be influenced by a range of environmental 
stimuli, among the most potent of which are growth factors.  However, the use of growth 
factors in tissue engineering scaffolds not only can be costly but also can induce 
undesired responses in surrounding tissues. Thus, MSC-based bone regeneration 
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strategies would be benefited by the identification of scaffold material properties which 
intrinsically promote osteoblast lineage progression in the absence of growth factors.   
A number of studies have shown that the addition of inorganic components to 
organic scaffolds can enhance both their osteoconductivity and osteoinductivity [31-36, 
53, 207-209].  These inorganic additives have included not only hydroxy atite, but also a 
range of silicon-containing compounds, such as silica, silane, and siloxane [33-36, 207-
209]. In addition, scaffold hydrophobicity has been demonstrated to influence osteogenic 
differentiation [37, 39, 210]. However, the combined effects of scaffold inorganic 
content and hydrophobicity have not been systematically explored. Furthermore, most of 
the aforementioned studies were performed in two-dimensional (2D) culture, and, thus, 
may not be indicative of the effects of the same scaffold variables in more biomimetic, 
three-dimensional (3D) culture systems. The aim of the present study was therefore to 
examine the impact of simultaneous increases in scaffold hydrophobicity and inorganic 
content on MSC osteogenic lineage progression in a 3D culture environment.   
Toward this goal, we developed a novel series of scaffolds comprised of varying 
levels of hydrophobic, inorganic PDMS and hydrophilic, organic PEG. PEG was 
selected for the hydrophilic, organic component due to its established biocompatibility 
and its previous use in bone regeneration applications [37, 53, 87, 211]. Similarly, 
PDMS was chosen as the inorganic component over silica, silane, and other 
polysiloxanes due to its processability and its intermediate level of hydrophobicity. In 
addition, PDMS is used extensively in biomedical applications and is considered 
biocompatible [68, 212-215]. For the present study, PDMS and PEG molecular weights 
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(Mn) and concentrations were selected to yield scaffolds with moduli within the 
“osteogenic” range identified in the 2D human MSC studies of Engler et al [68] and the 
3D human and mouse MSC studies of Huebsch et al [216].  
In analyzing the lineage progression of encapsulated mouse 10T½ MSCs, 
quantitative immunoassays were performed for mid-to-late term markers associated with 
osteoblast, chondrocytic, smooth muscle cell (SMC), and adipocytic fates. Furthermore, 
biochemical and histological analyses were conducted to assess the deposition of ECM 
components associated with mature bone (e.g. collagen I and calcium phosphate) [217] 
as well as ECM molecules which would be considered undesirable for bone regeneration 
(e.g. elastin and collagen type III).  
 
6.3. Material and Methods  
 
6.3.1. Preparation of Diacrylate-Terminated PEG 
 
Diacrylate-terminated PEG (PEGDA, Fig. 25) was prepared in accordance to 
known methods (23). Briefly, PEG (Mn = 3.4 kDa, Sigma) was dissolved in dry 
dichloromethane (20 mL mmol-1 PEG) in a 250 ml round bottom flask purged with Ar. 
Triethylamine (2:1 molar ratio, Sigma) was added slowly to the solution, followed by the 
drop-wise addition of acryloyl chloride (4:1 molar ratio, Sigma). The reaction mixture 
was allowed to stir at room temperature overnight. Removal of HCl was accomplished 
by washing the mixture twice with 2M K2CO3 and separating into aqueous and organic 
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phases. The organic phase was then dried with anhydrous MgSO4 and the volatiles 
removed under reduced pressure. The resulting crude oil was precipitated in diethyl ether 
in an ice bath, filtered, and dried under vacuum at room temperature overnight. Extent of 
diacrylation was confirmed to be approximately 85% by 1H NMR.  
 
6.3.2. Synthesis of Methacrylate-Terminated Star PDMS Methacrylate-terminated  
 
Star PDMS (PDMSstar-MA, Mn = 2 kDa) was prepared via a two-step synthetic 
strategy per a modification of the methodology in Grunlan et al [218]. A star 
conformation of PDMS was selected over a linear form in order to reduce phase 
separation between the hydrophobic PDMS and hydrophilic PEG prior to hydrogel 
polymerization [219]. In brief, silane (SiH)-terminated star PDMS (PDMSstar-SiH) was 
first prepared by the acid-catalyzed equilibration of octamethylcyclotetrasiloxane with 
tetrakis(dimethylsiloxane)silane (tetra-SiH) [218]. Octamethylcyclotetrasiloxane and 
tetra- SiH were combined in a 100 mL round bottom flask under N2 at a 4:1 molar ratio, 
with the ratio of octamethylcyclotetrasiloxane and tetra-SiH selected to yield a product 
of the desired Mn. Triflic acid (0.060 μl mmol
-1 octamethylcyclotetrasiloxane) was then 
added, and the reaction was allowed to stir for 1 h at 90 ºC. After cooling, the mixture 
was neutralized by combining with MgCO3 and dichloromethane (0.020 mL mmol
-1 
octamethylcyclotetrasiloxane) and stirring for 2 h. After filtration through a pad of 
Celite, the volatiles were removed under reduced pressure. The chemical structure and 
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Mn of the resulting colorless product (PDMSstar-SiH) were confirmed by 
1H NMR, 13C 
NMR, IR, and gel permeation chromatography (GPC).  
The SiH terminal groups of the PDMSstar-SiH were converted into photo-
sensitive methacrylate moieties by the subsequent hydrosilylation reaction with allyl 
methacrylate [220]. Briefly, PDMSstar-SiH was dissolved in dry toluene using a 100 ml 
round bottom flask and purged with N2. Karstedt’s catalyst (Pt-
divinyltetramethyldisiloxane complex in xylene, 2% Pt) was added at 33 μl mmol-1, and 
the reaction mixture was heated to 45 ºC. Allyl methacrylate was then added over 15 min 
in a 4:1 molar ratio, after which the reaction was heated to 90 ºC and stirred overnight. 
Completion of the reaction was confirmed by the disappearance of the Si-H (~2100 cm-
1) absorbance in the IR spectrum. The reaction mixture was decolorized by refluxing 
with activated carbon for 12 h. After filtration, the volatiles were removed under reduced 
pressure. The resulting product (PDMSstar-MA, Fig. 18) was confirmed by 
1H-NMR.  
 
6.3.3. Synthesis of Acrylate-Derivatized Cell Adhesion Ligand  
 
Cell adhesion peptide RGDS (American Peptide) was reacted with acryloyl-
PEGN- hydroxysuccinimide (ACRL-PEG-NHS, 3.4 kDa; Nektar) at a 1:1 molar ratio for 
2 h in 50 mM sodium bicarbonate buffer, pH 8.5 [71, 221]. The product (ACRL-PEG-
RGDS) was purified by dialysis, lyophilized, and stored at -20 ºC until use. 
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6.3.4. Hydrogel Preparation  
 
PEG-PDMSstar hybrid hydrogels were prepared by the photopolymerization of 
aqueous mixtures of PEGDA and PDMSstar-MA. Five distinct precursor solutions were 
prepared: i) three with 10 wt% total polymer, but with either a 100:0, 95:5, or 80:20 wt 
ratio of  PEGDA to PDMSstar-MA, and ii) two additional  PEGDA formulations 
containing 9.5 and 8.0 wt% total polymer but no PDMS (referred to as 95:0 and 80:0 
constructs, respectively). ACRL-PEG-RGDS was added to each solution so as to yield 1 
mM RGDS in the swollen gels. Photoinitiator consisting of a 30 wt% solution of 2,2- 
dimethyl-2-phenyl-acetophenone in N-vinylpyrrolidone was added to the precursor 
solutions at 10 μl ml-1. The resulting mixtures were vortexed and passed through 0.22 
μm PES filters, which served both to sterilize the solutions as well as to create fine, 
stable dispersions of hydrophobic PDMSstar in the aqueous PEG solutions. The filtered 
precursor solutions were immediately poured into 0.75 mm thick transparent rectangular 
molds, and polymerized by 6 min exposure to longwave UV light (~6 mW cm-2, 365 nm; 
Spectroline).  
 
6.3.5. Evaluation of Initial Scaffold Material Properties 
 
6.3.5.1. Dynamic Light Scattering 
 The average size of PDMSstar-MA particles in the PEG-PDMSstar hydrogels was 
estimated by dynamic light scattering (DLS) measurements of aqueous solutions of 0.5 
130 
 
wt% and 2 wt% PDMSstar-MA. Following 0.22 μm filtration, DLS measurements were 
performed on each solution using a Brookhaven ZetaPALS instrument. A laser with a 
wavelength of 660 nm was used as the incident beam, and scattered light was detected at 
a 90° scattering angle at 25 °C. The light scattering data were analyzed with the BI-
DLSW control software, and a non-negative constrained least squares algorithm was 
used to determine the size distributions. 
 
6.3.5.2. Hydrogel Mechanical Properties 
 
Bulk Mechanical Testing. Following 18 h immersion in PBS, four 8-mm discs 
were cored from each hydrogel formulation and mechanically tested under 
unconstrained compression using an Instron 3342. Following application of a 0.05 N 
preload, each hydrogel was subjected to compression at a rate of 1 mm min-1. The 
compressive modulus of each hydrogel was extracted from the resulting stress-strain 
data over a 5-25% strain range.  
 
Atomic Force Microscopy. Following 18 h of swelling in deionized water 
(dIH2O) [222], PEG-PDMSstar hydrogels were locally, mechanically tested using a 
Bioscope System AFM (Veeco Instruments) equipped with a Nanoscope IIIa controller 
and mounted on a Zeiss Axiovert 100 TV inverted optical microscope. Each hydrogel 
was fixed to a 60-mm diameter polystyrene petri-dish with RP30 instant adhesive 
(Adhesive Systems, Inc). The hydrogels were then submerged in 1.5 ml of dIH2O to 
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reduce tip-adhesion effects and to maintain sample hydration during testing. The gel 
samples were indented with a 600 nm diameter spherical tip (silicon dioxide glass bead) 
attached to a silicon-nitride cantilever with a manufacturer-calibrated spring constant of 
360 pN nm-1 (Novascan). Deflection sensitivity for the AFM probe was determined to be 
54 nm V-1. All indentations were performed at a frequency of 0.5 Hz with a z-scan size 
of 800 nm (speed of 0.8 μm s-1). After recording typically 30 consecutive indentation 
force-depth curves at each location on the hydrogel, the tip was retracted to its original 
position. At least ten distinct locations were analyzed per hydrogel sample.  
The applied force f sphere (pN) during indentation was taken to be the product of 
the measured cantilever deflection d (V), cantilever spring constant k (pN nm-1), and 
deflection sensitivity ds (nm V
-1). The indentation depth δ (nm) of the probe during an 
approachretraction cycle was calculated as the difference between the piezo 
displacement z (nm) and effective cantilever deflection dsd (nm). An effective Young’s 
modulus (E) was determined from AFM force curves based on the Hertzian equation 
[223-225]. However, the strict use of this equation requires simplifying assumptions, 
such as a flat, homogeneous, semi-infinite elastic material and a rigid probe [226]. Thus, 
to accommodate potential nonlinearities, we calculated the point-wise apparent modulus 
( Ei 
3
8
(
fi
sphere
√Rδi
3
)), or material stiffness, at each point (i) along all post-contact approach 
curves. All point-wise modulus values appeared to converge upon an asymptotic value at 
an indentation depth typically less than 30 nm. However, only point-wise moduli 
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corresponding to indention depths beyond 600 nm were used to calculate an average 
effective Young’s modulus for a particular location [225, 227].  
 
6.3.5.3. Hydrogel Mesh Size 
PEG-based hydrogel mesh structure cannot be readily visualized using 
techniques such as conventional scanning electron microscopy. Thus, a variety of 
methods to estimate  PEGDA hydrogel mesh size have been developed, including 
correlations linking measurable quantities, such as equilibrium hydrogel swelling and  
PEGDA Mn, to mesh size [228, 229]. Although these correlations yield reasonable 
average mesh size estimates for homopolymer hydrogels [228, 229], they cannot readily 
be applied to PEG-PDMSstar hybrid hydrogels. Thus, in this study, average hydrogel 
mesh size was characterized via dextran diffusion based on an adaptation of the 
methodology of Watkins et al [120]. Briefly, four 8-mm discs were cored from each 
hydrogel formulation following 24 h swelling and immersed in 0.5 mL HBS-azide 
(HEPES-buffered saline plus 0.05 wt% azide) containing 50 μg ml-1  FITC-labeled 
dextran (10 kDa, Sigma). Dextran was then allowed to diffuse into the hydrogels for 24 
h at 37 ºC, after which each disc was gently blotted and transferred to 0.5 ml fresh HBS-
azide. After 24 h at 37 ºC, the fluorescence of the HBS-azide solution surrounding each 
disc was measured at ex/em 488/532. Each fluorescence measure was converted to 
micrograms dextran using dextran standard curves and then divided by gel weight to 
yield a quantitative indicator of hydrogel permissivity (C). These permissivity measures 
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were used to estimate the mesh size ( ) of each hydrogel (x) relative to the 100:0 PEG-
PDMSstar formulation as follows:  x (
Cx
C1000 PEG-PDMS 
) 
 
6.3.5.4. Serum Protein Adsorption 
Following 24 h of swelling, four 36-mm discs were harvested from each PEG-
PDMSstar hydrogel formulation to evaluate the dependence of bulk serum protein 
adsorption on increasing PDMSstar content. Each disc sample was exposed to 10% fetal 
bovine serum in PBS for 24 h at 37 °C. Non-adsorbed proteins were then removed by 
immersing the specimens in dIH2O at 37 °C for 60 min, with dIH2O changes every 20 
min. Adsorbed proteins were subsequently stripped from the hydrogels by progressive 
extraction with a series of aqueous isopropanol solutions of increasing hydrophobicity 
[230]. Specifically, each hydrogel sample was successively immersed in 10%, 30%, 
50%, and 70% aqueous isopropanol solutions (I10, I30, I50, I70, respectively) for 20 
min per solution at 37 °C. The isopropanol fractions for a particular hydrogel sample 
were then combined, evaporated under vacuum, and resuspended in 500 μl of PBS. The 
total amount of protein stripped from each hydrogel sample was quantified using the 
CBQCA total protein quantitation kit (Invitrogen). For the purpose of comparison, the 
average protein measures for each gel composition were normalized to the 100:0 PEG-
PDMSstar formulation.  
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6.3.5.5. Relative Bulk Hydrophobicity 
Contact angle measurements are widely used to analyze differences in the 
hydrophobic character of material surfaces. However, this method is limited to 
assessment of surface hydrophobicity, and associated results cannot be readily extended 
to bulk behavior. We therefore developed a method to assess differences in bulk 
hydrogel hydrophobicity by comparing the extent of swelling in solvents of varying 
polarities [231]. Specifically, solvents of higher polarity indices (P) interact 
preferentially with hydrophilic domains of the bulk material, while solvents of lower P 
indices show greater affinity for hydrophobic segments of the material. Thus, differences 
in the relative uptake of solvents of distinct polarities by a given hydrogel formulation 
can serve as an indicator of its bulk hydrophobicity. In brief, four discs from each 
hydrogel formulation were submerged in dIH2O (P =12.1) or I70 (P = 10.0) [232] for 24 
h at room temperature, after which the swollen weight (Ws) of each disc was recorded. 
The samples were then dried under vacuum for 48 h and their corresponding dry weights 
(Wd) measured. The equilibrium mass swelling ratio (q) of each formulation in each 
solvent (x) was calculated as qx (
 s
 d
). The relative bulk hydrophobicity (H) of each 
hydrogel formulation was estimated as follows: H (
qI70
qdIH2O
). 
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6.3.6. Cell Culture 
 
Cryopreserved 10T½ mouse mesenchymal stem cells (ATCC) were thawed and 
expanded in monolayer culture. Prior to encapsulation, cells were maintained at 37 ºC 
and 5% CO2 in Dulbecco’s Modified Eagle’s Media (DMEM, Hyclone) supplemented 
with 10% heat-inactivated fetal bovine serum (FBS, Hyclone).  
 
6.3.7. Fabrication and Culture of Cell-Laden Constructs  
 
Precursor solutions for the 100:0, 95:5, and 80:20 PEG-PDMSstar gels and the 
95:0 and 80:0 controls were prepared in PBS. ACRL-PEG-RGDS was then added to 
each precursor solution so as to yield an RGDS concentration of 1 mM in the swollen 
gels. Following addition of photoinitiator, the mixtures were vortexed and sterilized by 
0.22 μm filtration. 10T½ cells were then resuspended in each precursor solution so as to 
yield a post-swelling cell density of ~2 x 106 cells g-1. The resulting suspensions were 
polymerized into hydrogel networks by 6 min exposure to longwave UV light (~6 mW 
cm-2, 365 nm), a process which has previously been demonstrated to be cytocompatible 
[73, 128, 233]. Gels were immersed in DMEM supplemented with 10% heatinactivated 
FBS, 100 U ml-1 penicillin and 100 mg l-1 streptomycin and maintained at 37 ºC and 5% 
CO2. Following 24 h, samples (n = 4 per formulation) were collected for bulk 
compressive analyses per the above procedure. Media in the remaining samples was 
changed every two days for 21 days.  
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6.3.8.  Endpoint Construct Analyses  
 
After 21 days of culture, a series of samples (n = 4 per formulation) were 
mechanically analyzed under bulk compression. Separate samples were collected from 
each hydrogel formulation for biochemical and histological analyses. All steps 
associated with the biochemical and histological procedures described below took place 
at room temperature unless otherwise noted.  
 
6.3.8.1. Biochemical Analyses  
Competitive ELISAs for Differentiation Markers. Proteins extracted by sample 
homogenization in Trizol followed by protein isolation [194] were evaluated for the 
housekeeping protein GAPDH as well as for mid-to-late term markers of osteogenesis, 
chondrogenesis, SMC progression, and adipogenesis via competitive ELISAs. In brief, 
appropriate primary antibodies and their corresponding peptide antigens were purchased 
from SCBT. High binding EIA 96 well plates (Costar) were coated overnight at 4 °C 
with 200 ng per well of peptide for adipocyte-fatty acid binding protein (A-FABP, C-
15), PPARγ (I-18), myocardin (M-16), SM22α (P-15), runx2 (S-19), collagen I (Col1A1, 
D-13), osteocalcin (M-15), sox-9 (C-20), or collagen II (Col2A1, N-19) and 100 ng per 
well of peptide for GAPDH (V-18). The coated wells were then blocked with BSA. 
Peptide standards and isolated sample proteins were diluted in PBS containing 3% BSA 
and 0.05% Tween 20 and incubated with primary antibody for 1 h, after which the 
mixtures were transferred to coated wells and incubated for an additional hour. Primary 
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antibody which had bound to each coated well surface was then detected using an 
appropriate HRP-conjugated secondary antibody (Jackson ImmunoResearch 
Laboratories, JIRL), followed by application of 2,2'-azino-bis(3-ethylbenzthiazoline-6-
sulphonic acid) [ABTS, Sigma]. Resulting sample absorbance was read at 410 nm and 
translated to a concentration using the associated standard curve. Each target protein was 
analyzed in duplicate for each sample (n = 3-6 per gel formulation) and normalized to 
GAPDH. For the purposes of comparison, the resulting protein concentrations for each 
formulation were further normalized to the 100:0 PEG-PDMSstar formulation.  
 
Total Collagen, Sulfated Glycosaminoglycan, Elastin, and Collagen III Assays. 
Based on the cell marker results, the 100:0, 95:5, and 80:20 gels were further analyzed 
for various ECM components. Sample proteins isolated by base hydrolysis [83] were 
used to quantify total collagen, sulfated GAG, elastin, and collagen III. For each of the 
following assays, the standards used were subjected to the same association with 
PEGDA and PDMSstar-MA and the same digestion conditions as the samples.  
GAGs production was measured using a modification of the Blyscan assay 
(Biocolor). In brief, 40 μl of protein from each sample (n   5-6 per formulation) was 
neutralized, mixed with 60 μl Blyscan dye reagent, and the absorbance immediately read 
at 525 nm relative to a chondroitin sulfate B standard (Sigma). Similarly, levels of the 
amino acid hydroxyproline were quantified as an indirect measure of total collagen. 
Extracted proteins were first further hydrolyzed for 18 h at 110 ºC in 6 M HCl. The 
samples (n = 5-6 per formulation) were then dried under vacuum followed by 
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resuspension in dIH2O and reaction with chloramine T and p-dimethylbenzaldehyde 
reagents [76]. Sample absorbance was read at 550 nm relative to an L-4-hydroxyproline 
standard (Sigma). Total collagen content was estimated from measured grams of 
hydroxyproline by dividing by 0.13.  
For collagen III quantification, samples (n = 4-6 per formulation) and standards 
were applied to a high binding 96 well EIA plate for 3 h, after which the plate was 
blocked with 3 wt% BSA. Following application of primary antibody for collagen III 
(Calbiochem), donkey anti-rabbit HRP secondary antibody (JIRL) and ABTS were 
applied. Absorbance was read at 410 nm, with human collagen III (Sigma) serving as a 
standard. To quantify elastin, the above procedure was followed except that isolated 
sample proteins were first exposed to 0.25 M oxalic acid at 100 ºC overnight to convert 
elastin to α-elastin. Oxalic acid was then removed and exchanged for PBS using 
Microcon YM-3 centrifugal filters (Millipore). Resulting samples (n = 5-6 per 
formulation) were then applied to a high binding EIA 96 well plate for 3 h. Adsorbed 
elastin fragments were detected by applying elastin primary antibody (BA-4, SCBT), 
with bovine α-elastin (Sigma) serving as a standard.  
Measured total collagen, sGAG, collagen III, and elastin levels were normalized 
to cell number as assessed by the PicoGreen assay (Invitrogen). For the purposes of 
comparison, the resulting concentrations for each formulation were further normalized to 
the 100:0 PEG-PDMSstar hydrogels.  
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Total Calcium Deposition. To assess construct calcium levels, hydrogel discs (n 
= 3-4 per formulation) were homogenized in 640 μl lysis buffer (1% TritonX-100, 0.5% 
SDS in calcium-free PBS) per 100 mg hydrogel. Total calcium was quantified using 10 
μl aliquots of each sample homogenate via the Calcium CPC liquid color kit (Stanbio).  
 
6.3.8.2. Histological Analyses 
Samples harvested for histological analyses were fixed with 10% formalin for 30 
min, embedded in Tissue-Tek media, and cut into 35 μm sections using a 
cryomicrotome.  
 
Immunostaining. Immunohistochemical staining was conducted using the same 
A-FABP, SM22α, osteocalcin, and collagen II primary antibodies used for competitive 
ELISA analyses. After 10 min treatment with peroxidase (Biocare Medical), sections 
were blocked with Terminator (Biocare Medical) for 30 min followed by 1 h exposure to 
primary antibody diluted in HBS. Bound primary antibody (SCBT) was detected by 
using either AP- or HRP-conjugated secondary antibodies (JIRL) followed by 
application of an appropriate chromogen (LabVision). Three sections from each sample 
of each formulation were stained per antibody. Immunostained sections were imaged 
under brightfield using an Axiovert microscope (Zeiss).  
 
Von Kossa Staining. To detect calcium deposits, three sections per sample of 
each formulation were stained using a standard von Kossa kit (American MasterTech 
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Scientific). In brief, rehydrated sections were rinsed with dIH2O, after which a 5% silver 
nitrate solution was applied. Sections were then exposed to full spectrum light in a 
humidified chamber for 45 min. After rinsing with dIH2O, sections were exposed to 5% 
sodium thiosulfate for 2.5 min, briefly rinsed, and mounted. Stained sections were 
imaged as previously described.  
 
6.3.9. Statistical Analyses  
 
Data are reported as mean ± standard deviation. Statistical differences among 
material property measures (e.g. modulus) were performed using ANOVA followed by a 
Tukey post-hoc test, p < 0.05. Statistical differences in biochemical or cell marker data 
were assessed via ANOVA followed by the Tamhane T2 post-hoc test for samples with 
unequal variances, p < 0.05 (SPSS software).  
 
6.4. Results  
 
6.4.1. Hydrogel Material Properties  
 
To gain insight into the shifts in scaffold material properties underlying observed 
alterations in cell behavior across formulations, various hydrogel properties were 
characterized. 
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Fig. 25. Schematic of the PEGDA and PDMSstar-MA components of PEG-PDMSstar hydrogels. 
 
 
6.4.1.1. PDMSstar Particle Size 
A previous study of PEG-PDMSstar hydrogels demonstrated that the phase 
separation between PDMSstar and PEG observed in aqueous solution resulted in PEG 
hydrogels embedded with spherical PDMSstar “particles” [234]. To characterize the 
average diameter of the PDMSstar particles incorporated into the present PEG-PDMSstar 
hydrogels, DLS studies were performed. These assays revealed an average PDMSstar 
particle size of 190 nm with a polydispersity index of 1.4 for both the 0.5% and 2% 
PDMSstar aqueous solutions (representative of the PDMSstar concentrations in the 95:5 
and 80:20 hydrogels, respectively). A representative DLS curve is provided in Fig. 26. 
These DLS results indicate that the scaffold inorganic content to which encapsulated 
cells could potentially be exposed (i.e. the PDMSstar total particle surface area) increased 
monotonically from the 100:0 to the 80:20 gels. 
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Fig. 26. Representative particle size distribution. 
 
 
6.4.1.2. Mechanical Properties  
As shown in Fig. 20A, hydrogel modulus under bulk compression was not 
significantly altered by the increase in PDMS content associated with the 100:0 and the 
95:5 gels. In contrast, the bulk compressive modulus of the 80:20 PEG-PDMSstar 
hydrogels was approximately 75% of that of the 95:5 formulation (p < 0.001). These 
bulk modulus values were not significantly affected by inclusion of cells (at 2 x 106 cells 
g-1) (Table 8 vs Fig. 20A). In addition, no significant differences in gel modulus were 
noted between day 1 and day 21 of culture (Table 8), indicating minimal scaffold 
degradation over the culture period, consistent with previous PEGDA literature [190]. 
This resistance to degradation implied that minimal alterations in bulk material 
properties occurred over the culture period and facilitated the correlation between initial 
scaffold material properties and observed cell behaviors.  
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Table 8. Moduli of Cell-Laden PEG-PDMSstar Hydrogels under Bulk Compression. 
 
*,statistical difference with the 100:0 formulation, p < 0.05; # statistical difference with the 95:5 
formulation, p < 0.05;  statistical difference with the 95:0 formulation, p < 0.05 † n = 4 per formulation per 
assay. 
 
 
To assess the degree to which the decrease in PEG between the 100:0 and 80:20 
gels was contributing to the observed differences in mechanical properties, control 
hydrogels containing 9.5 wt%  PEGDA and 8.0 wt%  PEGDA but no PDMSstar were 
prepared. These control gels are referred to as 95:0 and 80:0 PEG-PDMSstar hydrogels, 
respectively. Comparison of the bulk modulus values of the 95:5 and 95:0 gels as well as 
those of the 80:20 and 80:0 hydrogels (Fig. 27A) suggests that the PEG-containing phase 
was the primary determinant of the observed bulk compressive modulus values.  
To evaluate spatial variations in modulus associated with PEG-PDMSstar phase 
separation, microscale AFM-based compressive measurements were performed. In 
contrast to the bulk compression results, the average AFM modulus values for the 80:20 
and 80:0 hydrogels indicated that PDMSstar incorporation substantially altered hydrogel 
modulus at the microscale (Fig. 27B). This was reflected not only in the change in 
average modulus between these two formulations but also in the increased standard 
deviations associated with the average local moduli of the PDMSstar containing gels. The 
difference in the magnitude of the bulk compression and AFM-based modulus values 
PEG-PDMS 
Ratio 
Modulus at 24 h
†
  Modulus at 21 Days
†
 
100:0 148.5 ± 5.1  149.6 ± 16.0 
95:5 140.0 ± 5.2  140.4 ± 10.4 
80:20 108.8 ± 10.0*,#  111.7 ± 14.2*,#,  
95:0 134.7 ± 27.8  144.1 ± 11.7 
80:0 100.9 ± 33.0  102.3 ± 31.6 
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can be attributed to differences in mechanical testing method and conditions. In 
particular, the AFM assessments were conducted over a much lower strain range than 
the bulk compressive tests (0.08-0.1% versus 5-25% strain).  
 
6.4.1.3. Average Mesh Size and Relative Bulk Hydrophobicity 
The bulk average mesh size data reflected the AFM-modulus assessments. 
Namely, average mesh size increased significantly as the ratio of PEG to PDMSstar 
decreased (p < 0.001, Table 9). In addition, the average mesh sizes of the 95:0 and the 
80:0 control gels were significantly greater than that of the 95:5 (p = 0.001) and 80:20 (p 
= 0.001) hydrogels, respectively. These results reflect the inclusion of densely 
crosslinked nanoparticles of 2 kDa PDMSstar within a more loosely crosslinked 3.4 kDa 
PEG hydrogel network. In terms of relative bulk hydrophobicity, hydrogel H-values 
were significantly higher in the 80:20 and 95:5 hydrogels than in the 100:0 gels (p < 
0.001 and p = 0.003, respectively; Table 9). However, the H-values for the 80:0 and 95:0 
control gels could not be distinguished from those of the 100:0 hydrogels. Thus, the 
present data suggest that the increase in relative bulk hydrophobicity observed between 
the 100:0 and 80:20 hydrogels can be attributed to the increased incorporation of 
PDMSstar rather than to decreasing PEGDA levels.  
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Table 9. Relative Mesh Size, Bulk Hydrophobicity, and Serum Protein Adsorption. 
 
*statistical difference with the 100:0 formulation,  p < 0.05; #statistical difference with the 95:5 
formulation, p < 0.05;  , statistical difference with the 95:0 formulation, p < 0.05.  † n = 4 per formulation 
per assay. 
 
 
6.4.1.4. Serum Protein Adsorption 
A primary mechanism by which scaffold hydrophobicity impacts cell behavior is 
through modulation of the levels, identities, and orientations of absorbed proteins [31, 
34, 235, 236]. We therefore measured the amount of serum proteins adsorbed by the 
various hydrogel formulations. The levels of serum protein adsorbed onto the 95:5 and 
80:20 hydrogels were approximately 2-fold and 5-fold greater than the 100:0 gels (p = 
0.021 and p < 0.001, respectively; Table 9). Importantly, this increase in adsorbed serum 
proteins could not be attributed solely to the associated decrease in PEG levels from the 
100:0 to the 80:20 gels. Namely, the serum protein adsorption by the 80:20 gels was 
80% greater than that of the 80:0 hydrogels (p < 0.001). Thus, the presence of 
hydrophobic PDMSstar particles within the PEG-PDMSstar hydrogels altered bulk serum 
protein adsorption. 
 
PEG-PDMS 
Ratio 
Relative Mesh Size
†
 
H 
qI70/qdIH2O
†
 
Relative Adsorbed Protein
†
 
100:0 1.00 ± 0.02 1.04 ± 0.01 1.00 ± 0.15 
95:5 1.05 ± 0.03 1.10 ± 0.02*
 1.97 ± 0.29* 
80:20 1.37 ± 0.04*,#,  1.17 ± 0.03*,#,  5.06 ± 0.48*,#,  
95:0 1.10 ± 0.02*
 1.04 ± 0.02 1.12 ± 0.02 
80:0 1.52 ± 0.02*
,#,  1.03 ± 0.03# 2.76 ± 0.33*,  
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Figure 27. Average mechanical property measures of PEG-PDMSstar hydrogels obtained from (A) bulk 
compression and (B) AFM-based local compression tests. *significantly different from 100:0 gels; 
#significantly different from 95:5 gels;  significantly different from 95:0 gels. Samples for bulk 
compressive tests: n = 3-5 per formulation. Sample locations for AFM-based tests: n = 10 per formulation. 
 
 
6.4.2. Cell Phenotypic Markers and ECM Production 
 
To investigate the potential influence of alterations in PEG-PDMSstar hydrogel 
composition on 10T½ fate decisions, markers associated with chondrocyte-, osteoblast-, 
SMC-, and adipocyte-like fates were examined via competitive ELISA. Specifically, 
isolated sample proteins were evaluated for mid-to-late term markers of osteogenesis 
(runx2, osteocalcin), chondrogenesis (sox-9, collagen II), SMC progression (myocardin, 
SM22α), and adipogenesis (PPARγ, A-FABP).  
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Figure 28. Analyses of cell differentiation markers. (A) Levels of runx2, PPAR, sox-9, and mycoardin 
per PEG-PDMSstar formulation, and (B) levels of osteocalcin, A-FABP, collagen II, and SM22α per PEG-
PDMSstar gel type. Results were normalized to the 100:0 PEG-PDMSstar formulation for the purpose of 
comparison. *significantly different from 100:0 gels; #significantly different from 95:5 gels;  significantly 
different from 95:0 gels; significantly different from 80:0 gels. Samples per assay: n = 3-6 per 
formulation. 
 
 
 ELISA analyses revealed that expression of transcription factors sox-9, 
myocardin, and PPARγ did not vary significantly across formulations (Fig. 28A). In 
agreement with the sox-9 data, collagen II production was also not significantly altered 
with increasing PDMSstar content (Fig. 28B). Similarly, although A-FABP and SM22α 
levels appeared to increase slightly in the 80:20 hydrogels relative to the 100:0 
hydrogels, these differences fell below statistical significance. However, levels of the 
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osteogenic transcription factor runx2 increased approximately 4-fold as PDMS levels 
increased from the 100:0 gels to the 80:20 gels (p < 0.001). In addition, osteocalcin 
deposition was approximately 400 percent greater in the 80:20 hydrogels than in the 
100:0 hydrogels (p < 0.001). Immunostaining results for collagen II, osteocalcin, 
SM22α, and A-FABP were consistent with these ELISA results. A subset of these 
immunostaining images are shown in Fig. 29.  
 Based on the above differentiation marker results, the 100:0, 95:5, and 80:20 gels 
were further analyzed for ECM molecules associated with osteogenesis (collagen I, 
calcium deposits), chondrogenesis (GAGs), adipogenesis (elastin, collagen III), and 
SMC-lineage progression (collagen III, elastin). As shown in Fig. 30, collagen III 
deposition did not vary significantly with increasing PDMSstar content. Similarly, elastin 
and GAGs concentrations could not be distinguished across hydrogel formulations (Fig. 
30). However, collagen I levels were significantly higher in the 80:20 hydrogels relative 
to remaining formulations (p < 0.016). These collagen I results were reflected in the total 
collagen data (p < 0.010 for all pairwise comparisons). Furthermore, quantitative CPC 
assays revealed a marked increase in calcium deposits in the 80:20 gels relative to the 
100:0 and 95:5 gels (p < 0.002, Fig. 22A). Qualitative von Kossa staining supported 
these quantitative CPC results (Fig. 22B). Cumulatively, the cell marker and ECM data 
indicated increased MSC osteogenic differentiation with increasing scaffold PDMSstar 
content.  
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Figure 29. (A) Calcium measures per hydrogel formulation (n = 3-4 per formulation). *significantly 
different from 100:0 gels; #significantly different from 95:5 gels. (B) Representative images of PEG-
PDMSstar hydrogel sections stained for osteocalcin (blue), SM22α (red), and calcium deposits (brown-
black), n = 3 per gel type. The scale bar in the upper right-hand image equals 40 µm and applies to all 
images. 
 
 
6.5. Discussion  
 
In the present study, mouse 10T½ MSCs were encapsulated in a series of PEG-
PDMSstar hydrogels of varying inorganic content and hydrophobicity. Quantitative 
analyses indicated marked increases in a range of osteogenic markers with increasing 
PDMS levels. Specifically, runx2, osteocalcin, and calcium deposits were each 3-4 times 
greater in the 80:20 formulation versus the 100:0 control gels. Expression of collagen I, 
the primary collagen type in bone, was also elevated in hydrogels with increased PDMS 
content. In addition, the agreement in the collagen I and total collagen profiles suggests 
that collagen I was the dominant collagen type synthesized by the encapsulated cells.  
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In contrast, intracellular markers for adipogenesis (PPARγ, A-FABP), 
chondrogenesis (sox-9), and SMC lineage progression (myocardin, SM22α) were not 
altered in scaffolds with increased PDMS content, indicating that the observed 
osteogenic response was specific. To further confirm this, the levels of ECM molecules 
collagen III, elastin, and GAGs were quantified. Specifically, elastin- and collagen III-
rich matrices are generally associated with smooth muscle [183] and loose connective 
tissues [38, 237], whereas increased production of sGAG is generally associated with 
chondrogenesis [238]. Levels of these ECM moieties were similar across gel 
formulations, supporting the specificity of the associated osteogenic response. Since 
introduction of PDMSstar-MA into the  PEGDA hydrogel network could potentially alter 
bulk hydrogel modulus and mesh structure, the observed cell responses could not be 
attributed directly to the hydrophobic-inorganic character of PDMS without further 
material property assessments. Based on the collected modulus data, the decrease in 
average modulus from ~35 kPa in the 100:0 hydrogels to ~22 kPa in the 80:20 gels did 
not appear to play a significant role in the observed osteogenic response. Specifically, 
although osteogenic markers runx2 and osteocalcin were significantly greater in the 
80:20 gels than in the 80:0 control gels, the average modulus values (both bulk and 
AFM-based) could not be distinguished between these gels. The apparent independence 
of cell responses on average gel modulus is consistent with literature in that each of the 
analyzed PEG-PDMSstar scaffolds fell within the “osteogenic” modulus range identified 
by Huebsch et al [216] for both mouse and human MSCs in 3D culture. By a similar 
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argument, the variations in mesh size across hydrogel formulations are an unlikely 
source of the osteogenic response associated with the 80:20 gels.  
Thus, the hydrophobic-inorganic character of PDMS itself appears to promote 
the observed cellular responses. This would be consistent with prior studies linking 
increased scaffold silane [36] or siloxane [38] content to increased osteogenic responses. 
It is likely that both the inorganic nature of PDMS as well as its hydrophobicity played 
critical roles in the present results. In particular, silica, which is inorganic but 
hydrophilic, has been associated with increased osteogenesis [33, 34]. Similarly, the 
introduction of hydrophobic but non-inorganic species within scaffolds has been linked 
to bone formation [33].  
 
 
 
 
Figure 30. Levels of total collagen, collagen I, collagen III, GAGs and elastin in each PEG-PDMSstar 
formulation. Results were normalized to the 100:0 PEG-PDMSstar formulation for the purpose of 
comparison. *significantly different from 100:0 gels; #significantly different from 95:5 gels. Samples per 
assay: n = 4-6 per formulation. 
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Several limitations of the present study merit comment. First, the potential 
influence of the nanotopography introduced by the PDMS nanoparticles on observed cell 
responses requires further examination. In addition, the sample number per formulation 
and the range of PDMS levels examined were limited. More extensive in vitro studies 
followed by in vivo work would be required to definitely demonstrate that increased 
PDMS incorporation intrinsically promotes osteogenesis.  
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CHAPTER VII 
INFLUENCE OF CYCLIC STRETCH AND ENDOTHELIAL CELL PRESENCE 
ON MESENCHYMAL STEM CELL OSTEOGENIC COMMITMENT 
 
 
7.1. Overview 
 
MSCs are increasingly recognized as a viable cell source for bone regeneration 
applications. In addition to soluble factors, cyclic stretch has been shown to have a 
profound effect on mesenchymal stem cell (MSC) osteogenesis. Similarly, EC presence 
has been demonstrated to enhance MSC osteogenic differentiation. However, potential 
synergistic interactions between mechanical stimulation and EC presence remain to be 
elucidated.  The aim of the present manuscript was therefore to examine the 
simultaneous influence of cyclic stretch and EC paracrine signaling on MSC 
osteogenesis in the context of scaffolds with “osteogenic” moduli.  
 To accomplish this, 10T½ multipotent stem cells were encapsulated in PEGDA 
hydrogels with moduli within the “osteogenic” range. Half of the constructs were 
fabricated with a luminal EC layer. EC+ and EC- constructs were then subjected to 
continuous cyclic stretch. Following 10 days of culture, both EC+ and EC- constructs 
were associated with significantly elevated levels of chondrogenic transcription factor 
sox9 relative to initial (day 0) expression levels. By day 22 of culture, however, sox9 
levels in both the EC+ and EC- constructs had returned to or fallen below day 0 levels. 
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In contrast, osteocalcin expression was significantly higher in Day 22 EC+ constructs 
relative to EC- constructs and relative to day 0. Similarly, osteopontin and alkaline 
phosphatase levels were elevated in Day 22 EC+ constructs relative to EC- constructs. 
Cumulatively, the present results suggest that EC paracrine signaling enhances MSC 
osteogenesis in the presence of cyclic stretch. In addition, the observed transition from 
chondrogenic to osteogenic protein expression associated with the EC+ constructs would 
be consistent with the neovascularization-dependent transition from cartilage matrix to 
osteoid matrix associated with endochondral bone formation. 
 
7.2. Introduction 
 
Neovascularization and mechanical stress play critical roles in endochondral 
ossification, a key bone formation mechanism during bone growth and fracture healing 
[40]. Indeed, in endochondral ossification, blood vessels invade hyaline cartilage, and 
MSCs associated with invading vessels differentiate into osteoblasts which begin 
depositing bone matrix [40]. In addition, physiological loading during endochondral 
ossification enhances the rate and quality of bone matrix deposition [41, 42]. Consistent 
with the endochondral ossification process, studies have shown MSC osteogenic 
differentiation to be separately influenced by cyclic loading [43, 44] and EC presence 
[45-47]. However, potential synergistic interactions between mechanical stimulation and 
EC presence on MSC osteogenesis remain to be elucidated. This is significant since a 
deeper understanding of such interactions could lead to improved MSC-based bone 
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regeneration strategies. The goal of the present study was therefore to evaluate potential 
synergistic effects of EC paracrine signaling and cyclic stretch on MSC osteogenesis 
within the context of scaffolds with “osteogenic” moduli. 
 To accomplish this, 10T½ MSCs were encapsulated within tubular PEGDA 
hydrogels. The molecular weight and concentration of PEGDA were selected to yield 
constructs with moduli within the “osteogenic” range identified by Parekh et al. [239]. 
Specifically, Parekh et al. found that MSC osteogenesis increased with increasing 
modulus from ~11 kPa through at least 59 kPa. Thus, the present PEGDA constructs 
were fabricated with moduli of ~60 kPa. Initial MSC interactions with the hydrogel 
matrix were enabled by the conjugation of adhesion peptide RGDS to the hydrogel 
network. In addition, half of the constructs were fabricated with a luminal EC layer to 
allow for evaluation of the influence of EC paracrine signals on MSC differentiation. 
Tubular scaffold geometry was selected to enable construct mounting within a pulsatile 
flow bioreactor. This bioreactor setup allowed for simultaneous application of cyclic 
stretch while exposing luminal ECs to physiological wall shear stress. After 10 and 22 
days of culture, the levels of various differentiation markers expressed by encapsulated 
10T½ MSCs were characterized in order to evaluate MSC lineage progression. 
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7.3. Materials and Methods 
 
7.3.1. Polymer Synthesis 
 
PEGDA was prepared as previously described [191] by combining 0.1 mmol ml-1 
dry PEG (6 kDa, Sigma), 0.4 mmol ml-1 acryloyl chloride, and 0.2 mmol ml-1 
triethylamine in anhydrous DCM and stirring under argon overnight at 4 °C. The 
resulting solution was washed with 2 M K2CO3 and separated into aqueous and DCM 
phases to remove HCl. The DCM phase was subsequently dried with anhydrous MgSO4, 
and PEGDA was precipitated in diethyl ether, filtered, and dried under vacuum. 
Acrylation of the PEG end hydroxyl groups was characterized by 1H-NMR to be ~85%. 
Cell adhesion peptide RGDS (American Peptide) was conjugated to acryloyl-
PEG-N-hydroxysuccinimide (ACRL-PEG-NHS, 3.4 kDa, Laysan) at a 1:1 molar ratio 
for 2 h in 50 mM sodium bicarbonate buffer, pH 8.5 [221]. The product (ACRL-PEG-
RGDS) was purified by dialysis, lyophilized, and stored at -20 ºC until use. 
 
7.3.2. Cell Culture and Construct Fabrication 
 
Cryopreserved bovine aortic ECs (BAECs, Cell Applications) at passage 3-5 
were thawed and expanded at 37 ºC and 5% CO2. During expansion, cells were cultured 
in Dulbecco’s Modified Eagle’s Media (DMEM, Hyclone) containing 10% iron-
supplemented bovine calf serum (BCS, Hyclone), 100 U/mL penicillin, and 100 mg l-1 
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streptomycin (Hyclone). Cryopreserved 10T½ mouse MSCs (ATCC) at passage 2-5 
were thawed and expanded in DMEM supplemented with 10% heat-inactivated fetal 
bovine serum (FBS, Hyclone).  
10T½ cells were harvested from 4 separate populations, each at passage 5-7. A 
fraction of each population was allocated for “day 0” protein extraction. The remaining 
portions of each cell population were then combined and allocated for encapsulation 
within tubular PEGDA constructs. Similarly, BAECs at passage 5-8 were harvested, 
combined, and processed to form stable EC layers within the lumens of half of the 
tubular constructs. Protein extraction and construct fabrication procedures are described 
further in the following subsections. 
 
7.3.2.1. Day 0 Protein Extraction 
Proteins were extracted from Day 0 10T½ cell populations (n = 4) by the addition 
of Trizol (Invitrogen) per manufacture’s protocols. The resulting solutions were 
centrifuged, and the supernatants were mixed with chloroform (Sigma), vigorously 
shaken for 15 s, and centrifuged. Ethanol was then added to the lower, protein-rich 
phenol-chloroform phase of each mixture to precipitate residual DNA. The resulting 
phenol-ethanol phase was transferred to a 3.4 kDa SnakeSkin dialysis membrane 
(Pierce). Each solution was dialyzed for ~60 h at 4 °C against an aqueous solution of 
0.1% sodium dodecyl sulfate (SDS), with buffer exchange every 18 h. By the end of 
third 18 h dialysis period, the samples had partitioned into three phases: (1) a 
supernatant, (2) a globular mass, and (3) a colorless, viscous liquid. The globular mass 
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of each sample contained the bulk of sample proteins [194] and was resuspended in PBS 
containing 0.5% SDS and 1% Triton X-100. The isolated sample proteins were 
subsequently used in quantitative ELISA assays. 
 
7.3.2.2. Fabrication of Bilayered Hydrogels  
A series of constructs were fabricated for two experimental time points – day 0, 
day 10 and day 22. Since ECs seeded onto the surface of PEGDA hydrogels containing 
cell adhesion peptide RGDS tend to form cell layers that are unstable under flow 
conditions [240]. Day 0 EC+ constructs were prepared by a unique sequential 
polymerization process, termed “cementing”. In this process, luminal PEGDA served as 
a “grout” between adjacent ECs rather than as an encapsulating agent[240]. This process 
effectively prevents EC layer delamination under flow while allowing the “cemented” 
ECs to directly experience the luminal flow environment [240]. In brief, a precursor 
solution containing 0.1 g ml-1 PEGDA and 1 mM ACRL-PEG-RGDS in 10% sucrose 
was first prepared. Ten μl of a 300 mg ml-1 solution of 2,2- dimethoxy-2-phenyl-
acetophenone (DMAP) dissolved in N-vinyl pyrrolidone (NVP) was then added per mL 
of mixture, and the resulting solution was sterilized by filtration. BAECs were harvested 
and resuspended at high density (125x106 cells ml-1) in the PEGDA precursor solution. 
Fifty µL of the resulting mixture was spread evenly onto a 3 mm glass rod over a 5.5 cm 
length and was then dried as a thin layer by 8 min application of a sterile air stream. 
During air stream application, the rod was held horizontally and constantly rotated to 
facilitate the fabrication of an even coating.  
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Each EC coated rod was inserted as the inner mandrel of a double-walled 
cylindrical mold, the outer wall of which was composed of a hollow UV transparent 
plastic cylinder (5 mm ID). A separate precursor solution containing 0.1 g ml-1 PEGDA 
and 1 mM ACRL-PEG-RGDS in HBS-TEOA (10 mM HEPES, 150 mM NaCl, 115 mM 
triethanolamine, pH 7.4) was then prepared. Following the addition of 10 μl of a 300 mg 
ml-1 solution of DMAP in NVP, the solution was sterilized by filtration. Harvested 10T½ 
cells were then resuspended in the precursor solution at ~5x106 cells ml-1, and the 
resulting cell suspension was gently pipetted into the cylindrical molds and polymerized 
by exposure to UV light (365 nm, ~10 mW cm-2, UVP model B-100SP) for 6 min. The 
resulting bilayered hydrogels were removed from their molds and briefly rinsed in PBS 
containing 1% PSA (PSA: 10,000 U ml-1 Penicillin, 10,000 mg l-1 Streptomycin, and 25 
mg l-1 Amphotericin). Day 0 EC+ constructs (n = 11) were then transferred to DMEM 
containing 10% BCS and 1% PSA. Day 10 EC+ (n = 8) and Day 22 EC+ constructs (n = 
3) were prepared in a similar manner. 
Day 0 EC- constructs (n = 8), Day 10 EC- constructs (n = 5) and Day 22 EC- 
constructs (n = 3) were prepared as above, except that the PEGDA precursor solution for 
the luminal layer contained no BAECs. BAEC viability through the above construct 
fabrication process has previously been shown to be similar to BAEC viability following 
standard encapsulation in PEGDA gels [240]. In addition, “cemented” BAECs have 
previously been demonstrated to display a phenotype similar to that of BAECs seeded 
onto the surface of RGDS-containing PEGDA hydrogels [240]. In the present study, we 
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also confirmed an appropriate phenotype for “cemented” ECs by comparison with ECs 
seeded onto PEGDA hydrogels containing 1 mM ACRL-PEG-RGDS (Fig. 31). 
 
7.3.3. Day 0 Construct Characterization 
 
After 24 post-fabrication, constructs were harvested for mechanical and 
histological analyses. Each harvested EC+ and EC- construct was then cut into 6 ring 
segments approximately 4-6 mm in length. The two end ring segments of each construct 
were discarded. One of the 4 remaining segments of each construct was transferred to 
PBS for immediate mechanical testing, and a separate segment was processed for 
histological analyses. 
 
7.3.3.1. Mechanical Assessment  
Twenty-four hours post-fabrication, ring segments ~ 4mm in width were 
harvested from a subset of each construct set (n = 3 per construct type) to assess initial 
mechanical properties as well as to confirm similar moduli across gels. Mechanical 
analyses were conducted using a modification of the circumferential property testing 
technique validated in Johnson et al. [192] and Hiles et al. [193]. In brief, the dimensions 
of ring segments were measured using digital calipers. These measures served as 
dimension inputs for subsequent stress and strain calculations. Each ring was mounted 
onto an Instron 3342 by threading opposing stainless steel hooks through the segment 
lumen. The hooks were then uniaxially separated at a rate of 6 mm/min until construct 
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failure. As hook separation increased, the mounted ring was drawn into an increasingly 
oblong conformation. Johnson et al. [192] confirmed that the force applied by the hooks 
to this oblong oval could be approximated as being equally distributed between two 
rectangles, each with sides equal to the width and wall thickness, hv, of the ring. The 
gauge length, lg, was taken to be the inner diameter, Dv, of the unstretched ring plus hv, 
and the elastic modulus, E, of each sample was defined as the slope of the resulting 
stress–strain curve at a reference stress σ of 20 kPa [84]. Samples remained immersed in 
PBS until immediately prior to mechanical analyses, and testing was completed rapidly 
to avoid sample dehydration. 
 
7.3.4. Mechanical Conditioning 
 
 After 3 days of static culture, EC+ and EC- constructs were mounted onto the 
inner ports of separate bioreactor graft chambers. These graft chambers were then 
connected to separate bioreactor flow loops, described in further detail in the following 
section.  
 
7.3.4.1. Bioreactor Flow Loop 
Constructs were exposed to pulsatile flow conditions using a modification of the 
bioreactor system previously described in Bulick et al. [117]. In brief, a peristaltic pump 
drew media from a reservoir, generating the desired flow rate of media through the 
system. The media flow was then passed through a compliance chamber, and a CellMax 
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pump (Spectrum Labs) was used to overlay the desired pulsatile waveform. The flow 
was then passed through the constructs. Pressure profiles were monitored immediately 
upstream and downstream of each construct using sterile transducers (Merit Medical) 
equipped with inlet and outlet valves. After exiting the constructs, the media was passed 
back to the media reservoir, completing the flow circuit. Both the graft chamber and the 
media reservoir were fitted with vent ports. 
 
7.3.4.2. Mechanical Stimulation Regimen 
The graft chamber baths and the inner flow loops were filled with DMEM 
supplemented with 10%  BCS and 1%  PSA. At day 4 of culture, flow was initiated at 20 
ml min-1 per construct. After 3 h, the flow was ramped to 40 mL/min per construct. 
Following 24 h of flow, the mean pressure (Pavg) in each construct lumen was adjusted 
~ 90 mmHg using the pressure transducer valves. At day 7 of culture, pulsation at 120 
beats per minute [bmp] and a ΔP ~ 15 mmHg was initiated. After an additional 24 h, 
flow was increased to 120 ml min-1 per construct and a ΔP of ~25 mmHg. Continuous 
pulsatile flow was then applied through 22 days total culture time, with media changes 
every two days.  
 
7.3.4.3. Shear Stress Estimates and Viscosity Measures 
To estimate the shear stress experienced by ECs on the luminal surface of EC+ 
constructs, the Womersley number was first calculated [195, 196]. Specifically, rigorous 
estimates of the wall shear stress, τw, associated with the above pulsatile flow conditions 
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can be obtained from the mathematical descriptions of pulsatile flow in rigid pipes 
developed by Womersley [195, 196] and the associated dimensionless Womersley 
number,  α R√
  
μ
, where R   vessel inner radius,     frequency of oscillation,     
media density, and  μ   media viscosity. The magnitude of α is an indicator of the 
impact of pulsatile flow frequency relative to viscous effects on fluid flow.  
To estimate the Womersley number, the viscosity of DMEM containing 10% 
BCS and 1% PSA was determined using a Physica MCR 300 Modular Compact 
Rheometer fitted with a CP50-1 cone plate [197]. During testing, the temperature was 
held constant at 37 oC using a Peltier temperature controller. The change in media shear 
stress with increasing shear rate from 0.5-200 s-1 was monitored by the device and was 
used to calculate media viscosity. Through this technique, the viscosity of DMEM 
containing 10% BCS and 1% PSA was determined to be ~0.65 cP at 37 °C, in good 
agreement with previous literature [198]. 
Thus, for R   0.165 cm and     4π s-1, α was approximately 5.4. For α in the 
range of 3-10, the Hagen-Poiseuille equation can be assumed to provide a useful 
estimate of wall shear stress [199]. Specifically, the Hagen-Poiseuille equation predicts 
that τw 
4μQ
πR3
, where Q = volumetric flow rate. 
 
7.3.4.4. Circumferential Strain Estimates 
To estimate the circumferential strain experienced by the constructs, the 
measured elastic moduli and vessel dimensions were input into the Bernoulli equation  
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  ~
( P )R
hvE
, where R = inner vessel radius, hv = wall thickness, and E = construct modulus 
[201]. This equation has previously been shown to be in good agreement with actual 
strains experienced by PEGDA constructs in the present bioreactor setup [84]. 
 
7.3.5. Endpoint Analyses 
 
After 10 and 22 days total culture time, constructs were harvested for 
mechanical, histological, and biochemical analyses. In addition, constructs were 
harvested at 24 h post-fabrication for mechanical (Day 0 mechanical assesmensts) and 
histological analyses. Each EC+ construct was examined using a Leica stereomicroscope 
to confirm that the luminal EC layer was intact. Each harvested EC+ and EC- construct 
was then cut into 6 ring segments approximately 4-6 mm in length. The two end ring 
segments of each construct were discarded. One of the 4 remaining segments of each 
construct was transferred to PBS for immediate mechanical testing per the “Day 0” 
protocol, and a separate segment was processed for histological analyses. The two 
remaining segments per construct were immersed in formalin for 30 min, after which 
they were allocated for quantitative biochemical assays. For these segments, the luminal 
layer was removed using a dremel, and the remaining 10T½ layer was processed for 
biochemical analyses. For the EC+ segments, the removed luminal layer was also 
collected for further assessment. Details regarding the biochemical and histological 
assessments are given in the following subsections. 
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7.3.5.1. Biochemical Analyses 
Day 10 and Day 22 10T½ layers and Day 10 and Day 22 EC layers were 
homogenized in Trizol. Sample proteins were then isolated as described for the Day 0 
10T½ cell populations. The sample proteins isolated from Day 10 10T½ layers were 
evaluated for early-to-mid term markers of osteogenesis, chondrogenesis, adipogenesis, 
and myogenesis via competitive ELISAs. Based on Day 10 results, proteins extracted 
from Day 22 10T½ layers were analyzed for mid-to-late term markers of chondrogenesis 
and osteogenesis. Similarly, sample proteins isolated from the luminal layers of Day 10 
and Day 22 EC + constructs were evaluated for various EC phenotypic markers.  
 For each antibody examined, high binding EIA 96 well plates (Costar) were 
coated overnight at 4 °C with appropriate competitive peptide. The concentration of the 
applied competitive peptide was 200 ng/well, except for β-actin (50 ng/well). The coated 
wells were then blocked with BSA and rinsed with PBS. Aliquots of each sample were 
incubated with primary antibody for 1 h, after which the sample-antibody mixtures were 
applied to coated wells for 1 h. Standard curves were similarly prepared by incubating 
primary antibody with varying levels of competitive peptide for 1 h, followed by 
solution application to coated wells. For both samples and standards, primary antibody 
which had bound to the coated wells was detected using an appropriate HRP-conjugated 
secondary antibody (Jackson Immunoresearch), followed by application of 2,2'-azino-
bis(3-ethylbenzthiazoline-6-sulphonic acid) (Sigma) and monitoring of absorbance at 
410 nm. 
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 Each target protein was analyzed in duplicate for each sample and normalized to 
the average of housekeeping proteins β-actin and GAPDH. For the purpose of 
comparison, the resulting proteins concentrations for the Day 10 and Day 22 10T½ 
layers were normalized to Day 0 10T½ expression levels.  
 
7.3.5.2. Histological Analyses 
Construct segments reserved for immunostaining were fixed in formalin for 30 
min. Each sample was then transferred to Tissue-Tek freezing media, snap frozen, and 
cut into 35 μm sections using a cryotome. Rehydrated sections were blocked with 
peroxidase for 30 min followed by 30 min exposure to Terminator (Biocare Medical). 
Primary antibodies for sox9, alkaline phosphatase, and osteopontin were diluted in PBS 
containing 3% BSA and then applied to the sections for 1 h. Bound primary antibody 
was detected either using HRP-conjugated secondary antibody (Jackson 
ImmunoResearch) followed by application of chromogen AEC (LabVision) or using 
AP-conjugated secondary antibody followed by application of chromogen Ferangi Blue 
(Biocare Medical). EC+ constructs were also stained for VE-cadherin, PECAM-1, and 
thrombomodulin per the above procedure. Further details regarding the antibodies 
employed are given in Table 10. 
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Table 10. Antibodies Employed in Immunostaining and ELISA Assessments.  
 
 
†all antibodies were obtained from Santa Cruz Biotechnology. 
 
 
Stained sections were imaged using a Zeiss Axiovert microscope, and cell counts 
were carried out to semi-quantitatively evaluate immunostaining results for intracellular 
markers sox9 and alkaline phosphatase. These counting assessments were conducted 
according to established methods [53, 88, 89] on sections from each sample. For each 
cell, i, in a given section, a staining intensity, di, was recorded on a scale of 0–3, 0   “no 
staining” and 3   “highest intensity among both treatment groups for that antibody” by a 
single observer blinded to outcome. The cumulative staining intensity, d, for a given 
antibody in a particular section was calculated using the following equation: 
d   
 di
total cell number
. In addition, since deposited ECM remained localized around the parent 
cells in each construct, as is characteristic for PEGDA gels [12], the relative expression 
 
Antibody† Clone Immunostaining ELISA 
Runx2 S-19   
Osterix M-15   
Alkaline Phosphatase N-18   
Osteopontin AKm2A1   
Osteocalcin M-15   
PPAR I-18   
A-FABP C-15   
Sox 9 C-20   
Collagen II N-19   
Myocardin M-16   
SM22α P-15   
VE-Cadherin C-19   
PECAM-1 M-20   
Thrombomodulin M-17   
GAPDH V-15   
β-actin 13E5   
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of the ECM protein osteopontin was also evaluated by cell counts per the above 
procedure. Sox9 counts were used to internally validate the counting approach by direct 
comparison with corresponding quantitative ELISA data (Fig. 37). The degree of 
correlation between the two assessment techniques was 98.9% by Pearson’s correlation 
coefficient method. 
 
7.3.6. Statistical Analyses 
 
 Results are reported as mean ± standard error of the mean. Comparisons among 
hydrogel treatment groups were conducted using ANOVA and Tukey’s post-hoc test 
(SPSS software), p < 0.05.  
 
7.4. Results 
 
7.4.1. Construct Modulus and Applied Stress Conditions  
 
 As shown in Table 11, the initial moduli of the EC+ and EC- constructs were 
statistically indistinguishable at 64.4 ± 3.1 kPa and 70.3 ± 3.8, respectively. Importantly, 
these initial moduli were within the osteogenic r ange identified in the 3D studies of 
Parekh et al. [239]. Specifically, Parekh et al. found that MSC osteogenesis increased 
monotonically with increasing modulus from ~11 kPa through at least 59 kPa. Construct 
moduli in both treatment groups remained within the osteogenic range throughout the 22 
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day culture period. Furthermore, the similarity in the moduli of the EC+ and EC- 
constructs observed at day 0 was also observed at day 10 and day 22 (Table 11), 
indicating that modulus was not a source of difference between treatment groups. 
Similarly, gel dimension assessments indicated the inner radius and wall 
thickness of both the EC+ and EC- constructs were maintained at 1.65 ± 0.02 mm and 
1.18 ± 0.03 mm, respectively, over the culture period. These measures are consistent 
with the slow degradation rate (1-2 years) and resistance to cell-mediated compaction 
characteristic of PEGDA hydrogels [72, 84, 90-92]. Based on the construct moduli, 
dimension data, and the applied ΔP, the cyclic tensile strain experienced by the 
encapsulated 10T½ cells was ≈ 7.2% at full pulsation. Similarly, the average wall shear 
stress experienced by the luminal ECs was ≈ 3.7 dyn cm-2, within the physiological 
range for the microvessels [241] associated with developing bone. 
 
 
Table 11. Modulus for the EC+ and EC- Constructs with Time in Culture.† 
 
 Day 0 Day 10 Day 22 
EC+ 64.4 ± 3.1 58.8 ± 2.1 62.0 ± 10.9 
EC- 70.3 ± 3.8 63.9 ± 2.0 62.0 ± 3.8 
 
†no significant differences between treatment groups or between time points were detected. 
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7.4.2. EC Phenotype 
 
ECs seeded onto the surface of PEGDA hydrogels containing cell adhesion 
peptide RGDS tend to form cell layers that are unstable under flow conditions [240]. 
Therefore, the ensure stable, luminal EC layers for the EC+ constructs, a novel 
“cementing” technique was employed. In brief, this method uses PEGDA as a “grout” 
between adjacent cells rather than as an encapsulating agent [240]. Before evaluating the 
lineage progression associated with the 10T½ construct layers, it was important to 
confirm that ECs within the “cemented” EC layers were expressing an appropriate 
phenotype. Thus, the phenotype of “cemented” ECs was evaluated relative to 
conventionally “seeded” ECs, i.e. “cemented” ECs were compared to ECs which had 
been seeded as a confluent monolayer on the surface of PEGDA hydrogels containing 
cell adhesion ligand RGDS. Cells in both contexts expressed similar levels of the 
molecule VE-Cadherin and PECAM-1 (Fig. 31), markers associated with EC 
intercellular junctions and permeability regulation.  To further understand the impact of 
“cementing” on EC phenotype, competitive ELISAs were conducted for 
thrombomodulin, a protein downregulated following EC damage. As for VE-Cadherin 
and PECAM-1, levels of thrombomodulin were similar in “cemented” versus 
conventionally “seeded” constructs (Fig. 31). These results are consistent with a 
previous study demonstrating that “cemented” BAECs display a similar phenotype as 
conventionally “seeded” BAECs [240]. 
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Fig. 31. (A) Elisa analyses of EC functional and damage-associated markers (VE-Cadherin, Pecam-1 and 
Thrombomdulin). (B) Representative images of EC funtional markers immunostaining. Positive staining is 
indicated by blue coloration.  Scale bar = 20 µm. 
 
 
7.4.3. Day 10 10T½ MSC Differentiation 
 
 Following 10 days of culture, subsets of constructs were harvested to evaluate 
10T½ MSC lineage progression between treatment groups (EC+ and EC- constructs) and 
relative to day 0. To assess the specificity of potential osteogenic responses, early-to-
mid-term markers of chondrogenesis, smooth muscle progression, and adipogenesis 
were evaluated in addition to markers for osteogenesis. As shown in Fig. 32B, day 10 
expression of the smooth muscle transcription factor myocardin was similar between 
EC+ and EC- constructs (Fig. 33) and relative to day 0 (Fig. 32B). In addition, day 10 
levels of the smooth muscle cytoskeletal protein SM22α were indistinguishable from day 
0 levels in both EC+ and EC- constructs. Similarly, day 10 levels of adipogenic 
transcription factor PPARγ as well as of the adipocyte intracellular protein A-FABP 
172 
 
were statistically indistinguishable across treatment groups (Fig. 33) and relative to day 
0 (Fig. 32A). 
As with the adipogenic markers, 10T½ expression of osteogenic transcription 
factors runx2 and osterix at day 10 could not be distinguished between EC+ and EC- 
constructs (Fig. 33) or from day 0 levels (Fig. 34 B). Although day 10 expression of 
bone ECM protein osteocalcin appeared to be elevated in the EC+ constructs relative to 
day 0, this difference fell below statistical significance (data no show). In contrast, day 
10 expression of chondrogenic transcription factor sox9 was increased approximately 2-
fold relative to day 0 in both the EC+ and EC- constructs (p < 0.016). This increase in 
sox9 expression relative to day 0 levels had not yet translated to substantial increases in 
the cartilage ECM protein collagen II (Fig. 34A), suggesting initial stages of 
chondrogenesis.  
 
 
 
 
Fig. 32. ELISA analyses of day 10 expression of (A) smooth muscle lineage markers (myocardin and 
SM22a) relative to day 0 and (B) adipogenic markers (PPARg and A-FABP). n = 5-8 samples per day 10 
treatment group, n = 4 for day 0. 
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Fig. 33. Representative images of day 10 immunostaining for sox9, myocardin, PPARγ, and runx2. 
Positive staining is indicated by red (sox9, myocardin and PPARγ) or blue (rux2) coloration.  Scale bar = 
20 µm. 
 
 
7.4.4. Day 22 Cell Differentiation 
 
 Based on the day 10 sox9 and osteocalcin results, day 22 analyses focused on 
chondrogenic markers in addition to osteogenic markers. As for day 10, no differences in 
collagen II levels were noted between day 0 and day 22 (Fig. 35A). However, in contrast 
to day 10 data, sox9 levels in EC+ and EC- constructs at day 22 were no longer elevated 
relative to day 0. Specifically, sox9 expression in the Day 22 EC+ constructs had 
returned to day 0 levels, whereas sox9 expression in the Day 22 EC- constructs was 2.5-
fold lower than day 0 levels (p = 0.036). Furthermore, semi-quantitative cell counts 
results indicated that sox9 levels in the Day 22  EC+ and EC- constructs were 
approximately 2.0-fold lower than levels in the Day 0 EC- constructs (Fig. 36A, [Day 0 
EC+ and EC- constructs did not show significant differences between them for sox9, AP 
and osteopontin, data not showed]).  
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Fig. 34. ELISA analyses of day 10 expression of (A) chondrogenic markers (sox9 and collagen II) and 
(B) osteogenic markers (runx2 and osterix) relative to day 0. n = 5-8 samples per day 10 treatment group, 
n = 4 for day 0. * indicates a significant difference from EC+, p < 0.05. 
 
 
Evaluation of osteogenic transcription factor osterix indicated no significant 
differences at day 22 between the EC+ and EC- groups or relative to day 0 (Fig. 35B). 
Conversely, day 22 expression of bone ECM protein osteocalcin was approximately 1.6-
fold higher in EC+ constructs than at day 0 (p = 0.025). In addition, day 22 osteocalcin 
levels were approximately 1.6-fold greater in EC+ constructs than in EC- constructs (p = 
0.018). These osteocalcin ELISA assessments were underscored by semi-quantitative 
cell counts for mid-term bone markers alkaline phosphatase (AP) and osteopontin. In 
particular, AP and osteopontin levels were 1.7-fold (p = 0.002) and 2.1-fold (p = 0.005) 
greater, respectively, in Day 22 EC+ constructs than in Day 22 and Day 0 EC- constructs 
(Fig. 35 B and C). These results cumulatively suggest that the early chondrogenesis 
observed for EC+ constructs at day 10 had transitioned to osteogenesis by day 22.  
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Fig. 35. ELISA analyses of day 22 expression of (A) chondrogenic markers (sox9 and collagen II) and 
(B) osteogenic markers (osterix and osteocalcin) relative to day 0. n = 3-4 samples per day 22 treatment 
group and per day 0. 
 
 
7.5. Discussion 
 
 In the present study, the simultaneous influence of cyclic stretch and EC 
paracrine signaling on MSC osteogenesis was examined in the context of scaffolds with 
“osteogenic” moduli. To accomplish this goal, tubular constructs were prepared, half of 
which contained a luminal EC lining. These constructs were then mounted within a 
pulsatile flow bioreactor which enabled exposure of 10T½ MSCs to cyclic stretch while 
also exposing luminal ECs to physiological shear stress. Following 10 days and 22 days 
of culture, 10T½ MSC lineage progression was analyzed in both EC+ and EC- 
constructs. 
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Fig. 36.  Cell counting assessments of day 22 EC+ and EC- and day 0 EC- constructs expression of sox9, 
alkaline phosphatase (AP) and osteopontin. Sections from 3 separate samples of each treatment group 
were evaluated. Validation of the cell counting assessment method is given in Fig. 37. * indicates a 
significant difference from EC+/dyn+,  #  indicates a significant difference from EC- day 0. 
 
 
Day 10 data indicated an initial chondrogenic response, as evidence by increased 
10T½ sox9 expression in both EC+ and EC- constructs relative to day 0. The 
independence of this response on EC presence indicates that this initial chondrogenic 
behavior was either due to the rounded cell phenotype imposed by the tight crosslink 
density and slow degradation rate of PEGDA hydrogels Fig. 37 and/or due to the 
mechanical stresses experience by the 10T½ MSCs. Specifically, rounded cell 
morphologies have previously been associated with chondrogenesis [242]. In addition, 
the 10T½ cells in both treatment groups experienced cyclic stretch as well as dynamic 
hydrostatic pressure imparted by the pressurized media passing through the construct 
lumens. Although generally associated with cyclic compression [243-246], MSC 
chondrogenesis has also recently been shown to be stimulated by cyclic stretch. Indeed, 
McMahon et al. [247, 248] and Connelly et al. [249] found that 10% cyclic tensile strain 
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increased chondrogenic differentiation relative to static controls. Similarly, hydrostatic 
pressure has been shown to stimulate MSC chondrogenesis [250, 251]. In particular, 
Kisiday et al. demonstrated that hydrostatic pressure was able to induce a chondrogenic 
response of similar magnitude as that induced by chondrogenic media supplements [251] 
Thus, the initial increase in sox9 expression may represent the combined effects of 
rounded cell morphology, cyclic tensile strain, and hydrostatic pressure. 
 By day 22, however, sox9 expression in both EC+ and EC- constructs had 
returned to or fallen below day 0 levels. In addition, sox 9 levels in both EC+ and EC- 
constructs were lower than levels in EC- constructs at Day 0. This result is consistent 
with the work of Connelly et al. who found that increases in sulfated glycosaminoglycan 
production following 1 week of MSC exposure to cyclic tension and chondrogenic 
media were lost after 2 weeks of loading [249]. In contrast, levels of bone ECM protein 
osteocalcin were 1.6-fold  greater in Day 22 EC+ constructs relative to EC- constructs 
and relative to day 0. In addition, mid-term osteogenic markers AP and osteopontin were 
1.7-to-2 fold higher in EC+ constructs than in EC- constructs and Day 0 EC- constructs. 
Cumulatively, these results suggest that the applied cyclic stretch and associated 
hydrostatic pressure were not alone sufficient to induce osteogenesis. In agreement with 
these results, previous literature indicates that pure hydrostatic pressure loading inhibits 
MSC osteogenesis even in the presence of osteogenic media supplements [250]. In 
addition, although literature regarding the effects of cyclic stretch on MSC osteogenesis 
is mixed [43, 44, 252, 253], the present data are in agreement with those of Shi et 
al.[252] and Steinmetz et al. [253]. Specifically, Shi et al. found that continuous cyclic 
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mechanical stretch inhibited runx2 expression when MSCs were cultured in the presence 
of osteogenic supplements. Similarly, Steinmetz et al. found that an intermittent 15% 
cyclic strain inhibited osteogenesis even in the presence of osteoinductive media [253]. 
Given that osteocalcin, osteopontin, and AP were each elevated in EC+ 
constructs relative to EC- constructs, the current data imply either that EC paracrine 
signaling stimulates osteogenesis and/or that EC paracrine signaling alters the manner in 
which MSCs interpret the applied mechanical stimuli. Although EC presence has 
previously been linked to increased MSC osteogenesis, these osteogenic responses have 
generally occurred following direct EC-MSC contact and/or in the presence of 
osteogenic supplements [46, 47, 254]. For instance, Saleh et al. found that MSC 
osteogenic differentiation was significantly elevated in EC-MSC spheroid co-cultures 
relative to MSC spheroids not containing ECs when cultured under osteogenic 
conditions [46]. In addition, Kaigler et al. found that ECs significantly increased MSC 
osteogenic differentiation in vitro in the absence of osteogenic media supplements only 
when ECs and MSCs were cultured in direct contact [45]. In contrast, only paracrine 
signaling between ECs and MSCs was enabled by the current culture setup. Therefore, 
the exact mechanism of EC influence on the present MSC responses requires further 
investigation. That said, the observed transition from chondrogenic to osteogenic protein 
expression associated with the EC+ constructs would be consistent with the 
neovascularization-dependent transition from a cartilage matrix to an osteoid matrix 
associated with endochondral ossification [255].   
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Fig. 37.  Sox9 counts used to internally validate the counting approach by direct comparison with 
corresponding quantitative ELISA data. The degree of correlation between the two assessment techniques 
was 98.9% by Pearson’s correlation coefficient method. 
 
 
Several limitations of the present study merit comment. Osteogenesis represents 
a complex set of processes that are mediated by a number of factors. The interplay 
between these factors and the precise sequences leading to osteogenic commitment are 
not fully understood, and the present study examined only a limited subset of the 
interactions that mark osteogenesis. In addition, the present study examined mouse 
MSCs and thus, the current results may not be indicative of human MSC responses. 
Despite these limitations, the cumulative ECM and phenotypic data indicate EC 
paracrine signaling enhances MSC osteogenesis in the presence of cyclic stretch and 
hydrostatic pressure. Future studies explore a broader range of time points as well as 
varying mechanical stimulation regimens. 
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CHAPTER VIII 
CONCLUSIONS 
 
 
8.1.  Summary 
 
This work has shown that scaffold properties and paracrine EC-MSC interactions 
impact cell phenotype and cell differentiation. Specifically, PEG-GAG hydrogels have 
been shown to impact VFF and SMC behavior. Results indicate that subtle alterations in 
the biochemical stimuli presented to VFF cells (HAIMW versus HAHMW) altered VFF 
behavior. In particular, HAIMW increased VFF myofibroblastic phenotype, suggesting 
that, among the examined formulations, the HAHMW gels would be the most suitable 
system for VF regeneration. Moreover, the present results are in agreement with a 
previous 3D study of VFF responses to HAIMW relative to alginate in collagen-based 
scaffolds permissive of cell elongation, indicating that PEGDA hydrogels prove useful 
as VF regeneration scaffolds despite the fact that they impose non-native VFF 
morphologies.  In addition, PEG–HA gels may be the most appropriate for vocal fold 
SLP regeneration of the formulations examined, at least for the sulfated GAG types 
(CSC, HS and HA) and molecular weights investigated. Specifically, since collagen I, 
fibronectin, and SM-α-actin (myofibroblast marker) are generally elevated in scarred 
lamina propria these results suggest that CSC and HS may be undesirable for vocal fold 
implants relative to HA. Based on the results from these two vocal fold studies, future 
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work will explore a broader range of HA molecular weights on VFF function toward 
identifying suitable vocal fold regeneration scaffolds. 
In contrast to VFFs, cell shape is known to strongly impact SMC function. 
Indeed, SMCs take on rounded phenotypes as they transform into foam cells during 
early atherosclerosis. Thus, we exploited the fact that PEGDA hydrogel enforce rounded 
cell morphologies to examine SMC responses to biochemical stimuli in an 
atherosclerotic-mimetic environment. Results from the present study supported the 
hypothesis that specific GAG types have differential influences on SMC foam cell 
formation. Specifically, DS was associated with greater phagocytosis of apoB, sustained 
increases in A-FABP expression, and an increased synthetic phenotype as well as a 
decreased expression of contractile marker MHC. The present PEG-base model system 
can be expanded to probe the impact of a range of atherogenic stimuli on SMC 
phenotype, potentially leading to more effective treatments for atherosclerosis. 
In addition, EC paracrine signaling was demonstrated to induce MSC 
osteogenesis in the presence of cyclic stretch. Furthermore, we employed a novel class 
of hydrogels formed from the photocrosslink of PEG-DA and PDMSstar-MA to examine 
the influence of simultaneous increases in scaffold hydrophobicity and inorganic content 
on the osteogenic responses of encapsulated MSCs. Based on ECM and cell phenotypic 
data, elevated scaffold inorganic content and hydrophobicity were indeed correlated with 
increased osteogenic differentiation, indicating that PEG-PDMSstar hydrogels may be 
promising scaffolds for bone regeneration. Future studies will seek to elucidate the 
influence of PDMS chemistry versus nanotopography (form PEG-PDMS phase 
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separation) on MSC osteogenic differentiation. To further probe MSC osteogenesis, the 
impact of EC paracrine signaling on MSC osteogenic lineage progression was examined 
in the presence of physiological loading. Results indicated that EC paracrine signaling 
enhances MSC osteogenesis in the presence of cyclic stretch. Moreover, the observed 
temporal transition from chondrogenic to osteogenic protein expression associated with 
the EC+ constructs would be consistent with the neovascularization-dependent transition 
from cartilage matrix to osteoid matrix associated with endochondral bone formation. A 
potential limitation of this study is that the EC layers were formed using a novel method 
for fabricating mechanically stable EC layers in bi-layered TEVGs through the use of 
PEGDA as an intercellular ‘‘cementing’’ agent rather than as an encapsulating agent. 
These ECs, although exposed to luminal stresses associated with fluid flow, did not 
appear to respond to these mechanical signals in terms of increases in various EC 
markers. Since the ECs within these layers do not directly contact each other, it is 
possible that the lack of direct cell-cell communication limited normal responses to 
mechanical stress. Thus, future work will examine MSC osteogenesis in the presence of 
EC paracrine signaling both in the presence and absence of cyclic stretch so that the 
contribution of mechanical conditioning to observed cell responses can be understood.  
In addition, alternate strategies for forming stable EC layers will be explored. 
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8.2. Recommendations 
 
PEGDA hydrogels have been shown to be a useful tool in the study of the impact 
of biochemical stimuli and EC paracrine signaling on cell behavior. The blank slate 
nature of PEGDA hydrogels as well as the ability to tightly control of their material 
properties opens the possibility to design more efficient scaffolds for tissue engineering 
applications. For instance, in this work the PEGDA blank slate was modified by the 
incorporation of hydrophobic, inorganic PDMSstar. This modification was demonstrated 
to be promising for inducing mouse MSC osteogenic differentiation and may potentially 
be applicable for human MSC osteogenic differentiation.    
Although, PEGDA-based hydrogels have benefits as scaffolds for tissue 
engineering, the tight cross-link density and slow degradation rate of PEGDA gels 
provide some limitations that need to be addressed. For example, despite the presence of 
the cell adhesion ligand RGDS in the PEGDA hydrogels VFF take rounded/stellate 
morphologies, which are non-native for a number of cell types. In addition, direct 
intercellular contact is limited in PEGDA hydrogels. Thus, this scaffold system may not 
be appropriate for instances where the formation of intercellular junctions are critical to 
function. For instance, EC response to shear stress may be limited if direct EC-EC 
contact is limited. Furthermore, the microstructure of native ECM cannot be replicated 
in PEGDA hydrogels because deposited ECM is localized around individual cells due to 
tight crosslink density of PEGDA gels.  
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Several of these limitations could be addressed with the use of a degradable PEG 
based hydrogels which will allow the cells to have more freedom inside the hydrogel 
network. Modulation of PEG based hydrogels degradation rate can be achieved through 
the conjugation of degradable domains to PEG chains. For instance, the conjugation of 
polycaprolactone, polylactic acid or glycolide to PEG modulates the number of available 
ester hydrolysis sites which increase degradation rate. An alternative route involves the 
inclusion of enzymatically degradable peptides in which degradation rate is regulated by 
cell native enzyme release. 
In addition, the role of the proteoglycan core protein in modulating SMC responses 
to CSC or DS signals was not accounted for. In addition, GAG chain length and charge 
densities are determining factors in the levels of bound lipid per chain. Although we 
have attempted to mimic the GAG chain lengths associated with atherosclerotic vessels 
in the present work, the CSC and DS chains conjugated to the hydrogel networks may 
not have charge densities appropriate to the atherogenic environment.  Future work will 
probe a broader range of GAG charge densities and molecular weights on SMC foam 
cell formation. 
Moreover, the potential influence of the nanotopography introduced by the PDMS 
nanoparticles on observed cell responses requires further examination. In addition, the 
sample number per formulation and the range of PDMS levels examined were limited. 
More extensive in vitro studies followed by in vivo work would be required to definitely 
demonstrate that increased PDMS incorporation intrinsically promotes osteogenesis. 
Future studies will probe the impact of a broader range of PDMSstar levels and will 
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investigate the primary mechanisms through which they alter MSC behavior. In addition, 
various solvents will be employed to modulate the presence of PDMS nanoparticles 
within the hydrogel matrix, so that the impact of scaffold hydrophobicity and inorganic 
content can be more clearly parsed from the influence of nanotopography.  
Furthermore, the cumulative ECM and phenotypic data indicate that EC paracrine 
signaling enhances MSC osteogenesis in the presence of cyclic stretch and hydrostatic 
pressure. However, osteogenesis represents a complex set of processes that are mediated 
by a number of physiological factors. The interplay between these factors and the precise 
sequences leading to osteogenic commitment are not fully understood, and the present 
study examined only a limited subset of the interactions that mark osteogenesis. In 
addition, the present study examined mouse MSCs and thus, the current results may not 
be indicative of human MSC responses. Future studies will explore a broader range of 
time points as well as varying mechanical stimulation regimens. 
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